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1. Introduction 
1.1 Précis: Heart Failure in a low-income multiethnic population. 
 Heart failure (HF) is a major public health problem, particularly in the southeastern United States 
(US), which has been described as the “heart failure belt”.  However, most data informing the current 
understanding of the risk factors for, incidence of, and survival from HF were derived from cohorts 
outside of the southeast and primarily comprised of white individuals or multi-ethnic populations with 
high proportions of middle-class participants.  Consequently, there are limited data regarding HF among 
individuals in the region of US with the highest prevalence of HF and those with limited resources; and 
potential differences in the patterns of HF incidence and post-HF survival by race and sex in low-income 
multiethnic populations are not well characterized. 
 In addition, while there is increased recognition that individual socioeconomic factors contribute 
significantly to HF risk among middle-class persons in the US, recent evidence also suggests that 
neighborhood factors may in fact predict HF readmissions independently of individual-level factors in 
middle-class populations. However it remains uncertain whether such neighborhood factors are 
independent predictors of HF incidence and post-HF survival particularly in low-income populations.   
 Finally, in contrast to international trends, the existing data from US counties suggest that 
poverty-dense counties have high levels of obesity which are paralleled by high prevalence of cardio-
metabolic conditions including cardiovascular disease (CVD) and HF. Thus, it is important to critically 
examine the link between obesity and HF particularly among populations with scant resources. Prior 
epidemiologic evidence is suggestive of an independent association between excess body weight and 
increased risk of HF; as well as a contrasting decrease in the risk of post-HF mortality – a phenomenon 
coined as the obesity paradox. However, most studies investigating these relationships utilized categories 
of body mass index (BMI) or assumed linearity of effects thereby limiting the elucidation of the natural 
dose-response relationship between measures of obesity and HF risk as well as post-HF survival.  
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 More importantly, less thought has been given to the suitability of BMI – weight (W)/height (H)2 
– in investigating the link between obesity and both HF risk and post-HF survival despite differences in 
the performance of various weight-height indices across population groups defined by race and sex. 
Additionally, predictors with “pleiotropic” effects usually have differential functional relationships with 
varying outcomes suggesting the need to use the data to empirically derive an appropriate weight-height 
index for each outcome. Such approaches may be utilized to adequately model the intricacies in these data 
and reveal novel insights that may improve our understanding of anthropometry and general obesity in 
relation to HF risk and post-HF survival.  
 We propose to leverage the Southern Community Cohort Study (SCCS) which comprises a large 
number of black and white participants, predominantly low-income, living in a region with the highest 
rates of CVD to investigate disparities in HF incidence and mortality by race and sex as well as 
differential effects of anthropometric and neighborhood socio-economic factors.  
 Our specific aims are to investigate: 
 1. Differences in the incidence of HF as well as post-HF survival between groups defined by race 
and sex: white women, black women, white men and black men. 
 2. Whether neighborhood characteristics (defined by a composite deprivation index) predict the 
risk of a) incident HF and b) post-HF survival in the SCCS beyond individual-level socioeconomic status 
(defined by household income and highest level of education attained). 
 3a. The appropriate functional form of a data-derived weight-height index (W/Hn) for the 
association with a) incident HF and b) post-HF survival, and compare its performance in the prediction of 
either outcome with that of BMI based on model fit and “informativeness”. 
 3b. The dose-response relationship between W/Hn (as a surrogate measure of total body fat) and 
both incident HF and post-HF survival by race. We would specifically investigate departures from 
linearity and additivity of effects. 
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 3c. The dose-response relationship between waist circumference (as a surrogate measure of 
visceral fat) and the risk of incident HF by race and sex and contrast these findings with those obtained 
using W/Hn.  
 Heart failure events will be ascertained via linkage of the SCCS cohort with the Centers for 
Medicare and Medicaid Services (CMS) Research Identifiable Files.  For the proposed analyses, we 
would include SCCS participants ≥ 65years at cohort enrollment or participants < 65 years who: a) 
reported CMS coverage at baseline; or b) did not report Medicare or Medicaid on the baseline 
questionnaire but had a CMS claim within 90 days of being enrolled in SCCS. The restriction to these 
groups would maximize the likelihood of participants having continuous coverage in Medicare and/or 
Medicaid from the time of SCCS enrollment to the end of the follow-up period (December 31st, 2010), for 
the ascertainment of incident HF events.   
 Incident HF will be defined as the first occurrence of a medical claim with ICD-9 code 428.x 
within the Medicare institutional (Medicare Provider Analysis and Review, MEDPAR), Part B carrier, or 
outpatient-based claims files or the Medicaid Analytic Extract (MAX) Inpatient and Other Services 
claims files, from the date of SCCS enrollment through December 31st, 2010. All-cause mortality 
following a HF diagnosis will be ascertained via linkage of the SCCS cohort with both the Social Security 
Administration (SSA) vital status service for epidemiologic researchers and the National Death Index 
(NDI) through December 31st, 2010. 
 The relevance of the proposed study can be articulated across several axes: 
 a) It is essential to quantify the burden (incidence and mortality) of HF and any potential 
differential patterns of HF risk and post-HF survival – by race and sex – in a low-income population with 
high proportions of African-Americans and women living in a part of the country which is at particularly 
high risk for CVD. While the current understanding (based on data from cohorts enrolling mostly middle-
class participants) suggests higher HF risk among African-Americans (and men), it would be interesting 
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to see if the patterns persist in a setting with more comparable socioeconomic status between racial 
groups.   
 b) In addition to estimating the scope of the HF epidemic in low-income populations in the “HF 
belt”, it is equally important to provide valuable information on the relative contributions of individual 
and neighborhood socioeconomic factors that likely influence CVD outcomes – HF risk and mortality in 
particular – in this population. There are data suggesting greater rates of HF hospitalizations in 
neighborhoods with less resources. Is this trend similar for other HF outcomes like incidence and 
mortality? The AHA, the Canadian Heart Health plan and other cardiovascular societies recognize that 
improvements in heart health would require strategies that target the entire spectrum of the healthcare 
system:  public policy, prevention, acute care, chronic care and rehabilitation, and end-of-life planning 
and care. However, the more “upstream measures” which focus on public policy and prevention may have 
the greatest potential to mitigate the burden of CVD and improve human health. Areas with the most 
acute socioeconomic deprivation are most likely at the highest risk for CVD (including HF) and CVD 
mortality and hence may benefit most from such improvements in public health policies including (but 
not limited to): improvements in community-level resources (healthy food outlets, physical activity 
resources, smoking cessation programs etc.).  
 c) One of the major contributors to the elevated burden of HF in areas with limited resources may 
be the concomitant increase in the levels of obesity in these settings. Thus, it is important to critically 
examine the link between adiposity and HF risk (and mortality). With most cohorts relying on surrogate 
measures of adiposity collected in routine clinical practice, robust approaches are needed to adequately 
model these data and reveal novel insights that would potentially refine the strategies used to risk-stratify 
persons in clinical and/or public health settings. Our proposed analysis accomplishes the following: It 
utilizes the data to empirically derive an appropriate weight-index to investigate the flexible dose 
response between HF risk (and post-HF survival) and a surrogate marker of total adiposity without 
making assumptions related to a) using BMI as the “de facto index of choice” regardless of the 
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demographic make-up of the population under study; b) using pre-specified cut-points that may be ill-
suited to the study sample c) linearity and/or additivity of effects across sex and racial groups. Most 
cardiovascular societies (including the AHA and the ACCF) as well as the WHO make recommendations 
about specific cut-points for BMI as targets to be utilized in routine clinical practice, risk-stratification, 
preventive care and public health programs in order to mitigate CVD and HF risk. These 
recommendations regarding specific BMI cut-points implicitly assume a discontinuity in the dose-
response association between BMI and HF (or CVD) risk or the existence of definite inflexion points in a 
continuum of risk. If the dose-response relationship between the weight-height index (as a surrogate 
measures of total adiposity) and HF risk (as well as post-HF mortality) is continuous and non-linear (and 
is modified by race and sex), that would suggest that the use of cut-points for decision making is 
seemingly counter-intuitive. An alternative decision-making paradigm would be to develop a prediction 
model for HF risk (and HF mortality) using the relevant anthropometric, lifestyle, clinical and 
demographic factors in this population; and using the estimates of predicted risk for individuals and cost-
effectiveness ratios of efficacious interventions to make decisions in clinical or public heath settings. In 
such models, for example the HF risk calculator developed by the Meta-Analysis Global Group in 
Chronic Heart Failure (MAGGIC), it would be interesting to explore differences in model fit (as well as 
discriminant  and calibration properties) when using the established anthropometric surrogates or 
composite weight-height indices derived for specific race-sex groups. 
 d) The results of the proposed analyses could provide preliminary data for additional studies of 
the association between data-derived weight-height indices – as proxies for total body fat – and measures 
of subclinical CVD like cardiac troponin T as well as N-Terminal pro Brain Natriuretic Peptide (NT-
proBNP). The relationship between anthropometric measures and cardiac troponin T is particularly 
apropos as the latter is thought to be one of the potential links between increased adiposity and incident 
HF. Cross-sectional data from the ARIC cohort suggest that there is a positive association between BMI 
and high cardiac troponin T (using a cut-point of 14ng/l) measured with a new high-sensitivity assay (hs-
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cTnT). In future studies it would be interesting to leverage the SCCS cohort and flexible modeling 
approaches accounting for potential nonlinearity of effects and interactions with race and/or sex to 
investigate the prospective association between proxy-indicators of total and visceral adiposity and hs-
cTnT amongst persons free of CVD at baseline. An improved understanding of the association between 
weight-height indices (used in routine clinical practice and public health) and subclinical CVD could 
potentially improve risk stratification and prediction.  
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1.2 Specific Aims 
 There are over 26 million persons living with heart failure (HF) worldwide.[1]  In the US, over 
5.7 million adults (≈ 2.5% of the US adult population) are estimated to have HF.[2]  About half of persons 
diagnosed with HF die within 5 years and the estimated total costs of HF in the US exceeded $30 billion 
in 2012.[3],[4]    
 Several established cardiovascular disease (CVD) cohorts have investigated HF incidence and 
mortality, including the Framingham Heart Study (FHS), Cardiovascular Health Study (CHS), Multi-
ethnic Study of Atherosclerosis (MESA) and Atherosclerosis Risk in Communities (ARIC).[5-8] The 
FHS included predominantly white individuals.  Other cohorts, including CHS, MESA, and ARIC, 
enrolled multi-ethnic middle-class populations from select communities and their relatively small sample 
sizes limited assessment of differential risk patterns between demographic groups defined by both race 
and sex. 
 Whilst the data from these previous cohorts are suggestive of differences in incidence rates of HF 
as well as post-HF mortality between population subgroups, knowledge gaps persist regarding the 
magnitude and direction of these differences in multi-ethnic low income populations (comprising larger 
numbers of blacks and women) with high burden of CVD risk factors. 
 Also, while there is evidence suggesting that individual socioeconomic status (SES) contributes 
to HF risk among middle-class persons in the US [9, 10], recent data also suggests that neighborhood 
factors may in fact predict HF readmissions independently of individual-level SES in middle-class 
populations [11]. However, it is not known whether such neighborhood factors are independent predictors 
of other HF outcomes like HF incidence and post-HF mortality particularly in low-income populations. It 
would be of interest to investigate whether among persons with very limited resources, a dearth of 
community-level resources i.e. neighborhood deprivation, compounds the risk of HF and post-HF 
mortality above and beyond what is contributed by scant resources and reduced literacy at the individual-
level. 
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 Data from varying communities across the US suggest that poverty-dense counties have high 
levels of obesity which are paralleled by high prevalence of chronic conditions including CVD and heart 
failure [12]. It is ever so important to critically examine the link between adiposity and HF risk (and 
survival following a diagnosis of HF) particularly among populations with scant resources. Most cohorts 
investigating the obesity-HF link have relied on body mass index – weight (W)/height (H)2 – as a proxy 
for total body fat and increased body mass index has been found to be positively correlated with HF 
incidence and survival [13-15] but there is little data on potential effect modification by race. Less 
thought has been given to the suitability of W/H2 in investigating the obesity-HF link despite differences 
in the performance of various weight-height indices across population groups defined by race and sex [16, 
17]. Additionally, predictors with “pleiotropic” effects usually have differential functional relationships 
with varying outcomes suggesting the need to use the data to derive the appropriate weight-height index 
for each outcome. Hypothetically, for any weight-height index given by the general form W/Hn, 
regressing the log-hazard of HF on the natural logs of both weight and height, would yield n as the 
absolute value of the ratio of the coefficients of log height and log weight; this could be used to generate a 
W-H index suitable for a given setting. Also, any potential departures from additivity of effects by race 
and sex could be investigated using interaction terms with the appropriate weight-height index. Such 
robust approaches are needed to adequately model these data and reveal novel insights that would 
potentially refine the strategies used to risk-stratify persons in clinical and/or public health settings. 
 We therefore propose to use data from the Southern Community Cohort Study (SCCS) to 
investigate disparities in the risk of incident HF (and post-HF survival) between sex and racial groups and 
the contribution of neighborhood socioeconomic factors and anthropometric measures to HF risk and 
mortality. The SCCS is a large, prospective cohort study that enrolled approximately 86,000 adults (over 
two-thirds black) aged 40 and 79 living in the southeastern region of the US between 2002 and 2009 [18]. 
Data on personal medical history, demographic, socioeconomic, neighborhood factors, lifestyle, and 
anthropometric characteristics were ascertained at cohort enrollment. 
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 Our specific aims are to investigate: 
 1. Differences in the incidence of HF as well as post-HF survival between groups defined by race 
and sex: white women, black women, white men and black men. 
 2. Whether neighborhood characteristics (defined by a composite deprivation index) predict the 
risk of a) incident HF and b) post-HF survival in the SCCS beyond individual-level socioeconomic status 
(defined by household income and highest level of education attained). 
 3a. The appropriate functional form of a data-derived weight-height index (W/Hn) for the 
association with a) incident HF and b) post-HF survival, and compare its performance in the prediction of 
either outcome with that of BMI based on model fit and “informativeness”. 
 3b. The dose-response relationship between W/Hn (as a surrogate measure of total body fat) and 
both incident HF and post-HF survival by race. We would specifically investigate departures from 
linearity and additivity of effects. 
 3c. The dose-response relationship between waist circumference (as a surrogate measure of 
visceral fat) and the risk of incident HF by race and sex and contrast these findings with those obtained 
using W/Hn. 
 Heart failure events would be ascertained via linkage of the SCCS cohort with Centers for 
Medicare and Medicaid Services (CMS) Research Identifiable Files. SCCS participants (n = 27,078) who 
meet the following inclusion criteria would be included in our analyses:  
 ≥ 65years (n = 7001) at cohort enrollment 
 < 65 years (n = 20,077) at enrollment and either:  
i. reported being covered by Medicaid on the baseline questionnaire;  
ii. reported being covered by Medicare on the baseline questionnaire;  
iii. did not report Medicare or Medicaid on the baseline questionnaire but had a CMS claim 
within 90 days of being enrolled in SCCS.  
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 The restriction to these groups maximizes the likelihood of participants having continuous 
coverage in Medicare and/or Medicaid from the time of SCCS enrollment to the end of the follow-up 
period (December 31st, 2010), for the ascertainment of incident HF events.   
 Incident HF will be defined as the first occurrence of a medical claim with ICD-9 code 428.x 
within the Medicare institutional (Medicare Provider Analysis and Review, MEDPAR), Part B carrier, or 
outpatient-based claims files or the Medicaid Analytic Extract (MAX) Inpatient and Other Services 
claims files, from the date of SCCS enrollment through December 31st, 2010. Death from any cause will 
be ascertained via linkage of the SCCS cohort with both the Social Security Administration (SSA) vital 
status service for epidemiologic researchers and the National Death Index (NDI) through December 31, 
2010. 
 For aim 1, we will investigate differential patterns of HF incidence and post-HF survival by race 
and sex (and contrast the findings with those from previous CVD cohorts investigating HF risk and 
survival) using nonparametric methods and multivariable Cox Models. To obtain HF incidence rates, 
duration of follow-up would be computed from date of entry into the SCCS until the date of the first 
diagnosis of HF, date of death, or December 31, 2010, whichever occurred first. Incidence rates (IR) of 
heart failure would be calculated for white women, black women, white men and black men by dividing 
the number of HF cases by person-time of follow-up, and the rates would be presented per 1,000 person-
years. For analyses of post-HF survival among those with a diagnosis of incident HF, follow-up time will 
be defined as time from HF diagnosis to death or December 31st 2010 whichever occurred first. Kaplan-
Meier survival curves would be plotted by race and sex and the Wald tests in Cox models would be used 
to test for differences in survival between the four groups. In the multivariable models for both outcomes 
(HF incidence and post-HF survival), we would include indicator variables for white men, black women 
and black men, with white women as the reference group. The covariates would include: BMI, history of 
diabetes, hypertension, high cholesterol, MI/CABG or stroke, household income, education, smoking, 
alcohol intake, marital status and enrollment source (community health centers vs general population).  
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 For aim 2, the data will be considered to have a hierarchical structure with study participants 
(level-1units) nested within census tracks (level-2 units). The social and economic characteristics of the 
latter will used to compute neighborhood deprivation index for all SCCS participants. We will test for the 
effects of neighborhood deprivation index (the level-2 predictor) on the risk of incident HF after 
adjustment for individual-level factors including SES (annual household income and education); 
demographics (age, sex and race); lifestyle (smoking and alcohol use) and clinical factors (BMI and 
history of diabetes, hypertension, high cholesterol, MI/CABG or stroke). Given the correlation of the data 
points within each census track, and the limitations of a multilevel modelling approach in this setting 
(related to unbalanced data between clusters with the potential of biasing group-level variances and fixed 
effects) our primary approach for aim 2 will be a Cox proportional hazards model that takes into account 
non-independence using the Huber-White cluster Sandwich estimator of variance. 
 For aim 3, we would first derive the appropriate weight-height index for the current cohort based 
on the coefficient of the log weight and log height variables in a bivariate Cox model for the log hazard of 
HF. Second, in separate Cox models, we would regress the restricted cubic splines of the natural log of 
the data-derived weight-height index and that of BMI on the log hazard of HF. Then, model fit statistics 
(LR chi square, χ² and AIC) would be used to compare the performance of the data-derived weight-index 
versus that of BMI in relation to a model utilizing restricted cubic splines of log weight and log height.  
Third, we would use multivariable Cox models which take into account nonlinearity and non-additivity to 
model a flexible dose-response association between the better performing weight-height index (W/Hn) 
(modelled using restricted cubic splines with 5 evenly spaced knots) and HF risk adjusting for relevant 
covariates namely: demographics (age, race, sex); lifestyle factors (smoking and alcohol use); 
socioeconomic status (household income and education), clinical history (history of diabetes, 
hypertension, high cholesterol, MI/CABG or stroke) and total physical activity. Interactions between 
W/Hn and race as well as sex would be tested. These analyses would be repeated for the association 
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between (W/Hn) and post-HF survival. Similar multivariable models will be utilized to investigate the 
relationship between waist circumference and HF.  
 The SCCS cohort comprises a large number of low-income participants (over 52% with annual 
household income < $15,000), a high proportion of blacks (two-thirds) and women (60%), and overall 
represents a segment of the US population that has a high burden of CVD risk factors. In addition, data 
from previous SCCS studies suggests that there is a high prevalence of obesity (defined as body mass 
index >30 kg/m2); the prevalence of hypertension is > 50% overall [19] and the prevalence of diabetes is 
over 21% [20] (compared to a national average of 11% [21]). These characteristics of the SCCS 
participants make it a unique cohort for the examination of the inter-relationship between anthropometric, 
demographic and socioeconomic (individual and neighborhood) factors in the etiology of HF and post-HF 
mortality in a region of the country with the highest rates of CVD.   
 The results of the proposed study will a) quantify the burden of HF (incidence and mortality) in a 
low-income population that has been under-represented in previous cardiovascular cohorts b) improve the 
understanding of the dose-response relationship between weight-height indices (as surrogates of total 
adiposity) and HF risk and the potential differential influences of race and sex in these relationships c) 
provide information on the independent contrasting and/or synergistic relationships between individual-
level and neighborhood-level effects which may inform individual and community-level interventions 
aimed at reducing the burden of the HF epidemic.  
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2. Literature Review and Rationale for Specific Aims 
2.1 Background for Specific Aim 1 
2.1.1 Heart Failure – definition, etiology and classification. 
 Heart Failure (HF) is a complex clinical syndrome resulting from the inability of the heart to 
provide sufficient blood flow at normal filling pressures to meet the metabolic demands of the body [22]. 
The cardinal manifestations of HF are dyspnea and fatigue and fluid retention, which may lead to 
pulmonary and/or splanchnic congestion and/or peripheral edema [22].  
 Heart failure usually results from a variety of conditions affecting the myocardium, heart valves, 
pericardium, or electrical conduction system, and may be due to hypertension, coronary artery disease, 
toxins, inflammatory/infectious diseases, genetic or metabolic disorders.  Most patients with HF have 
some form of cardiomyopathy and impaired left ventricular (LV) function; and the latter is usually 
responsible for the symptoms they present. Heart Failure is often associated with a variety of LV 
functional abnormalities, ranging from normal LV size and preserved ejection fraction (EF) to severe 
dilatation and/or markedly reduced EF [22]. However, regardless of EF, varying degrees of diastolic and 
systolic dysfunction co-occur in most persons with HF. Ejection fraction is important for classifying 
patients – as having heart failure with reduced ejection fraction or HF with preserved ejection fraction – 
because of differences in patient prognosis, therapeutic response, comorbidities and demographics [23]. 
 Different cut-points for EF have been proposed for defining Heart Failure with reduced ejection 
fraction (HFrEF) including ≤35% and ≤40% [24, 25]; the ACCF/AHA guidelines recommends using 
≤40%. Coronary artery disease (CAD) with antecedent myocardial infarction remains the main etiology 
for HFrEF which occurs in conjunction with varying degrees of LV enlargement [26, 27]. 
 There are several criteria that have been proposed to define HF with preserved EF (HFpEF).  
These include: i) clinical signs or symptoms of HF; ii) evidence of preserved or normal LVEF; and iii) 
evidence of abnormal LV diastolic dysfunction that can be determined by Doppler echocardiography or 
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cardiac catheterization [28]. Just as for HFrEF, different investigators have proposed variable EF cut-
points for defining HFpEF ranging from >40% to ≥55% [29].  There appears to be a trend towards 
increasing proportions of persons with of HFpEF [30] which is paralleled by the increasing prevalence of 
some of its major causal factors including diabetes and obesity. Other factors incriminated in the 
occurrence of HFpEF include dyslipidemia, CAD and atrial fibrillation but hypertension remains the 
principal etiology of HFpEF at the population level [31, 32]. 
 The ACCF/AHA and the NYHA classifications have been used to stratify persons with heart 
failure with respect to HF stage and functional classification respectively [33, 34].  
Table 1: Comparison of ACCF/AHA Stages of HF and NYHA Functional Classifications 
ACCF/AHA Stages of HF [34]  NYHA Functional Classification [33] 
A At high risk for HF but without 
structural heart disease or 
symptoms of HF 
None  
B Structural heart disease but without 
signs or symptoms of HF 
I No limitation of physical activity. Ordinary physical 
activity does not cause symptoms of HF. 
C 
 
Structural heart disease with prior 
or current symptoms of HF 
 
I No limitation of physical activity. Ordinary physical 
activity does not cause symptoms of HF. 
II Slight limitation of physical activity.  
III Marked limitation of physical activity. Comfortable 
at rest, but less than ordinary activity causes 
symptoms of HF. 
IV Unable to carry on any physical activity without 
symptoms of HF, or symptoms of HF at rest. 
D Refractory HF requiring specialized 
interventions 
IV Unable to carry on any physical activity without 
symptoms of HF, or symptoms of HF at rest. 
ACCF: American College of Cardiology Foundation; AHA: American Heart Association. 
NYHA: New York Heart Association. 
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2.1.2 The Burden and risk factors of Heart Failure in the United States. 
 2.1.2.1 Prevalence, costs and risk factors 
 It is difficult to overestimate the impact of heart failure (HF) in the US; experts have long 
recognized it as an important cause of morbidity and mortality and its prevalence continues to rise [35-
37].  With the aging of the US population and increasing prevalence of major risk factors for HF 
(especially diabetes), it has become a serious health concern particularly for elderly Americans [38-41]. 
Currently, over 5.5 million Americans (2.5%) are estimated to have heart failure [42]. In 2007, the 
estimated direct and indirect costs of heart failure in the U.S. were in excess of $33.2 billion [42].  
 Previous studies have suggested that the main risk factors for heart failure include older age, high 
blood pressure, diabetes, coronary artery disease, valvular heart disease, and atrial fibrillation [6, 43-49]. 
In addition, other investigators found evidence suggesting that race, body mass index and socioeconomic 
status also contribute to disparities in heart failure risk in US adults. Using data from the Multi-Ethnic 
Study of Atherosclerosis, Bahrami et al found that African-Americans had the highest incidence rate of 
HF, followed by Hispanic, white, and Chinese-American participants. Although the risk of developing HF 
was higher among black compared with white participants (HR, 1.8; 95% CI, 1.1-3.1) in the more 
parsimonious models, adding hypertension or diabetes mellitus to the models attenuated racial/ethnic 
differences in the risk of incident HF[6]. 
 2.1.2.2 Heart Failure Incidence and Mortality  
 Several established cardiovascular disease (CVD) cohorts have investigated HF incidence and 
mortality – the Framingham Heart study, Cardiovascular Health Study (CHS), Multi-Ethnic Study of 
Atherosclerosis (MESA) and Atherosclerosis Risk In Communities (ARIC) among others (Tables 2, 3 
and 4). 
 The earlier cohorts – particularly Framingham – included mostly white participants. Other 
cohorts like CHS enrolled elderly participants and a small proportion of African-Americans. Subsequent 
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cohorts like MESA and ARIC enrolled multi-ethnic middle-class populations from restricted communities 
and had relatively small sample sizes to adequately explore differential risk patterns between 
demographic groups defined by both race and sex. 
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Table 2: Incidence rates for HF in other CVD cohorts. 
ARIC [8] CHS [5]  
Age Group  Incidence rate per 1000 PY* Age Group 5yr Incidence rate per 1000 PY 10yr Incidence rate per 1000 PY 
Overall 5.7 Overall - - 
White Men 6.0 White Men 25.3 29.7 
  45-49 2.4   65-69 14.8 18.7 
  50-54 5.6   70-74 20.1 23.9 
  55-59 8.4   75-79 33.3 41.4 
  60-64 14.3    
White Women 3.4 White Women 13.6 17.8 
  45-49 1.7   65-69 7.1 10.7 
  50-54 3.1   70-74 11.8 15.7 
  55-59 4.4   75-79 19.3 26.6 
  60-64 7.7    
Black Men 9.1 Black Men 22.1 25.5 
  45-49 5.2   65-69 13.6 18.4 
  50-54 7.2   70-74 17.3 20.8 
  55-59 14.0   75-79 28.2 34.6 
  60-64 13.4    
Black Women 8.1 Black Women 19.5 22.1 
  45-49 3.8   65-69 13.4 13.4 
  50-54 7.6   70-74 20.1 22.7 
  55-59 10.1   75-79 20.1 30.0 
  60-64 17.4    
MESA: Overall incidence = 3.1/1000 person-years [50]. Framingham: Overall in persons ≥45 years, age-standardized incidence rate in men = 7.2/1000 
P-Y; in women = 4.2/1000 P-Y. Trend of increasing IR with age from 3/1000 in 50-59 to 27/1000 P-Y amongst 80-89yr males and from 2/1000 in 50-59 to 
22/1000 amongst 80-89yr females [7]. 
*PY: person-years. 
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Table 3: Post-HF mortality in CHS and ARIC. 
Mortality rates among persons with HF in the Cardiovascular Health Study [51]. 
 Person-Years 
At risk 
Number of Deaths All-cause Mortality rate per 
100 P-Y (95% CI) 
Overall 2690 1020 37.9 (35.8-40.0) 
Women 1399 492 35.2 (32.5-37.9) 
Men 1291 528 40.9 (37.7-44.1) 
Caucasians 2340 889 38.0 (35.7-40.2) 
African-Americans 350 131 37.5 (31.9-43.1) 
Caucasian Women 1173 416 35.5 (32.5-38.5) 
African-American 
Women 
226 76 33.6 (27.2-40.0) 
African-American Men 124 55 44.4 (33.7-55.1) 
Caucasian Men 1168 473 40.5 (37.1-43.9) 
Case Fatality rates among hospitalized HF patients in the ARIC study [8]. 
 Persons at risk Age-adjusted 1yr Case 
fatality (95% CI) 
Age-adjusted 5yr Case 
fatality (95% CI) 
Overall 1198 22.0 42.3 
Caucasian Men 495 19.6 (16.2-23.5) 41.2 (36.9-45.6) 
African-American Men 164 23.9 (17.8-31.2) 51.8 (44.1-59.4) 
Caucasian Women 301 20.8 (16.6-25.8) 35.8 (30.6-41.4) 
African-American 
Women 
238 23.5 (18.5-29.4) 46.1 (39.8-52.5) 
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 While these studies suggest differences in incidence rates of HF as well as post-HF all-cause 
mortality between population subgroups, the studies were limited by small numbers and a few knowledge 
gaps persist regarding the magnitude and direction of these differences in low income populations (with 
larger numbers of African-Americans and women) (and better adjustment for SES by design) with high 
burden of CVD risk factors. 
 More importantly it remains uncertain whether these racial and sex differences persist across the 
age spectrum and whether there are differential risk factor associations with HF across categories defined 
by these demographic variables. The Southern Community Cohort Study (SCCS) could be a valuable tool 
to investigate these hypotheses.  
 We therefore propose to use data from the SCCS to investigate differences in the cumulative 
incidence and incidence rates of heart failure as well as differences in post-HF survival/mortality between 
groups defined by sex and race in univariate and multivariable models. The SCCS is a large, prospective 
cohort study that enrolled approximately 86,000 adults (over two-thirds black) aged 40 to 79 living in the 
southeastern US between 2002 and 2009 [18]. Data on personal medical history, demographic, 
socioeconomic, neighborhood factors, lifestyle, and anthropometric characteristics were ascertained at 
cohort enrolment. 
 Our findings could provide valuable information for risk stratification and prediction in 
populations with an enormous CVD risk burden. This data could also provide the preliminary data for 
investigating metabolic correlates of HF and particularly biomarkers (including hs-cTnT) for subclinical 
CVD. 
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2.2 Background and rationale for Specific aim 2 
2.2.1 The relationship between demographic, socioeconomic and neighborhood 
factors in the prediction of HF risk in low-income communities.  
 Current evidence suggests that the highest rates of heart failure have been reported for inhabitants 
of the southeastern United States. This may in part be related to a higher prevalence of established risk 
factors (including CVD, obesity, diabetes and high blood pressure) in the southeast [52] which, in turn, 
could be attributed in part to socioeconomic characteristics (including education and income) that 
influence health outcomes. Data from ARIC and CHS suggests that individual socioeconomic status 
(SES) contributes to HF risk among middle-class persons in the US [9, 10]; recent data also suggests that 
neighborhood factors may in fact predict HF readmissions independently of individual-level SES in 
middle-class populations [11]. However, it is not known whether such neighborhood factors are 
independent predictors of other HF outcomes like HF incidence and post-HF mortality particularly in 
low-income populations. It would be of interest to investigate whether among persons with very limited 
resources, a dearth of community-level resources i.e. neighborhood deprivation, compounds the risk of 
HF and post-HF mortality above and beyond what is contributed by scant resources and reduced literacy 
at the individual-level. Additionally the potential “moderating” effects of race in the form of cross-level 
interactions could be relevant as well.     
 The potential relationships between demographic, anthropometric, individual and neighborhood 
socioeconomic factors are depicted in figure 2. 
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Figure 1: Causal Model showing the relationship between community-level factors, individual-level 
predictors, causal intermediaries and heart failure. We hypothesize that neighborhoods with high proportions 
of persons without a high school diploma are likely to be those with the lowest density of physical activity 
resources and healthy food outlets. This, in concert with individual level factors (gender, race, income, 
employment, education etc) may influence an individual’s obesity status. Increased adiposity is expected to 
increase the likelihood of Ischemic and non-Ischemic heart failure by increasing the risk of causal intermediaries 
namely diabetes, hypertension and dyslipidemia. In our study, the community-level factors are summarized in the 
neighborhood deprivation index. We hypothesize that the neighborhood effects may vary for persons of different 
race and gender, just as the nefarious effects of increased BMI could be mitigated by favorable neighborhood 
characteristics - “cross-level interactions” 
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 We therefore propose to use data from the Southern Community Cohort Study (SCCS) to 
investigate whether neighborhood characteristics (defined by a composite deprivation index) predict the 
risk of incident heart failure beyond individual-level socioeconomic status (defined by household income 
and highest level of education attained).   
 For these analyses, study participants (level-1units) are nested within census tracts (level-2 units) 
and the socio-economic characteristics of the latter were used to compute neighborhood deprivation. We 
will test for the effects of neighborhood deprivation index (the level-2 predictor) on the risk of incident 
HF after adjustment for individual-level factors including SES (annual household income and education); 
demographics (age, sex and race); lifestyle (smoking and alcohol use) and clinical factors (BMI and 
history of diabetes, hypertension, high cholesterol, MI/CABG or stroke).  
 We hypothesize that there exists a positive association between neighborhood deprivation and 
heart failure risk even after adjusting for individual-level socioeconomic factors like income and 
education. 
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2.3 Background for specific aim 3   
2.3.1 Measuring Obesity/Adiposity 
 2.3.1.1 Direct and indirect measures of adiposity in biomedical research and clinical 
practice. 
 In routine clinical practice and public health, body mass index is often used as a surrogate 
measure of general obesity or “overweightness” even though it is not ideal to distinguish lean mass vs. fat 
mass [53]. Body mass index (BMI) is defined simply as weight (Kg)/height2 (m2) and is customarily used 
to classify persons as overweight or obese based on the WHO classification - normal weight: 18.9-24.9 
Kg/m2; overweight: 25.0 to 29.9 Kg/m2; class I obesity: 30.0 to 34.9 Kg/m2; class II: 35.0 to 39.9 Kg/m2 
and class III: ≥40.0 Kg/m2 [54].  
 Waist circumference (and waist-hip ratio) is also frequently utilized in clinical practice 
particularly in NCEP ATP II guidelines for defining cut-points for the “metabolic syndrome” (>102 
cm/40 inches for men and >90 cm/35 inches for women), in the American Diabetes Association (ADA) 
standards of care for diabetes and International Diabetes Federation (IDF) clinical practice guidelines for 
diabetes management [55, 56] [57] [58] [59] .  
 Table 4 shows the correlation between BMI, WC and several adipose tissue measurements. The 
data suggests that overall, both BMI and WC have strong positive correlations with total body fat mass 
but there are some differential patterns by sex [60]. Body mass index appears to be a better surrogate 
measure for total fat mass and percent body fat amongst women while the reverse is true among men. 
However, WC is a better predictor of intra-abdominal adipose tissue (IAAT) i.e. visceral fat [61] in both 
men and women and some studies have found WC to be more predictive of type 2 diabetes and some 
cardio-renal events including chronic kidney disease and CHD [62-64]. Additionally, WC is better 
correlated with measures of abdominal adipose tissue (both subcutaneous abdominal adipose tissue, 
SAAT and IAAT) from gold standard techniques like Computed Tomography (CT) scans and magnetic 
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resonance imaging (MRI) [60]. That notwithstanding, both BMI and WC have been shown to be 
significantly associated with cardio-metabolic risk factors (including hypertension, hyperglycemia and 
dyslipidemia) and hard endpoints including CHD and cardiovascular death [65-69].  
Table 4: Correlation, ρ between BMI, WC and adipose tissue compartments in men and women [70]. 
 Men Women 
 BMI WC BMI WC 
Total adipose tissue 0.82 0.87 0.91 0.87 
Percent body fat 0.70 0.79 0.86 0.82 
Total subcutaneous adipose tissue  0.82 0.83 0.91 0.86 
Total intra-abdominal  adipose tissue (IAAT) 0.59 0.79 0.69 0.77 
 
 Most adipose tissue (~85%) is in fact situated subcutaneously and distributed throughout the body 
in discrete homogenous pockets and adjacent to body tissues [71]. The contribution of intra-abdominal or 
visceral fat to total adipose tissue varies with demographic factors – sex, race/ethnicity, age – physical 
activity and total fat mass [60]. Several methods are currently available for measuring total body fat and 
assessing body composition either directly or using surrogate measurements. Importantly, the assessment 
of body composition relies on assumptions regarding the density of body tissues, concentration of water 
and electrolytes; and /or relationships between body components, body tissues and the distribution of the 
estimates of these measures among healthy subjects [72]. 
 In addition to BMI and WC (and waist-hip ratio), skinfold thickness is another anthropometric 
surrogate used as a proxy for assessing adiposity. Measurements of Skin fold thickness (which represent 
the thickness of the subcutaneous tissue in that area of the body) can be obtained from a variety of body 
sites including the subscapular and triceps area which are the skinfolds for which we have the most 
national reference tables available [73]. Their utility is rather limited in overweight and obese individuals 
and there are significant variations by sex [73].  
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 Bio-impedance absorptiometry (BIA) is another indirect method used to provide estimates of fat 
mass (FM) by measuring the body’s resistance (using sensors/electrodes) to a small amount of alternating 
current. Bioelectric impedance analyzers produce a measure of impedance that is proportional to total 
body water (TBW) and is used as predictor variable in a regression equation to provide estimates of FM. 
The equations used by the analyzers are derived using data from a given “reference population” and these 
measures are only valid for subjects with the same body type and shape as the subjects from the reference 
in question [73]. More importantly, the data for the use of BIA in overweight and obese persons is scant 
and its accuracy in these populations is rather limited [74]. 
 Direct methods like the measurement of total body water (fat free mass is estimated from total 
body water and FM can then be obtained), total body counting and neutron activation produce somewhat 
more accurate results [73]. 
 There are also criterion methods that include a) measurements of body density b) dual x-ray 
absorptiometry (DEXA) and c) CT and MRI. Hydro-densitometry and air displacement plethysmography 
(ADP) are the 2 main body density measurement techniques currently in use. For the former, body density 
is measured via underwater weighing and multi-compartment models are used to combine body density 
with measures of bone density and total body water to calculate body fatness [75, 76]. ADP works 
follows similar underlying principles without the drawback of subjects having to hold their breath during 
the measurement to ensure compliance and accuracy [77]. DEXA is the most widely used technique for 
assessing lean mass, FM and bone density. The two low-energy levels used in DEXA and their 
differential attenuation through the body allow the discrimination between tissues types – soft tissues 
(FFM and FM) and bone tissue. Mathematical algorithms allow calculation of the separation components 
using various physical and biological models. DEXA measurement make assumptions (which vary by 
manufacturer) related to hydration, potassium content or tissue density. However, DEXA is considered to 
be 1 of the most reliable and valid techniques for estimating FFM, FM and bone density in much of the 
population and is currently included in the ongoing National Health and Nutrition Examination Survey 
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(NHANES) [73, 78]. Computed Tomography and MRI are gold standard techniques for body 
composition measurements. The former is rarely considered for “whole-body” assessments due to the 
high level of radiation exposure and thus is mainly used to measure abdominal fat. CT can also provide 
measurements of intrahepatic and intramyocellular fat which are known to be correlated with the risk of 
type 2 diabetes [79, 80]. Magnetic resonance imaging is often not able to accommodate large body sizes 
but can provide accurate whole-body measurements for normal or “moderately overweight” persons [73].   
 2.3.1.2 Weight-height indices as surrogate measures of total adiposity  
 Given their relative ease of collection and potential biologic relevance to the occurrence of 
chronic diseases, anthropometric data like weight (W) and height (H) are often utilized in epidemiologic 
studies to compute ‘weight-height indices’ which serve for the most part as proxy measures of obesity or 
body “fatness”. 
 Almost 2 centuries ago, Quetelet noted that compared to W/H and W/H³, W/H²  – later renamed 
as body mass index by Keys et al [81] – was more stable with increasing height in young adults but he 
never actively advocated for the latter to be used as a ‘measure of adiposity’. However, in the 
biomedical/epidemiologic research community, the need for a surrogate measure of body fatness that 
could be readily obtained from anthropometric surrogates – like W and H – routinely measured in clinical 
settings led to the investigation of several weight-height indices and measures of relative weight as 
potential proxy indicators of obesity.   
 Two main criteria have been used to assess these indices. First, such an index would have to be 
relatively uncorrelated with height [16, 17]. The goal here was to obtain an index that was summarily “a 
measure of weight-corrected-for height” such that head-to-head comparisons of persons of different 
heights could be performed using this index regardless of the (modest) correlation between weight and 
height. Differences in such an index could therefore be attributed primarily to differences in fat (or fat-
free) mass. Second, the index had to be highly correlated with a robust measure of body fat [16, 17] like 
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body density (measured via underwater weighing) or other measures of body fat. However, several 
studies have found that the performance of these indices on these two criteria varies across population 
groups defined according race, sex and age.  
 One of such studies was conducted by Keys et al using data from 7424 healthy men, aged 18-60 
in 12 cohorts from 5 countries (US, Finland, Italy, South Africa and Japan) to compare 4 indices – the 
ponderal index (PI), W/H, W/H² and relative weight [17]. The relative weight of the subjects was 
expressed as a percentage of the average weight (from life insurance industry tables) of a sample of 
persons of the same height, age and sex in the population to which they belonged. The PI was defined as: 
H ∛W⁄ . Among white men, W/H² had the weakest correlation with height: in particular, among the 249 
male executives from Minnesota, aged 49-59, the Pearson correlation coefficient, r of W/H² with height 
was 0.015 while the values for relative weight, W/H and PI were 0.102, 0.181 and 0.304 respectively[17]. 
Thus, the PI had the strongest correlation with height and hence was the least suitable index based on the 
first criteria. In contrast, among Bantu men (n = 116, age range: 31-60years) in South Africa, the values 
of the correlation with height for these indices (W/H², W/H and PI) were: 0.249, 0.509 and 0.102 
respectively[17]; thus PI had the lowest correlation with height. This suggests that the finding of which 
index was least correlated with height varied by race.  
 In addition, in the study by Florey et al – which was based on data from the fourth examination of 
the Framingham Heart Study – there were sex differences in the correlation of the aforementioned indices 
(W/H², W/H and PI) with height[16]. The Pearson correlation coefficient for W/H², W/H and PI among 
women (n = 2519) were -0.20, 0.03 and 0.41 respectively. In men (n = 2003), the corresponding values 
were: 0.08, 0.22 and 0.36[16]. Hence based on the first criteria (relative independence with height) W/H 
would be the best choice among women while among men it would be W/H².  
 Several studies have reported on the correlation between these weight-height indices and 
measures of body fat (skin fold thickness or body density). Overall, most investigators suggested that 
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W/H² (BMI) was: a) more strongly correlated with measures of body fat compared to PI[16, 17] and b) 
more or at least as correlated as W/H and W/H³ with body fat measures[16, 17, 82]; with substantive 
variations related to the demographic characteristics (age, sex and race) of the population under 
investigation and the attending differences in the anthropometry of these population subgroups. In the 
study by Keys et al, among 180 young adults (aged 18-24) from the University of Minnesota, the 
correlation between body density (measured via underwater weighing) and W/H², W/H and PI were: -
0.850, -0.833 and -0.791 respectively[17]. These values were -0.666, 0.658 and 0.657 among the middle-
aged Minnesota executives (n = 249, age range: 49-59years) suggesting differential patterns by age[17]. 
In other words, while W/H² performed better than the other indices among young white males, there were 
no differences in the correlation of the said indices with body fat among middle-aged adults. Among the 
middle-aged black men in South Africa, the values of the correlations with body density were not 
available but the correlation with skin fold thickness for W/H², W/H and PI were: 0.732, 0.756 and 0.629 
suggesting W/H performed slightly better; a trend different from that observed among middle-aged white 
men[17]. Also, Florey et al suggested sex differences in the correlation between the indices and infra-
scapular skin fold thickness among white women in the Framingham Heart study but the observed 
differences were minimal – the values of r for W/H², W/H and PI were: 0.65, 0.66 and -0.64 
respectively[16].  
 In summary, it would be safe to say that on both criteria – independence from height and strong 
correlation with body fat measures – there is significant variation in the performance of the indices 
depending on the demographic characteristics of the population under study. Using simulations, Florey 
showed that the correlation of the indices with height depended particularly on the slope (and the 
intercept) of the height variable in a regression equation where weight was regressed on height [16]. 
Incidentally, the slope parameter (i.e. the mean change/increase in weight per unit increase in height) 
appears to be vary based on the demographic characteristics of the study population. For instance, in the 
National Health Survey population, investigators found a slope of 4.0 among white men; among white 
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women the slope was 2.3 [83]. Similar values among men and women have been reported in other 
studies[16]. This difference in the association between weight and height across sex groups could be 
viewed across the lens of the fundamental axioms of Rothman’s sufficient-component cause model. 
According to this model, component causes in a sufficient cause interact causally in varying patterns to 
influence outcomes [84]. As such, the association between a component cause and an outcome is 
influenced by its causal complement in the sufficient cause. Height may be independently correlated with 
weight but the slope of the height variable when weight is regressed on height may vary based on age, 
sex, race or ancestry and other unknown/unmeasured (U) covariates as shown in the causal pie below. 
And working on the premise of the simulations of Florey et al, this would influence the correlation 
between height and a given weight-height index; which may explain the differences seen across studies.  
 
 With such potential variations, it would seem intuitive to use a data-driven approach to determine 
the appropriate weight-height index to be utilized in any given study. In theory, for any weight-height 
index given by the general form W/Hn, a regression of body fat on the natural logs of both weight and 
height, would yield an absolute value of n (i.e. the exponent of the height variable in the ‘composite’ 
weight-height index) for the ratio of the coefficient of log height to that of log weight. Ergo, if the 
appropriate composite index of weight and height was one of W/H, W/H² or W/H³, then by regressing 
body fat on the natural logs of both weight and height, the absolute value of the regression coefficient for 
 
U 
Sex 
Race 
Height 
Age 
Weight 
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the log height variable would be 1, 2 and 3 respectively (i.e. the exponent of the height variable in the 
‘composite’ weight-height index) 
 Working on this premise, one could obtain the appropriate exponent of the height variable for the 
weight-height index by regressing body fat on log weight and log height in a given dataset obtained from 
the population under study. The same could be done for any potential outcome e.g. CVD (including HF) 
that is thought to associated with the said weight-height-index (used here as a surrogate measure of body 
fat). Hence, the exponent of the height variable in the composite index would likely vary depending on 
the outcome under study. Theoretically, one could view this heterogeneity of the functional form of the 
composite weight-height index via prisms afforded by an “adaptation” or “extension” of the Rothman’s 
model. One could postulate that the functional form of the weight-height index (i.e. the value of n) could 
vary based on a) the characteristics of the population under study and b) the outcome being investigated.  
 
 
 Separate indices may have to be constructed to study the association of interest within subgroups 
defined by race and/or sex. Otherwise, using a common composite index, interaction terms could be 
included in multivariable models to investigate differential associations of the weight-height index with 
CVD including HF.  
 
U 
Sex 
Race 
W/Hn Age 
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2.3.2 The Burden of Obesity in the United States. 
 Every year in the US, overweight and obesity contribute to substantial morbidity and 
mortality[85, 86] and are responsible for billions of dollars in medical costs and lost productivity [87] . 
Their prevalence has increased to the extent that a majority of adult Americans are now considered 
overweight or obese (body mass index   25 kg/m2) [88]. Obesity is associated with a myriad of adverse 
health outcomes including metabolic abnormalities such as dyslipidemia, type 2 diabetes, hypertension, as 
well as chronic kidney disease and cardiovascular disease [89]. 
2.3.3 Obesity and the Heart – Metabolic, Hemodynamic, Structural and Functional 
changes. 
 Individuals with elevated body mass index usually have both increased adiposity and fat-free 
mass and these are associated with metabolic, cellular and hemodynamic changes which are in turn 
associated with alterations in myocardial structure and performance [14]. 
 2.3.3.1 Hemodynamic changes 
 In persons with excess body weight – both adipose tissue and fat-free mass – there is a 
proportionate increase in cardiac output which results primarily from an increased left ventricular (LV) 
stroke volume (figure 1) [90]. In addition, compared to persons with normal weight, persons with class II 
or III obesity also have higher right ventricular (RV) end-diastolic pressure, mean pulmonary artery 
pressure, pulmonary vascular resistance, and mean arterial pressure [90].  
 2.3.3.2 Structural Changes 
Increases in adiposity and lean body mass are also associated with obesity-related myocardial changes 
which are correlated with the extent and duration of obesity [91], systolic blood pressure, LV end-systolic 
wall stress and LV chamber size in diastole [92, 93].  
The most common structural changes observed include: hypertrophy of cardiac myocytes, concentric 
remodeling, eccentric and concentric LV hypertrophy, increased LV mass, dilated cardiomyopathy and 
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increased RV wall thickness which occur in varying degrees depending on the presence or absence of 
hypertension and obesity class [90, 92-99].  
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Figure 2: Pathophysiology of Obesity Cardiomyopathy 
This figure shows the central hemodynamic, cardiac structural abnormalities, and alterations in ventricular function that 
may occur in severely obese patients and predispose them to heart failure. Left ventricular (LV) hypertrophy in severe 
obesity may be eccentric or concentric. In uncomplicated (normotensive) severe obesity, eccentric LV hypertrophy 
predominates. In severely obese patients with long-standing systemic hypertension, concentric LV hypertrophy is 
frequently observed and may occur more commonly than eccentric LV hypertrophy. Whether and to what extent 
metabolic disturbances such as lipotoxicity, insulin resistance, leptin resistance, and alterations of the renin-angiotensin-
aldosterone system contribute to obesity cardiomyopathy in humans is uncertain. RV = right ventricular. (Adapted from 
Lavie CJ et al: Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart 
failure 2013, 1(2):93-102). 
Inadequate Adequate 
Hypertension 
Unchanged heart rate 
↓Systemic vascular resistance 
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 2.3.3.3 Functional Changes – LV Diastolic and Systolic dysfunction 
The presence of LV hypertrophy predisposes obese persons to diastolic dysfunction. Several 
hemodynamic studies found increased LV end-diastolic pressure [90, 92] and other studies utilizing 
echocardiography and radionuclide techniques reported abnormal diastolic filling pressures suggestive of 
LV diastolic dysfunction in obese persons, which worsened with increasing levels of obesity [92, 100-
103]. 
Depression of LV systolic myocardial performance is uncommon in obese persons in the absence of 
concomitant cardiovascular disease. In some obese subjects there was some subclinical LV dysfunction 
characterized by abnormal myocardial strain which was load-independent [103]. 
 2.3.3.4 Metabolic, cellular and neuro-hormonal changes 
Based on data from animal models, it has been hypothesized that the structural and functional changes 
seen in obese individuals are related to several abnormalities in biochemical and metabolic pathways. 
These include: decreased insulin sensitivity, hyperinsulinemia, leptin resistance and hyperleptinemia, 
decreased serum adiponectin levels, increased sympathetic tone, and activation of the Renin Angiotensin 
Aldosterone System (RAAS), low-grade systemic inflammation (with increased C-reactive protein and 
tumor necrosis factor). Cellular insults accompanying these processes may engender fibrosis, apoptosis 
and hypertrophy of cardiac myocytes which ultimately impact diastolic function [14]. 
2.4 Previous epidemiologic Studies on the association between Obesity and Heart 
Failure  
 Previous epidemiologic studies have suggested a strong independent association between elevated 
body mass index and incident heart failure (Table 5). However, in a community-based study of 550 
diabetes-free men and women in Greece, elevated BMI alone was not independently associated with HF 
risk, whilst metabolic syndrome was associated with a 2.5-fold (95% CI: 1.64-3.58) higher HF risk [104]. 
Metabolic syndrome was defined using the National Cholesterol Education Program Adult Treatment 
Panel (NCEP-ATP) III criteria i.e. the presence of 3 or more of the following conditions: abdominal 
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obesity given as waist circumference (>102 cm in men and >88 cm in women), serum triglycerides >150 
mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, BP ≥130/85 mm 
Hg or use of antihypertensive medications, fasting glucose ≥100 mg/dl. 
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Table 5: Previous studies investigating the association between measures of obesity and heart failure risk 
Authors Study Description Covariates Findings Limitations 
Kenchaiah et al 
[13]. 
Framingham Heart 
Study (n= 5881, 
mostly Caucasian, 
54% female, mean 
age = 55.4 years). 
Age, alcohol 
consumption, smoking, 
total cholesterol, 
diabetes, hypertension, 
valvular heart disease, 
myocardial infarction, 
LVH (on ECG) 
496 (258 women, 238 men) incident HF cases. 
1. Continuous BMI 
HR (95% CI) per 1Kg/m2 increase: 
Men: 1.05 (1.02-1.09). Women: 1.07 (1.04-1.10)  
2. BMI categories 
- Overweight vs Normal 
Men: 1.20 (0.87-1.24). Women: 1.50 (1.12-2.02) 
- Obese vs. Normal 
Men: 1.90 (1.30-2.79). Women: 2.12 (1.51-2.97) 
1. Assumptions of linearity for 
continuous BMI analysis. 
2. Categorization: loss of 
precision and misrepresentation 
of the nature of the dose-
response relationship. 
3. Couldn’t investigate 
potential differential effects by 
race.  
Ndumele et al 
[15]. 
ARIC study (n= 
9507, 58.2 female, 
21.6% black, mean 
age = 62.4 years). 
Age, sex, race, 
smoking, diabetes, 
hypertension, LDL 
cholesterol, HDL 
cholesterol, 
triglycerides, alcohol 
intake, NT-proBNP, 
and estimated GFR.  
868 incident HF events. 
1. Continuous BMI 
HR per 5Kg/m2 increase: 1.32. 
2. Categorical BMI 
BMI≥35Kg/m2 vs Normal (18.5 – 24.9Kg/m2)  
Age-adjusted: 3.39 (2.74 - 4.19) 
Full-adjustment: 2.39 (95% CI: 1.89 -3.01). 
 
1. Assumptions of linearity for 
continuous BMI analysis. 
2. Categorization: loss of 
precision and misrepresentation 
of the nature of the dose-
response relationship. 
3. Potential differential effects 
by race and sex weren’t 
investigated. 
He et al [105]. NHANES (n= 
13,643; 59.4% 
female; 14.8% 
black, mean age = 
49.8 years).  
Sex, education, physical 
activity, cigarette 
smoking, diabetes, 
hypertension, valvular 
heart disease, and 
coronary heart disease. 
1382 CHF events. 
Categorical BMI 
Overweight vs Normal:  
RR (95% CI): 1.30 (1.12-1.52). 
1. Categorization: loss of 
precision and misrepresentation 
of the nature of the dose-
response relationship. 
2. Potential differential effects 
by race and sex weren’t 
investigated. 
Chen et al [106]. Established 
Populations for 
Epidemiologic 
studies of the 
Elderly, New Haven 
cohort (n= 1749, 
58.9% female, 
18.4%, black, mean 
age=74.2 years) 
Age categories, type of 
housing, sex, pulse 
pressure and diabetes. 
173 incident HF events. 
Categorical BMI 
BMI≥28Kg/m2 vs <24.0Kg/m2)  
RR (95% CI): 1.6 (1.0-2.4). 
1. Categorization: loss of 
precision and misrepresentation 
of the nature of the dose-
response relationship. 
2. Potential differential effects 
by race and sex weren’t 
investigated. 
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2.5 Rationale for investigating the association between a weight-height index (as a 
proxy for total body fat) and HF risk in SCCS.   
 2.5.1 Rationale for considering a data-derived weight-index (W/Hn)  
 Data from varying communities across the US suggest that poverty-dense counties have high 
levels of obesity which are paralleled by high prevalence of chronic conditions including CVD and heart 
failure [12]. It is ever so important to critically examine the link between adiposity and HF risk (and 
survival following a diagnosis of HF) particularly among populations with scant resources. Most cohorts 
investigating the obesity-HF link have relied on body mass index – weight (W)/height (H)2 – as a proxy 
for total body fat and increased body mass index has been found to be positively correlated with HF 
incidence and survival [13-15] but there is little data on potential effect modification by race. Less 
thought has been given to the suitability of W/H2 in investigating the obesity-HF link despite differences 
in the performance of various weight-height indices across population groups defined by race and sex [16, 
17]. Additionally, predictors with “pleiotropic” effects usually have differential functional relationships 
with varying outcomes suggesting the need to use the data to derive the appropriate weight-height index 
for each outcome. Hypothetically, for any weight-height index given by the general form W/Hn, 
regressing the log-hazard of HF on the natural logs of both weight and height, would yield n as the 
absolute value of the ratio of the coefficients of log height and log weight; this could be used to a W-H 
index suitable for a given setting. Also, any potential departures from additivity of effects by race and sex 
could be investigate using interaction terms with the appropriate weight-height index. Such robust 
approaches are needed to adequately model these data and reveal novel insights that would potentially 
refine the strategies used to risk-stratify persons in clinical and/or public health settings. 
 2.5.2 Rationale for investigating departures from additivity of effects by race in SCCS. 
 Most of the previous studies enrolled predominantly white populations or small numbers of 
middle class multi-ethnic populations from small communities; thus the obesity-HF association in blacks 
was understudied. Importantly, some studies have found that increased BMI have less detrimental health 
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effects in blacks. Cohen et al and Calle et al reported stronger associations between BMI and 
cardiovascular outcomes in whites compared to blacks [66, 107]. In the SCCS cohort, we have previously 
shown that whites with BMI ≥ 40Kg/m2 had a greater than 2-fold increased risk of cardiovascular death 
compared to those with normal weight, while in blacks the increase in risk was modest (17-40%) and non-
significant [107].  Similarly, using data from the SCCS cohort, Lipworth et al found that in whites the risk 
of atrial fibrillation was 49% (HR: 1.49; 95%CI: 1.11, 2.01) higher in obese persons compared to those of 
normal weight, while among blacks the corresponding HR was 0.90 (95%CI: 0.69, 1.16) [108]. This 
suggests that the association between BMI (and potentially other anthropometric surrogates of total body 
fat) and cardiovascular outcomes including HF needs to be further contrasted between blacks and whites. 
Additionally, a more flexible modeling approach take into account potential nonlinearity of effects may 
reveal additional insights into the causal relationships between W/Hn and HF. 
 Hence, we plan to use the unique opportunity afforded by the SCCS data to investigate potential 
differential patterns in the dose-response relationship between W/Hn and the risk of incident heart failure 
by race and sex.  
 We will investigate these associations using data from the linkage of the SCCS cohort with CMS 
Research Identifiable Files to ascertain incident HF events. We would use data for body mass index at 
enrollment based on self-reported weight and height (and validated in a sub-cohort of SCCS) to 
investigate the W/Hn-HF association.  
 For all these analyses we would use data for SCCS participants (n = 27,078) who meet the 
following inclusion criteria would be included in our analyses:  
 ≥ 65years (n = 7001) at cohort enrollment 
 < 65 years (n = 20,077) at enrollment and either:  
i. reported being covered by Medicaid on the baseline questionnaire;  
ii. reported being covered by Medicare on the baseline questionnaire;  
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iii. did not report Medicare or Medicaid on the baseline questionnaire but had a CMS claim 
within 90 days of being enrolled in SCCS. 
 We hypothesize that a) there is a positive non-linear dose-response association between W/Hn and 
incident HF which is stronger in whites compared to blacks. Cox regression analyses would be used to 
model the association between W/Hn and the instantaneous risk of incident HF while adjusting for all 
relevant covariates (age, history of MI/CABG, stroke, hypertension, diabetes, dyslipidemia, income, 
education, smoking, alcohol use, and total physical activity) and modelling interactions with race and sex.   
 We would repeat these analyses using waist circumference data which is available for a subset (n 
≈ 3300) of our study sample. 
2.5.6 Obesity and post-HF survival  
2.5.6.1 The Obesity Paradox 
 Whilst the biologic evidence for the nefarious effects of excess body weight on the structure and 
functioning of the myocardium and the epidemiologic evidence linking obesity to increased HF incidence 
are both compelling, several studies (table 6) have suggested that overweight and obese persons with 
heart failure have a demonstrably higher survival compared to leaner subjects – a phenomenon coined as 
the obesity paradox.
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Table 6: Previous studies investigating the association between measures of Obesity and post-HF mortality. 
Authors Study Description Covariates Findings Limitations 
Horwich et al 
[109]. 
1203 patients (23.4% 
female, mean age = 52 
years) with advanced HF 
(mean LVEF = 22%) 
referred for care.  
Age, sex, medications, 
hypertension, diabetes, 
LVEF, peak VO2, 
serum sodium, serum 
lipids, serum 
creatinine, mitral and 
tricuspid regurgitation. 
- 537 deaths  
- HR for 1Kg/m2 increase in BMI: 0.952 (0.915-
0.991).  
- Higher Cumulative survival at 2 years in 
overweight (BMI= 27.8-31Kg/m2) and obese (BMI 
>31Kg/m2) groups compared to normal weight. 
1. Small sample size 
2. Categorization: loss of 
precision and 
misrepresentation of the 
nature of the dose-response 
relationship. 
3. Potential differential 
effects by race wasn’t 
investigated.  
Lavie et al [110]. 209 ambulatory HF 
patients (mean age = 
53.9yrs) with chronic 
systolic HF referred for 
care at UCLA 
cardiomyopathy center. 
Age, sex, ischemic vs 
non-ischemic 
cardiomyopathy, 
NYHA class, LVEF 
and peak VO2. 
28 major events (urgent transplant or CV death). 
1. Percent body fat: 
For every 1% increase in percent body fat there was 
a 13% reduction in major CV events. 
2. Categorical BMI 
Kaplan-Meier plot showed higher survival for 5th 
BMI quintile compared to 1st quintile. 
 
1. Small sample size 
2. Categorization: loss of 
precision and potential 
misrepresentation of the 
dose-response relationship. 
 
Clark et al [111]. 3187 patients (25.2% 
female, mean age = 53.0 
years, mean LVEF = 
22.9%) referred for HF 
management or 
transplant evaluation at 
UCLA. 
Age, diabetes, LVEF, 
peak VO2, NYHA 
class, HF cause 
(ischemic vs non-
ischemic)  
988 Major events (deaths, heart transplants, 
ventricular assist device placements) 
1. Body Mass Index 
HR (95%CI) for normal vs High BMI (≥25 Kg/m2):  
- Men: 1.34 (1.13-1.58);  Women:1.38 (1.02-1.89) 
2. Waist circumference (WC) 
- Men 
HR (95%CI) for normal vs High WC (≥102cm): 2.02 
(1.18-3.45) 
- Women 
HR (95%CI) for normal vs High WC (≥88cm): 2.99 
(0.90-4.8). 
 
1. Categorization: loss of 
precision and 
misrepresentation of the 
nature of the dose-response 
relationship. 
2. Potential differential 
effects by race wasn’t 
investigated. 
Oreopoulos et al 
[112]. 
Meta-Analysis of 9 
observational HF studies 
(n= 28,209) with average 
follow-up ≈ 2.7 years. 
 BMI categories 
- HR (95% CI) for Overweight vs Normal 
CV death: 0.81 (0.72 – 0.92)  
All-cause Mortality: 0.84 (0.79 – 0.90) 
- HR (95% CI) Obese vs. Normal 
CV death: 0.60 (0.53 – 0.69)   
All-cause Mortality: 0.67 (0.62 – 0.73) 
Categorization: loss of 
precision and 
misrepresentation of the 
nature of the dose-response 
relationship 
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 Some authors have suggested a few underlying biological reasons to explain this phenomenon. 
- Higher metabolic reserve among obese persons in addition to leaner HF patients having a higher 
likelihood of being cachectic and thus at a higher risk of death [113]. 
-  The specificities of the neuro-humoral profile and hemodynamics of obese persons with heart failure 
such as the secretion of  soluble TNF alpha receptors which have beneficial neutralizing effects; higher 
circulating lipoproteins which may bind and detoxify lipopolysaccharides that play a role in stimulating 
the release of inflammatory cytokines and  elevated blood pressure which raises the tolerance of obese 
individuals to higher doses of cardio-protective agents including beta blockers, aldosterone antagonists 
and RAAS inhibitors [114, 115].  
 Other investigators have advanced epidemiologic reasons related to: 
1) Study participants who experienced unintended weight loss before study enrollment and who may have 
had higher mortality risk [114]. 
2) The fact that compared to normal weight persons, overweight and obese persons were found to have 
lower atrial natriuretic peptide levels which was correlated with having higher muscle mass and muscle 
strength [116]. The latter have been associated with improved survival in other patient populations and 
this may be analogous to patients with advanced HF as well [117]. 
 2.5.6.2 Rationale for investigating the association between anthropometric surrogates and 
all-cause mortality among HF patients in SCCS. 
 There is a wealth of data suggesting that in persons with HF, intentional weight loss mitigates 
some of the hemodynamic abnormalities and reduces LV mass and chamber size [90, 92, 93, 100, 114, 
118]. However, in light of the epidemiologic evidence suggesting an obesity paradox, some 
cardiovascular societies – whilst still advocating weight loss – have been conservative, recommending 
intentional weight reduction only at higher cut-points for BMI. For example, the AHA recommends 
intentional weight loss in HF only for persons with BMI >40 kg/m2, the Heart Failure Society of America 
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for individuals with BMI >35 kg/m2, both the European Society of Cardiology and the Canadian 
Cardiovascular Society recommend weight loss above a BMI cut-point of 30 kg/m2 and none of the major 
societies recommend weight loss for overweight patients with HF.  
 These recommendations seem to make the assumption that there exists a discontinuous 
relationship between the survival probability of persons with heart failure and body mass index; and the 
discontinuities (or sharp inflexion points) are found at the recommended cut points. If the dose-response 
relationship between body mass index and survival probability in heart failure is in fact a smooth 
function, making recommendations about specific cut-points may be counter-intuitive. 
 We plan to use data from SCCS to investigate the dose-response relationship between W/Hn and 
mortality risk in persons with incident heart failure while accommodating potential nonlinearity of effects 
and effect modification by race.  
[However, many experts acknowledge that in patients with heart failure more data on the effects of 
intentional weight loss on morbidity (hospitalizations) and long-term prognosis including hard endpoints 
like cardiovascular and all-cause mortality would provide better insights.] 
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3. Materials and Methods 
 The current study would leverage existing data from the Southern Community Cohort Study to a) 
quantify the burden of heart failure (incidence and mortality) in a low-income population that has been 
under-represented in previous cardiovascular cohorts b) improve the understanding of the dose-response 
relationship between weight-height indices (as surrogates of total adiposity) and HF risk and the potential 
differential influences of race and sex in these relationships c) elucidate the independent contrasting 
and/or synergistic relationships between individual-level and neighborhood-level effects which may 
inform individual and community-level interventions aimed at reducing the burden of the heart failure 
epidemic. 
3.1 Study Population: The Southern Community Cohort Study 
 The SCCS enrolled approximately 86,000 adults, age 40-79, living in rural and urban settings in a 
12-state area of the southeastern United States (Tennessee, Arkansas, Louisiana, Missouri, Alabama, 
Georgia, Florida, South Carolina, North Carolina, Virginia, West Virginia and Kentucky) between 2002 
and 2009 [18].  The majority of participants (~85%) were recruited primarily at community health centers 
(CHCs), which are federally funded healthcare facilities primarily servicing low-income individuals and 
medically underserved populations. Thus, most SCCS participants are of similar (usually low) 
socioeconomic and at especially elevated risk of adverse health outcomes including obesity, hypertension 
(~56%), diabetes (~21%) and cardiovascular disease. The characteristics of participants enrolled in the 
SCCS are summarized in Table 7.
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Table 7. Baseline characteristics of 76,614  SCCS Participants by Sex and Race, 2002–2009 
 Black Men White Men Black Women White Women 
 No. % No. % No. % No. % 
Age, years  
40–49 11,179 51 3,407 37 14,59
9 
47 5,486 38 
50–59 7,526 34 3,222 34 10,47
4 
34 5,176 36 
≥60 3,309 15 2,714 29 5,737 19 3,785 26 
Mean 51.3  54.7  52.
2 
 54.
2 
 
Education  
<9 years 1,913 9 777 8 2,192 7 1,060 7 
9–11 years 5,422 25 1,261 14 6,954 23 2,388 17 
High school 8,996 41 3,214 34 11,95
5 
39 5,625 39 
Some  college 3,766 17 1,810 19 6,314 21 2,975 21 
College  or postgraduate 1,899 9 2,270 24 3,366 11 2,392 17 
Income  
<$15,000 12,925 59 3,730 41 17,94
5 
59 6,955 49 
$15,000–$24,999 4,693 22 1,565 17 7,064 23 2,778 20 
$25,000–$49,999 2,799 13 1,611 18 3,887 13 2,344 17 
$50,000 or more 1,351 6 2,291 25 1,491 5 2,125 15 
Smoking  
Never 4,863 22 2,389 26 14,57
8 
48 5,573 39 
Former 4,553 21 3,137 34 5,978 20 3,628 25 
Current,  <1 pack/day 8,983 41 1,200 13 7,684 25 2,268 16 
Current,  ≥1 packs/day 3,411 16 2,467 27 2,299 8 2,875 20 
Alcohol consumption  
None 6,607 30 3,631 40 16,68
4 
55 7,999 56 
<1 drink/day 6,284 29 2,964 32 9,610 32 4,944 35 
≥1 drinks/day 8,792 41 2,534 28 3,971 13 1,231 9 
Body mass index at cohort entry  
  <18.5 278 1 82 1 311 1 254 2 
   18.5–24.9 7639 35 2544 27 4777 16 3638 25 
   25–29.9    737 35 3542 38 7860 26 3831 26 
  ≥ 30    5,535 29 2,705 34 17,95
2 
58 6,824 47 
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3.2 Study population for our proposed analyses 
 SCCS participants (n = 27,078) who meet the following inclusion criteria would be included in 
our analyses: ≥ 65years (n = 7001) at cohort enrollment or < 65 years (n = 20,077) at enrollment and 
either: a) reported being covered by Medicaid on the baseline questionnaire; b) reported being covered by 
Medicare on the baseline questionnaire or c) did not report Medicare or Medicaid on the baseline 
questionnaire but had a CMS claim within 90 days of being enrolled in SCCS.  
 The restriction to these groups increases the likelihood of participants having continuous 
coverage in Medicare and/or Medicaid from the time of SCCS enrollment to the end of the follow-up 
period (December 31st, 2010), for the ascertainment of incident HF events. 
 Based on these criteria we had n = 33,018 participants. We further excluded the following groups 
of persons successively (given these groups were not mutually exclusive) (fig. 4): 
a) Persons (n = 1571) who did not self-report as “Black” or “White” given the sample sizes for these 
groups were too small to make significant inferences. 
b) Persons (n = 4312) with a known history of HF before cohort entry (enrollment) i.e. prevalent 
HF. 
c) Persons (n = 51) whose date of HF diagnosis was coincident with date of enrollment (i.e. follow-
up time from cohort entry to HF diagnosis = 0) as these persons may have had prevalent HF. 
Given HF is a chronic condition whose onset is often insidious, these participants may have been 
symptomatic for HF before enrollment. 
d) Persons (n = 6) whose diagnosis of HF was later confirmed to have occurred after end of follow-
up (December 31st 2010). 
In summary, a further 5940 subjects were excluded leaving a total sample size of 27,078.  
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Fig 3: Flow diagram indicating participant eligibility for the proposed study. 
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3.3 Comparison between SCCS and other cohorts investigating HF 
Table 8: Baseline characteristics of SCCS, ARIC, CHS, MESA and FHS participants 
 
SCCS   
(n= 27,078) 
ARIC[8]  
(n= 14,993) 
CHS[5]  
(n= 5,888) 
MESA[6]  
(n = 5,923)† 
FHS[7]  
(n=9,405)‡ 
Age (years)* 55.5 (10.4) 54 (6) 72.8 (5.6) 61.8 (10.3) 41 (10) 
Women (%) 62.6 54 57.6 53 53 
Blacks (%) 68.8 27 15.7 26.1 ≈ 0 
Education (<high school) (%) 38.4 24 29.5 16 56§ 
BMI (kg/m2)* 30.4 (7.8) 27.3 (5.1) 26.7 (4.7) 28.0 (5.4) 24.9 (3.8)|| 
Obese (BMI > 30) % 44.8 26 19 32 10.8|| 
Diabetes (%) 26.5 11 16.4 11.6 4.1 
Hypertension (%) 62.5 33 57.7 42 7 
Myocardial infarction (%) 8.6 4 9.6 n/a 1.6# 
Stroke (%) 9.6 1.4 4.2 n/a 0.5** 
Ever smoked cigarettes (%) 65.3 58.2 53.5 49 57.3§ 
 
 Compared to ARIC, SCCS participants included in the current study had higher proportions of 
persons reporting a history of myocardial infarction at baseline as well as hypertension, BMI≥30Kg/m2 
and proportion of black participants.  
 Compared to CHS and MESA, the SCCS population was younger at baseline, had higher 
proportions of women and African-Americans; and equally had higher mean BMI and prevalence of 
hypertension and diabetes.  
3.4 Data Collection in SCCS 
 At enrollment into the SCCS, participants completed a questionnaire which ascertained 
information about demographics (date of birth, sex, race), lifestyle factors (including smoking and alcohol 
use), personal and family medical history, anthropometric factors, education, occupation, income, and 
physical activity data [18].  For CHC participants, the questionnaire was administered in person via a 
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computer-assisted personal interview (CAPI) with logic-checking and skip pattern technology.  Trained 
interviewers administered the questionnaires with the assistance of handheld cards to facilitate responses, 
and abstracted anthropometric and clinical information from participants’ medical records if those 
measurements were also collected on the day of enrollment. General population participants (~15%) 
completed and mailed in a paper version of the study questionnaire. Recruitment began in March 2002 
and was completed in September 2009.  Institutional review boards at Vanderbilt University Medical 
Center and Meharry Medical College approved all SCCS research protocols and participants provided 
informed consent and signed HIPAA authorization forms. 
3.5 Quality Control for Measurements and Questionnaires 
 Most of the questions in the SCCS questionnaire were adapted from questionnaires used and 
validated in other settings. However the SCCS investigators performed a series of validation studies to 
assess the reliability of the questionnaires used in data collection. Samples of approximately 150-800 
SCCS participants were selected to validate physical activity patterns via repeat interviews and use of 
accelerometers, tobacco use status via measurement of serum nicotine, and disease occurrence for self-
reported diabetes via confirmation in medical records and by measurement of HbA1c [18]. Over 96% of 
self-reported diabetes diagnoses were validated with data from confirmatory medical records or elevated 
HbAlc measurements. Self-reported height and weight were compared with contemporaneous clinic 
recorded measurements for over 20% of the participants (correlation was >95%) [18]. Repeat blood 
samples were also collected and banked from over 650 participants and repeat urine samples from over 
240 participants for future comparability assays to check for concordance of biomarker levels over time 
periods spanning one to three years. 
3.6 Outcomes and Outcome ascertainment 
 The main outcomes for our study would be incident heart failure and survival following a first 
diagnosis of heart failure. Heart failure events would be ascertained via linkage of the SCCS cohort (using 
Social Security Number, date of birth, and sex) with national Centers for Medicare and Medicaid Services 
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(CMS) Research Identifiable Files. Given that Medicare coverage is almost universal for persons who are 
aged 65 or older, and the low-income status of SCCS participants under age 65 results in many being 
eligible for Medicaid, the CMS linkage affords the opportunity for ascertainment of heart failure 
diagnoses for a significant proportion of subjects (n = 27,078) in the SCCS.  
3.6.1 Incident Heart Failure 
 Incident HF would be defined as the first occurrence of a medical claim with ICD-9 code 428.x 
within the Medicare institutional (Medicare Provider Analysis and Review, MEDPAR), Part B carrier, or 
outpatient-based claims files or the Medicaid Analytic Extract (MAX) Inpatient and Other Services 
claims files, from the date of SCCS enrollment through December 31st, 2010.  
 The diagnosis code (ICD-9 428x) [119] algorithms for identification of HF in the proposed study 
have been previously validated.  A review of the detection of heart failure in administrative claims data 
included eight studies conducted among Medicare beneficiaries reported positive predictive values 
(PPVs) between 76% and 99%, with the majority of the studies reporting PPVs over 90% [119].  These 
codes have also been used with high specificity in a number of studies [120, 121]. 
3.6.2 All-cause mortality/Post-HF Survival 
 Deaths, including dates and causes of death, would be ascertained via linkage of the SCCS cohort 
with both the Social Security Administration (SSA) vital status service for epidemiologic researchers and 
the National Death Index (NDI) through December 31, 2010. Both NDI and SSA are well-established and 
reliable means of identifying deaths in the US, and are expected to capture nearly all deaths [51, 122, 
123].   
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3.6.3 Understanding the linkage with CMS research Files for HF ascertainment 
3.6.3.1 Medicare  
 3.6.3.1.1 Types of Medicare coverage  
 Medicare is the primary health insurance program for persons aged ≥ 65; hence Medicare data is 
a valuable resource for making inferences about medical care of older adults. The program also provides 
insurance coverage for persons < 65 with certain disabilities, and individuals of all ages with ESRD.  
 Almost all Medicare beneficiaries receive Part A hospital insurance benefits, which helps cover 
inpatient hospital care, skilled nursing facility stays, home health and hospice care. The majority of 
beneficiaries equally subscribe to Part B medical insurance benefits, which help to cover physician 
services, outpatient care, and durable medical equipment (DME) and some home health care. Also, many 
beneficiaries elect to purchase Medicare Part D prescription drug coverage.  
 Beneficiaries may elect to receive fee-for-service (FFS) Medicare.  In an FFS plan, treatment and 
diagnostic procedure decisions are under the control of the physician/hospital based on what they consider 
to be best practice and they’re reimbursed for every service offered to the patient or client. As an 
alternative to FFS Medicare, beneficiaries can enroll in Medicare Part C (Medicare Advantage). These are 
 
03/2002 
 
12/2010 09/2009 
End of recruitment – 
Indirect Follow-up 
continues 
Exit date for all 
incident HF cases 
and mortality. 
 
- Recruitment 
starts/entry date 
- CAPI 
 
Figure 4: Timeline for recruitment, data collection and ascertainment of outcomes 
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private plans similar to manage care organizations which provide Medicare Part A and Part B services. 
Managed care organizations supervise the financing of medical care delivered to their members. They 
include health maintenance organizations (HMOs), preferred provider organizations (PPOs) and points of 
service and the flexibility afforded to the clients in (e.g. for specialist consultation options) vary across 
these plans. 
 3.6.3.1.2 The Chronic Condition Ware house (CCW) Medicare research data files 
 The Chronic Condition Data Warehouse (CCW) Medicare data are extracted from the Centers for 
Medicare & Medicaid Services (CMS) enrollment files and fee-for service administrative claims 
submitted for payment to CMS. Data for all beneficiaries enrolled in Medicare is available from the 
CCW. The CMS Institutional and Non-institutional data files found in the CCW generally represent 
Medicare FFS claims only (i.e., managed care encounter information is not available). A few exceptions 
exist, including coverage of Hospice services. 
 The CCW data files were designed in such a way as to facilitate research across the continuum of 
care, using data files that could be easily merged and analyzed by beneficiary. Each beneficiary in the 
CCW is assigned a unique, unidentifiable link key, which allows researchers to easily merge data files 
and perform relevant analyses across different claim types and enrollment files.  
 3.6.3.1.3 The Master Beneficiary Summary File (MBSF) 
 The Master Beneficiary Summary File is created annually and contains demographic and 
enrollment data for all beneficiaries enrolled in Medicare for any part of the year. This annual person 
level summary file can be used to determine whether a beneficiary has a sufficient surveillance period for 
inclusion in the analytic file being created. Variables contained in this file include: the number of months 
of Medicare Part A, B, C, and D coverage; whether the beneficiary died during the year and other 
beneficiary demographic and geographic information. 
 3.6.3.1.4 Claim Types 
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 In general, all CMS administrative data files contain variables which can be used to join the CCW 
files. When medical services provided to a beneficiary are the focus, the primary linkage will be at the 
person level, after aggregation of the claim level files. 
  a) Medicare Institutional Claims 
 Claims from institutional providers which are covered by the Medicare Part A benefit appear in 
the Institutional claims file and are processed by Medicare Administrative Contractors (MAC). In 
addition, claims for institutional-based services covered by the Medicare Part B benefit (e.g., home 
health, hospital outpatient) appear in the Institutional claims file. For each setting, there is a base file and 
a revenue center file. These files include the following types of claims:  
 Inpatient - This file includes ICD-9 diagnosis and procedure codes, Diagnosis Related Group 
(DRG) information, dates of service, reimbursement amount, hospital provider, and beneficiary 
demographic information. 
 Outpatient - Contains claims data for outpatient services submitted by institutional outpatient 
providers (e.g., hospital outpatient departments, Rural Health Centers [RHCs], Federally 
Qualified Health Centers [FQHCs], renal dialysis facilities, outpatient rehabilitation facilities, 
comprehensive outpatient rehabilitation facilities, and community mental health centers). This file 
includes ICD-9 diagnosis codes and CMS Common Procedure Coding System (HCPCS) codes. 
 Skilled Nursing Facility (SNF), Hospice, Home Health Agency (HHA) which provide base files 
for claims submitted by the SNF, Hospice and HHA respectively and all include ICD-9 diagnosis 
codes. 
Institutional claims have base files (contains beneficiary ID, claim type, admitting diagnosis, primary 
diagnosis, and up to ten additional diagnosis code fields and six procedure codes with associated dates, as 
well as the DRG; and beginning with claims files from 2009, the claims allow for 25 diagnosis codes and 
25 procedure codes) and revenue center files. 
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  b) Medicare Non-Institutional Claims 
 The Medicare Non-Institutional claims include services covered by the Part B benefit, and consist 
largely of professional services and DME. All claims are processed by MACs; also known as Carriers. 
These files include the following types of claims: 
 Carrier – Contains claims data for non- institutional providers (e.g., physicians, physician 
assistants, nurse practitioners, independent clinical laboratories, ambulance providers, and 
freestanding ambulatory surgical centers).  
 Durable Medical Equipment (DME) – Contains non-institutional claims for the Durable Medical 
Equipment Regional Carrier submitted by DME suppliers and providers.  
 Non-institutional claims have base files (contains the beneficiary ID, claim type, referring 
physician, carrier number and up 8-12 diagnosis codes) and line files (contains the HCPCS and 
ICD-9 diagnosis codes as well).  
 3.6.3.1.5 Investigating chronic disease rates in a sample of Medicare Beneficiaries 
 Ideally, in order to capture all cases of disease and comorbid conditions in a sample of Medicare 
beneficiaries, it may be best practice to restrict analyses to enrollees who have FFS Medicare A and B 
coverage. However many beneficiaries with part A coverage have a state buy-in via Medicaid to cover the 
part B premium. Those enrolled in Medicare Part C have managed care coverage, and the transactional 
data regarding services received are not included in the claims data files. The MBSF indicates the type of 
Medicare coverage obtained. The Medicare state buy-in variable appears 12 times in the MBSF to 
represent each month of coverage. The values within this variable indicate whether the beneficiary had 
Medicare Part A and/or B coverage for the month, and whether there was state buy- in (i.e., Medicaid) for 
the Part B premium. A limitation of this state buy-in variable is that it does not provide information 
regarding whether the beneficiary was entitled to full or only partial Medicaid benefits. To determine 
whether the beneficiary had Medicare FFS or managed care coverage, the HMO indicator variable 
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appears 12 times to represent each month of coverage. The MBSF also contains information regarding 
whether the person was dually eligible for both Medicare and Medicaid services. 
 Not all Medicare enrolled beneficiaries will have used Medicare-paid services in a particular time 
frame. Some do not use any medical services at all, while others may use services that are paid by a third 
party (e.g., the Veteran’s Administration). Third party claims do not appear in the Medicare data files. 
 3.6.3.1.6 Patterns of Health Care Utilization 
 Institutional claims cover both inpatient and outpatient settings. Non-Institutional claims cover a 
variety of settings including physician office, laboratory, imaging, procedures, and others. Visits with 
health care professionals in the ambulatory setting may take place in an outpatient facility or a provider 
office setting. Outpatient care is identified from the Institutional Outpatient claims files. Physician Office 
Care, is a small portion of the claims found in the Part B Carrier files.  
 Hospital Outpatient (HOP) claims are considered Institutional data files due to the type of claim 
used with Medicare, even though these claims are generally paid through the Medicare Part B benefit. 
Part B non-institutional – “carrier” – claims include: evaluation and management (physician office, 
specialist, consultation…), procedures (anesthesia, major cardiac procedure…), Imaging (echography, 
standard imaging), labs, DME etc.  
 For some services there could be an Institutional or Non- Institutional claim, or both claim types. 
In general, the professional component of a service (e.g., the physician or therapist care) appears in the 
Non-Institutional file (Part B Carrier), whereas the facility claim for an associated service, when 
applicable, appears in the Institutional file (Part A Inpatient or Skilled Nursing Facility [SNF]). 
 One of the most common examples of a type of service which may appear in either the 
Institutional or Non-Institutional claims is outpatient clinic-type services for physician/other provider 
care. Understanding the ambulatory care provided to a patient (e.g., a physician/clinic visit for a service), 
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requires examining the hospital outpatient file (hospital-based clinics, RHCs and FQHCs) in addition to 
the Part B Carrier files. 
 3.6.3.1.7 Diagnosing Disease in Medicare 
 Medicare claims use the ninth version of the International Classification of Diseases (ICD-9) to 
classify all diagnoses, which identify the condition(s) for which a patient is receiving care. Claims data 
generally allow providers to specify numerous diagnosis codes (up to 25 codes for Part A claims and up 
to 12 codes for Part B claims beginning with claims files from 2009, when the version J data file layout 
was implemented), with one diagnosis identified on the claim as the principal or primary diagnosis. The 
diagnosis codes appear on the base claims.  
 Medicare assigns hospital discharges to diagnosis-related groups (DRGs), a classification system 
that groups similar clinical conditions and procedures. The beneficiary’s principal diagnosis and 
secondary diagnoses, as well as any procedures performed during the stay, are used to determine the 
appropriate DRG. Medicare switched to a modified system, called Medicare Severity Diagnosis Related 
Groups (MS-DRGs) on October 1, 2007; both DRGs and MS-DRGs appear in the base portion of the 
claims. 
 Sometimes, to reduce the risk of false positives during outcome ascertainment, it may be prudent 
to require the presence of more than one claim to rule-in the condition of interest. In the CCW, for 
example, some chronic conditions in the Medicare population are pre-coded and appear in the MBSF – 
Chronic Conditions segment. The algorithms for these conditions are very precise regarding the number 
of claims, the specific types of services, and the number of years of data which must be examined to make 
a CCW determination regarding whether a person was likely receiving care for a particular condition. 
Incidentally, the use of this information assumes that if a claim was processed with a particular diagnosis 
code, the patient was receiving care for that particular condition.  
 3.6.3.1.8 Limitations of using Medicare data for computing rates for persons < 65. 
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 Medicare beneficiaries aged < 65 may differ from the general Medicare population and the 
general U.S. population in several ways that may affect disease outcomes. So when the goal is to calculate 
rates for certain metrics, it may be desirable to consider sensitivity analyses excluding these persons.  
3.6.3.2 Medicaid 
 3.6.3.2.1 The Medicaid Program 
 The Medicaid Program provides medical benefits to groups of low-income adults, children (State 
Children’s Health Insurance Program), pregnant women, elderly adults and people with disabilities, some 
who may have no medical insurance or inadequate medical insurance. Medicaid is administered by states, 
according to federal requirements and the program is funded jointly by states and the federal government. 
 Medicaid key eligibility groups include: a) the categorically needy like pregnant women and 
children under age 6 whose family income ≤ 133 % of the Federal poverty level; b) medically needy like 
persons aged ≥65 and disabled persons whose income levels do not allow them to qualify as categorically 
needy; and c) Special groups like Qualified Medicare Beneficiaries (Medicaid pays Medicare premiums, 
deductibles and coinsurance for individuals with income ≤100% of the Federal poverty level and 
resources ≤ 2× the standard allowed under SSI). 
 Mandatory services provided by State Medicaid plans include Inpatient and Outpatient hospital 
services including FQHCs and RHCs, Labs and X-rays etc. 
 3.6.3.2.2 Medicaid data sources 
 Each state’s Medicaid agency collects enrollment and claims data for persons enrolled in 
Medicaid and the Children’s Health Insurance Program (CHIP).  These data are collected in the state’s 
Medicaid Management Information System (MMIS) which is the basic source of state-submitted 
eligibility and claims data on the Medicaid population, their characteristics, utilization, and payments.  
Because the Medicaid program varies by state, the data in the MMIS are converted into a national 
standard and submitted to CMS via the Medicaid and CHIP Statistical Information System (MSIS). 
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 The MSIS enrollment and claims data are reported to CMS on a quarterly basis.  The enrollment 
data identify Medicaid and CHIP enrollees in each month of that quarter and whose enrollment in a prior 
period should be revised (due to a correction or retroactive enrollment).  The fee-for-service (FFS) claims 
data identify persons who received service.  The FFS claims data are submitted based on the quarter in 
which the claim was adjudicated, not when the service was performed.  The managed care encounter 
records identify who received what service under which managed care organization and from which 
provider. The encounter records are submitted based on the quarter in which the encounter was processed, 
not when the service was performed.   
 The MSIS data are challenging to use for research because the data represent a mixture of time 
periods.  CMS developed the Medicaid Analytic Extract (MAX) files, which is a more research-friendly 
set of Medicaid administrative files. The enrollment information in MAX identifies monthly enrollment 
after the retroactive/correction records have been applied and after certain state-specific data elements are 
transformed into a consistent, national format.  The claims in MAX identify the services rendered.  The 
enrollment pertains to people enrolled in the given calendar year and claims pertain to the services 
rendered in that same time period, thereby making a consistent—and more meaningful—time period for 
analyses of enrollment and service utilization. 
 3.6.3.2.3 Medicaid Analytic eXtract (MAX) Data for Research Purposes 
 Medicaid analytic extract (MAX) data are person-level data files on Medicaid eligibility, service 
utilization and payment information for all Medicaid enrollees – whether they have received one or more 
Medicaid service in a given calendar year or none. The purpose of MAX is to produce data to support 
research and policy analysis on Medicaid populations.  
 MAX is produced from 7 Fiscal Year quarters of MSIS data from all 50 states plus the District of 
Columbia. All 7 quarters of MSIS data needs to be approved (due to lags in obtaining updated eligibility 
information and adjudicating claims) in order to create MAX data.  
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 a) MAX Production 
MAX transforms data from the 7 fiscal year quarters to a calendar year; MAX data is event based. For 
every service rendered for every Medicaid beneficiary, MAX combines initial claims voids and other 
adjustments to create a “final action event”. 
 b) MAX Datasets 
MAX consists of 1 Person Summary File and 4 Claims Files inpatient, long term care, prescription drug 
and other services). The former includes person level data on eligibility, demographics, managed care 
enrollment, a summary of utilization and Medicaid payment by type of service. The files include fee for 
service (FFS) claims as well as managed care encounter data. 
 c) MAX Enhancements to MSIS Data 
 MAX provides more detail on Medicaid Eligibility: Improved identification of unique enrollees; 
retroactive eligibility in proper chronology; verified eligibility with eligibility data added to each claim. 
 Data on Dual Medicare and Medicaid Status: 
• Qualified Medicare Beneficiaries. (QMB’s) 
• Specified Low –Income Medicare Beneficiaries. (SLMB’s) 
• Identifies and links Medicare HIC number and Medicaid Case Number. 
MAX provides detail on service claims including types of service and detailed data on conditions and 
treatments such as ICD-9-CM Diagnostic Codes, Procedure Codes and National Drug Codes, Improved 
Coding for Services and therapeutic usage data added to each prescription drug record. 
 d) Enhancements to MAX Data 
 Some key novel enhancements to the data include: improved verification of SSNs, expanded 
detail on enrollee race and ethnicity, Monthly dual Medicare and Medicaid enrollment (earlier years were 
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reported quarterly); link to Medicare Enrollment Data Base (best way to identify dual eligible) and 
capability for other linkages (e.g. SSA) 
  e) Challenges in Developing Consistent Medicaid Data 
There are challenges related to a) Medicaid differences (including eligibility and types of services 
provided) across states, over time and when Fiscal Agents change; b) Eligibility and Type of services 
provided  
 f) Limitations of Medicaid Data 
These are related to a) Eligibility (e.g. minimal information on other insurance coverage) and b) Services 
(provided only during “spells of eligibility”, varying service coverage varies by state, incomplete data for 
“dual eligibles”) c) data are not always available in a timely fashion. 
 3.6.3.3 Preliminary data and challenges in ascertaining complete and continuous CMS 
coverage for SCCS Sub-cohort  
  1. Inclusion Criteria for the proposed study  
 As the SCCS uniquely captures a population of underserved, underrepresented, and often 
uninsured participants, in order to ascertain incident HF, use of Medicaid and Medicare claims databases 
will be used.  To increase the likelihood of participants having complete and continuous coverage in 
Medicare and/or Medicaid from the time of SCCS enrollment to the end of the follow-up period 
(December 31st, 2010), for the ascertainment of incident HF events we are restricting the analyses to: 
 Persons ≥ 65years (n = 7001) at cohort enrollment, or persons < 65 years (n = 20,077) at 
enrollment who: a) reported being covered by Medicaid on the baseline questionnaire; or b) 
reported being covered by Medicare on the baseline questionnaire; or c) did not report Medicare 
or Medicaid on the baseline questionnaire but had a CMS claim within 3 months of being 
enrolled in SCCS.  
The numbers for the mutually exclusive groups are given in Table 9 below: 
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Table 9: Exclusive participant categories based on the inclusion criteria for the current study 
Criteria n % 
Aged ≥ 65 at enrollment 7001 25.9 
Aged ≤ 65 and reported Medicaid at enrollment 12023 44.4 
Aged ≤ 65 and reported Medicare at enrollment 4852 17.9 
Aged ≤ 65 and Any CMS Claim within 90 days 3202 11.8 
Total 27078 100 
  
 2. Ascertaining CMS coverage for participants aged ≥ 65 for proposed study 
  Table 10: Self-reported CMS categories among participants aged ≥ 65 
 n % Any CMS Claim ≤90 days, % 
Medicaid Only 537 7.7 76.7 
Medicare Only 4264 60.9 75.1 
Both 1513 21.6 82.2 
None 394 5.6 42.1 
Missing 293 4.2 62.8 
Total 7001 100 74.4 
 
 Overall, over 82% of persons in the current SCCS sub-cohort filed a claim in CMS within 90 
days of enrollment regardless of self-reported CMS coverage at baseline; that figure is ~74% among 
persons aged ≥65. For participants 65 years and older, there may be near-complete capture of Inpatient 
claims through Medicare; but with data suggesting over 80% of the general Medicare population having 
part B coverage, it would be important to investigate the proportion of participants in our study with part 
B coverage to ensure we’re capturing events reported via physician encounters. However, with over 21% 
of persons reporting both Medicare and Medicaid, this could suggest there is a sizable proportion of 
persons with Medicaid state buy-ins to cover part B carrier benefits. 
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 3. Ascertaining CMS coverage for participants aged < 65 in the proposed study 
  Table 11. Self-reported CMS categories among participants aged < 65 
 n % Any CMS Claim ≤90 days, % 
Medicaid Only 8910 44.4 81.6 
Medicare Only 4852 24.2 78.5 
Both 3113 15.5 88.3 
None 739 3.7 100 
Missing 2463 12.2 100 
Total 20077 100 84.8 
 Among participants < 65, over 84% had a CMS claim within 90 days of enrollment; importantly, 
even among those who reported no CMS coverage, 100% of them filed a CMS claim probably due to the 
fact that States allow eligible persons to enroll in Medicaid at the points-of-care when service is needed 
(and many do in fact enroll at the time care is needed at their coverage status is updated retroactively in 
MAX). Eligibility for Medicaid does change over time so follow-up data (based on SCCS follow-up 
interviews) is needed to document the proportion of study participants claiming Medicaid coverage at 
baseline who still reported Medicaid at follow-up. However, as this preliminary findings suggests, 
eligible persons could still obtain care via Medicaid (and hence considered as having “continued CMS 
coverage”) when care is needed regardless of self-reported Medicaid coverage or lack thereof. Also, while 
a participant’s enrollment in Medicaid may vary over time, it is likely in the low socioeconomic status 
population of the SCCS that participants in Medicaid at enrollment will remain in Medicaid throughout 
the follow up period.  
 We would consider additional analyses among participants with documented CMS encounters; 
with over 81% having a Medicaid claim within 90 days of enrollment, we may have higher numbers of 
persons with documented Medicaid encounters throughout the study. 
 3.6.3.4 Assessing the validity of International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) codes for HF 
 The diagnosis code (ICD-9 428x) [119] algorithms for identification of HF in the proposed study 
have been previously validated.  A review of the detection of heart failure in administrative claims data 
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included eight studies conducted among Medicare beneficiaries reported positive predictive values 
(PPVs) between 76% and 99%, with the majority of the studies reporting PPVs over 90% [119].  These 
codes have also been used with high specificity in a number of studies [120, 121]. 
 Goff et al investigated the validity of the use of ICD 9 codes to identify hospitalizations with 
clinical evidence of CHF using data from the Corpus Christi Heart Project, a population-based 
surveillance program set up to investigate the natural history of CHD in non-Hispanic whites and 
Mexican Americans [119]. Eligible cases (n= 5083, mean age = 60.4, 37% female) were subjects 
admitted for possible acute myocardial infarction, aortocoronary bypass surgery, percutaneous 
transluminal coronary angioplasty, and related revascularization procedures.  Enrollment took place by 
monitoring admissions to special care units at the 7 hospitals in the Nueces County, TX. For all potential 
cases, data on sociodemographic factors, medical history, electrocardiograms, and hospital discharge 
diagnostic codes were collected. 
 The clinical documentation of CHF was considered the validation standard and was ascertained 
based on clinical evidence of acute CHF i.e. a composite variable including a) the presence of physician-
diagnosed acute CHF in the medical records and b) radiographic evidence of pulmonary edema [119]. 
The choice of the clinical diagnosis as the validation standard was based on the premise that the sources 
of the clinical evidence were the primary data in the medical record; whereas, the discharge diagnoses 
were applied based on a review of the record by the attending physician and/or other members of the 
health care team. Thus, the discharge diagnoses are a secondary source of data. 
 The sensitivity, specificity, PPV and NPV were examined 3 ICD discharge diagnosis code–based 
classification algorithms: (1) the presence of ICD code 428, (2) the presence of either ICD code 428 or 
402, and (3) the presence of any of the ICD codes listed in the table below: 
 The prevalence of a medical record documented episode of acute CHF was 27.1% when defined 
either by either criteria. The 2 sources of information agreed for 64.4% of the patients classified as having 
clinical evidence of an episode of acute CHF, 24.4% were classified on the basis of medical record 
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notations alone, and 11.2% were classified on the basis of data from the chest radiograph alone; the 
overall agreement of classification was 90.4% (κ = 0.72, P < 0.001). 
 The ICD code 428.x for HF, assigned as the primary or a secondary discharge diagnosis, was 
associated with 62.8% sensitivity, 95.4% specificity, 83.5% positive predictive value, 87.4% negative 
predictive value, and a 24.8% under-estimation of CHF-related hospitalizations. So while the PPV and 
NPV were good, there was an underestimation of the number of CHF cases. There were differences in 
performance across the age spectrum and Goff et al suggested that these performance statistics were 
likely to differ with those observed in a non-CHD population [119].  
 Fisher et al examined the accuracy of ICD 9 codes as performed in the 1985 National DRG 
Validation Study, which carefully re-abstracted and reassigned ICD-9-CM diagnosis and procedure codes 
from a national sample of 7050 medical records, to determine whether coding accuracy had improved 
since the Institute of Medicine studies of the 1970s and to assess the contemporaneous coding accuracy of 
specific diagnoses and procedures [124]. For the identification of CHF among Medicare enrollees, the 
validation standard were ICD 9 codes applied by accredited medical records technicians who were 
blinded to the diagnoses assigned by the hospitals. Ergo, this study could be viewed as an assessment of 
agreement between coders. The sensitivity of any of HF-related ICD codes 402.01, 402.11, 402.91, and 
428-428.9, was reported to be 85% (with a PPV of 87%) when the principal diagnosis was examined for 
the ability to detect the primary reason for admission and 89% when any of the diagnoses were examined 
for the ability to detect a case of HF identified and treated during the admission; specificity was 99% and 
95%, respectively. Thus, greater performance statistics were observed in this Medicare population using a 
different validation strategy.  
 In summary, the results of the validation studies suggest that reliance on ICD codes may 
underestimate the proportion of persons with HF particularly if there is over reliance on a primary claim 
for HF.  
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 In the proposed study, we would use both primary (i.e. code in the first position) and non-primary 
(i.e. code in any position) diagnoses of HF to boost our capture of HF cases. However, we do recognize 
that given there may be some misclassification of cases as non-cases; less so in the reverse direction since 
most studies have shown very high specificity. This may lead to an under-estimation of our incidence 
rates given the reduction of the numerator in the incidence rate calculation.  
 Also, we hypothesize that this misclassification would be non-differential across levels of our 
predictors of interest (race-sex categories; weight-height index and deprivation index). It is known that 
the presence (or absence thereof) of bias when we have non-differential misclassification of a binary 
disease outcome depends on whether we have incomplete ascertainment of outcome (<100% sensitivity) 
or persons without the outcome are misclassified (< 100%specificity) [125]. If the former, the risk ratio 
estimate remains unbiased but the absolute magnitude of the risk difference is biased towards the null by 
a factor equal to the probability of false-negatives. On the other hand if we have imperfect specificity but 
perfect sensitivity the risk ratio is biased towards the null; the risk difference is biased towards the null by 
a factor equal to the false-positive probability. With near-perfect specificity reported in most studies and 
lower sensitivity, there may be little bias in our effect estimates.   
3.7 Predictors and Covariates 
 During recruitment, SCCS participants provided information about demographics (race, sex and 
date of birth/age), socioeconomic characteristics (annual household income and level of education), 
personal and family medical history, anthropometric parameters (height, weight and waist circumference), 
lifestyle factors (tobacco and alcohol use history), marital status and total physical activity.  
 Participants also provided information on their residential address at the time of interview. The 
full address history for SCCS participants was then geocoded by a multi-stage process incorporating both 
batch and interactive processes. The Census 2000 area unit (state, county, census tract and ZIP Code 
Tabulation Areas – ZCTAs) for the geocoded address was determined by a spatial join to TIGER/Line® 
Shapefiles using ESRI ArcMap 10.0 software (ESRI, Redlands, CA). Geocoding of SCCS participants’ 
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addresses and linkage to geographic information datasets such as census tract data, allowed development 
of residence-specific characteristics (and environmental measures using information from external data 
resources) including an SCCS-derived deprivation index.  
 Census Tracts are small, relatively permanent statistical subdivisions of a county or equivalent 
entity that are updated by local participants prior to each decennial census as part of the Census Bureau's 
Participant Statistical Areas Program [126]. Census tracts generally have a population size between 1200-
8000 persons, with an optimum size of 4000.  A census tract usually covers a contiguous area; however, 
the spatial size of census tracts varies widely depending on the density of settlement.  Census tract 
boundaries are delineated with the intention of being maintained over a long time so that statistical 
comparisons can be made from census to census. Census tracts will be used as proxies for neighborhoods 
in these analyses. 
3.7.1 Weight-Height Index (W/Hn)  
 We would derive the appropriate weight-height index for the current cohort based on the 
coefficient of the log weight and log height variables in a bivariate Cox model for the log hazard of HF.  
As previously mentioned, SCCS participants reported their height and weight at baseline. These were 
validated using data from a random sample (n ≈ 14,000) of SCCS participants for whom measured weight 
and height were either a) abstracted from contemporaneous CHC medical records or b) obtained via 
measurements performed by trained interviewers using a SECA 703 digital scale and a stadiometer on the 
day of the interview [107]. There was a very high correlation (r > 0.95) between measured and self-
reported weight and height [18]. 
3.7.2 Deprivation Index  
 The SCCS-derived deprivation index is a clustering of social and economic indicators which 
reflect neighborhood deprivation and that have been linked to adverse health outcomes. It was constructed 
using principal components analysis. 
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 Principal components is a data reduction technique used to create orthogonal (uncorrelated) 
variables – from a group of possibly correlated predictors – that best explain the variation in the 
predictors or “x-space”. These orthogonal variables or eigenvectors are linear combinations of the original 
variables; they described how variables "contribute" to each factor axis and the eigenvalues of each 
orthogonal variable represents how much of the variance of the “X-space” is predicted by the variable in 
question. The variables are often scaled and centered before the computation of the principal components. 
The first principal component, PC1, is the linear combination of the standardized variables having 
maximum variance [127]. The second principal component (PC2) is the linear combination of predictors 
having the second largest variance such that PC2 is orthogonal to PC1. For a total of p predictors, the first 
k PCs (where k < p), will explain only part of the variance in the whole system of p predictors or the “x-
space” unless one or more of the original variables is exactly a linear combination of the remaining 
variables [127]. 
 To construct the PCs for neighborhood-deprivation index in SCCS, 11 census tract-level variables 
representing 4 main dimensions were considered: 
a) Social indicators – percentage of housing units with ≥ 1 occupant per room and percent female 
headed households with dependent children.  
b) Wealth and income – percentage of households with income < $30,000 per year, percentage of 
households with public assistance income, percentage of households with no car and median 
household value, percentage of occupied housing units with renter/owner’s costs > 50% of 
income and percentage of persons with income below the 1999 poverty status. 
c) Education – percentage of persons aged ≥ 25 that did not graduate high school  
d) Occupation – percentage of males and females who are unemployed and percentage males in 
professional occupations.  
 Only the first principal component was retained for the construction of the deprivation index 
given it explained most of the variability in the component measures [128].    
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3.7.3 Socioeconomic Status 
     a. Education: SCCS participants were placed in 8 categories according to their highest level of 
education attained ranging from less than high school to graduate-level degrees.   
     b. Income: Participants reported the range of their total household income for the year prior to 
enrollment and were placed in 5 categories ranging from less than $15 to over $100,000 or more. 
3.7.4 Covariates 
 Participants reported history of tobacco smoking as never, former and current and also in terms of 
number of cigarettes per day and alcohol use in number of drinks per day. The presence of traditional 
cardiovascular risk factors at baseline was based on a self-reported history of physician-diagnosed 
hypertension, diabetes mellitus, high cholesterol, as well as self-reported use of medications for 
hypertension, diabetes mellitus, or high cholesterol.  History of chronic disease occurrence for self-
reported conditions was confirmed via confirmation medical records for a small random sample of SCCS 
participants. Total physical activity was measured as total metabolic equivalent-hours per day spent doing 
light, moderate and strenuous occupational/household work and moderate and vigorous exercise. 
 3.7.4.1 Challenges related to covariate measurements 
  3.7.4.1.1 Determination of covariates at baseline 
  Demographic, anthropometric, and cardiovascular risk factors will be determined by self-report 
of a physician diagnosis and use of medications (for traditional cardiovascular risk factors).  While self-
report may be susceptible to recall and misclassification bias, these methods have been successfully used 
and validated in large epidemiologic cohorts. Many of the questions on the SCCS questionnaire were 
adapted from questionnaires used and validated in other settings, and a series of independent validation 
studies using biomarkers, repeat interviews or medical records have demonstrated the reliability of the 
questionnaire within the SCCS population for variables such as tobacco use status, self-reported diseases 
including diabetes, height and weight. 
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  3.7.4.1.2 Handling changes in covariates over time 
 Another major challenge we’re faced with is the temporal variations in the values of certain 
covariates during the follow-up period particularly smoking status, diabetes status and body weight. 
Ignoring these secular variations in the values of these key covariates could be a potential source of bias 
of our effect estimates and the direction of bias can be difficult to predict.  One option would be to model 
these variables as time-varying covariates (TVCs) in our multivariable Cox Models. There is follow-up 
data for close to 60% of the SCCS cohort. If this proportion is the same for our current sub-cohort (n = 
27078, identified based on our inclusion criteria for the current analyses) we could perform time-
dependent analyses for close to 16,000 persons.  
 However this poses another conundrum; namely: how do we guard against any potential selection 
bias if those with covariate data for these key time-varying covariates differ meaningfully from those 
without ( n ~ 10,000) on other important covariates such demographics and other lifestyle and clinical 
factors? Also, given our goals of investigating differences in measures of frequency (incidence rates) 
across groups defined by race and sex as well as examining potential departures from additivity of effects 
by race and sex, an analyses restricted to this smaller sample may lack sufficient power. Striking an 
optimum bias-precision trade-off in this approach would be crucial. One way of boosting the power and 
precision of these supplemental analyses using TVCs would be to perform multiple imputation of 
covariate values for study participants without covariate data at follow-up, if the data can be considered to 
be “missing at random”. By utilizing multiple imputation in an attempt to “preserve” information we 
would simultaneously reduce bias in estimates and provide estimates of the variance-covariance estimates 
of beta-hat penalized for imputation [127]. 
 Another important consideration in our supplemental analysis would be the selection of the 
functional form for modelling smoking status in relation to post-HF survival. As seen with previous 
studies between smoking status and survival different options e.g. using a step function for “current 
smoking” that is updated at every time point (1 if yes, 0 if no)  or using a time-lagged variable could yield 
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different results [129]. In the Coronary Artery Surgery Study (CASS) in which patients with mild angina 
were randomized to medical treatment or CABG, data on smoking status were collected every 6 months, 
and, for the first analysis, a step function (with 6 months intervals) was used [130]. Much to the surprise 
of the investigators, whilst not statistically significant, the estimated effect of current smoking on survival 
was positive i.e. protective. A closer look at the patient’s smoking histories revealed that most patients 
who died were in fact smokers but many had quit smoking at the last follow-up before their death. In 
several instances this was apparently explainable by hospitalization for a myocardial infarction or 
congestive heart failure and other compelling health reasons that prompted smoking cessation at last 
follow-up. So if smokers with a high risk of death quit just before dying we may have ended up with a 
scenario similar to confounding by indication. By using time-lagged covariates or percentage of time 
during follow-up for which the subject smoked the investigators found an inverse relationship (as 
expected) between smoking and survival. In order to adequately model the confounding effect of smoking 
in our proposed supplemental analyses, similar approaches would have to be employed. 
 Similarly, study participants could likely experience weight gains (or loss) during follow-up 
suggesting it may be appropriate to model weight-height index using TVCs vis-a-vis its relationship with 
post-HF mortality. However, persons who are subsequently diagnosed with HF may experience some 
unintentional weight loss before HF diagnosis (and lower BMI has been found to be associated with 
lower post-HF survival – the “obesity paradox”). Hence, would it be appropriate to utilize their weight 
measurements during follow-up that may be taken just before HF diagnosis? On the other hand if the 
baseline measure is used, would that be a true measure of the exposure experience for persons whose HF 
is diagnosed several years later after enrollment? It may be argued that both approaches have trade-offs 
that have to be weighed-up against each other. 
 Also we would have to give careful thought to our working hypothesis of the relationships 
between our time varying covariates as well as their relationship with HF incidence. For example let’s 
examine the hypothesized relationship between smoking, body weight (or weight-height index) and heart 
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failure risk. First, at baseline there could be an association between smoking status and weight-height 
index, based on a priori epidemiologic evidence suggesting weight loss among smokers. Second, persons 
who have lost weight while smoking may subsequently decide to either a) smoke even more in order to 
foster more weight loss or b) quit; having achieved their goal. The association could be conceived as 
shown below: 
  
 
 
 
 
 
 If these assumptions of the associations between these variables are true, then smoking status at 
baseline could be considered as a confounder of the association between W/Hn and HF risk; while 
smoking status at follow-up would be considered a mediator hence the term “time-varying confounder-
mediator” in some statistics literature. Adjusting for only the baseline or follow-up values of cigarette 
smoking will lead to biased estimates. One option would be to use marginal structural models to estimate 
the effect of weight-height index on HF risk by appropriate control for the effects of time-dependent 
confounders. In these models, the predictor – outcome association is estimated in a regression model that 
is weighted using the inverse probability of treatment weights [131]. 
 3.7.4.1.3 Residual Confounding and Unmeasured Confounders 
 The unique design of the SCCS cohort with participants who are of similar (and generally low) 
SES regardless of race or sex, as well as the well-documented nature of the information on socioeconomic 
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characteristics that can be additionally controlled for statistically, would mitigate potential confounding 
by socioeconomic factors of differences in HF risk and post-HF survival by race and sex. 
 However there is always the possibility of residual confounding due to unmeasured factors. One 
such unmeasured factor is the treatment for HF; the latter not be available via linkage with the Medicare 
part A/B carrier and outpatient base files. As an important predictor of heart failure survival, if there are 
unobserved differential patterns in HF treatment between groups defined by race and sex, these could 
confound our findings on the patterns of post-HF survival. Importantly, even if HF therapy didn’t differ 
across levels of any of our predictors of interest, being a strong predictor of the outcome, failing to adjust 
for it moves our hazard ratios towards the null. 
3.8 Statistical analyses 
3.8.1 Data Management and handling of “missingness” 
 Data management and quality control for the SCCS data is performed at the International 
Epidemiology Institute (IEI) which provides de-identified datasets to investigators upon approval of 
proposal applications.   
 Before performing substantive data analyses we will screen all variables for abnormal or 
inconsistent values (e.g. a male subject with an entry for menopausal status) and outliers.  Implausible 
values would be reported to the SCCS data management team at the International Epidemiology Institute 
for appropriate checks and if unresolved, the observation would be considered for case-wise deletion 
given that other measurements for that participant may have been incorrectly entered as well.   
 Proportion of missingness for each variable would be computed and reasons for missingness will 
be examined (e.g. missing value for number of cigarettes smoked per day because participant was a non-
smoker). Logistic models would be used to predict the probability of missingness for each predictor 
variable given the other covariables and the outcome. Patterns of simultaneously missing variables would 
be described; we would perform cluster analyses of the missing value status of all variables. Complete 
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cases would be examined in detail to investigate patterns in the probability of observations being a 
complete vs non-complete case.    
 Assuming data are missing at random we will perform multiple imputation for the missing values 
utilizing the aregImpute algorithm in the Hmisc package in R. The aregImpute algorithm takes all aspects 
of uncertainty in the imputations into account by using the bootstrap to approximate the process of 
drawing predicted values from a full Bayesian predictive distribution [132]. Different bootstrap resamples 
are used for each of the multiple imputations. A flexible additive model, is fitted on a sample with 
replacement from the original data and this model is used to predict all of the original missing and non-
missing values for the target variable, then the imputation models are run. By default, linearity is assumed 
for target variables (variables being imputed) and nk  = 3 knots are assumed for continuous predictors 
transformed using restricted cubic splines. AregImpute uses predictive mean matching with optional 
weighted probability sampling of donors rather than using only the closest match [132].  Predictive mean 
matching works for binary, categorical, and continuous variables without the need for iterative maximum 
likelihood fitting for categorical variables, and without the need for computing residuals or for curtailing 
imputed values to be in the range of actual data. 
 The missing data will be filled-in using these simulations a number of times to create that same 
number of complete datasets.  For each completed dataset, the regression model will be fitted and the 
regression coefficients will be averaged over multiple imputations.   
3.8.2 General analytic approach 
 Descriptive statistics (means and standard deviations for continuous variables and counts and 
percentages for categorical variables) would be computed for HF cases and non-cases.  
 To investigate the incidence of HF, duration of follow-up would be computed from date of entry 
into the SCCS until the date of the first diagnosis of HF, date of death, or December 31, 2010, whichever 
occurred first. Incidence rates (IR) of heart failure would be calculated for white women, black women, 
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white men and black men by dividing the number of HF cases by person-time of follow-up, and the rates 
would be presented per 1,000 person-years.  
 For analyses of post-HF survival among those with a diagnosis of incident HF, follow-up time 
was defined as time from HF diagnosis to death or December 31st 2010 whichever occurred first. Kaplan-
Meier survival curves would be plotted by race and sex. 
 In the multivariable models for both outcomes (HF incidence and post-HF survival), we would 
include indicator variables for white men, black women and black men, with white women as the 
reference group. The covariates would include: BMI, history of diabetes, hypertension, high cholesterol, 
MI/CABG or stroke, household income, education, cigarette smoking, alcohol intake, marital status and 
enrollment source (community health centers vs general population). Tests for interaction of 
anthropometric surrogates (W/Hn) and deprivation index with sex and race will be conducted by adding 
the corresponding cross-product terms (including the linear and non-linear spline terms) to the models.  
3.8.3 Selection of Candidate Confounders and spending degrees of freedom for 
covariates 
 3.8.3.1. General Approach to selecting confounders for the multivariable models. 
 1. Directed acyclic graphs. 
 For each aim we would first develop a conceptual model of the hypothesized relationships 
between the main predictor of interest (race, sex, weight-height index and deprivation index), the outcome 
(heart failure incidence or post-HF death) and the covariates that are potentially associated with both the 
exposure and the outcome based on prior epidemiologic evidence. 
 Second we would develop directed acyclic graphs for each association of interest in other to 
ascertain the full model required to properly adjust for confounding effects without opening backdoor 
paths by adjusting for colliders. 
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 However, in order to avoid compromising precision, we would choose a minimum sufficient set 
of candidate confounders that minimizes bias and maximizes precision hence optimizing the bias-
precision trade-off. Once the minimum sufficient set is fixed models would not be further simplified in 
order to avoid problems related to “phantom” degrees of freedom or potentially introducing bias into the 
models resulting from residual confounding or “incomplete conditioning”. Also we would choose the 
number of degrees of freedom to be spent on each variable based on its predictive promise in order to 
maximize precision.   
 Colliders would not be adjusted for in the models (unless we can close all open-paths which are 
opened by adjusting for these) and variables that are considered to be mediators (diabetes, dyslipidemia 
and hypertension, past history of myocardial infarction and stroke) would only be included subsequently 
during “mediation” analyses.  
 We would use this approach for all 4 aims as this ensures the best bias-precision trade-off. Other 
options are discussed below which we would not consider as each has shortcomings related to residual 
confounding and a less than optimal bias-precision trade-off. 
 2. Including covariates in the Full Model if they are found to be both associated with the exposure 
in the total population and the outcome in the referent group of the predictor of interest (the 
“unexposed”).   
 Hypothetically, for this approach, first any covariate that has a significant association with the 
predictor of interest (which varies from aims 1 through 4) and is also associated with the outcome (HF or 
post-HF death) would be included in the full model. Second, variable removal would be performed by 
backward elimination based on the variable which results in the least change in log hazard ratio of the 
exposure of interest when left out of the full model. The model is refitted and the variable with least 
change in log hazard ratio is removed again until all remaining variables result in a change of more than 
10% of the log hazard ratio. This method is not appropriate as it is likely to leave out some important 
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(albeit weaker) confounders; produce biased estimates of effect; problems related to phantom degrees of 
freedom subsists and the method is unlikely reproducible making results incomparable across studies. 
 3. Selecting covariates for inclusion in the full model based on whether they result in a 10% 
change in estimate (log hazard ratio) when added to a model containing only the predictor of interest.     
  3.8.3.2 Covariates for the association between race (and sex) and heart failure 
incidence (and post-HF survival).    
 Based on the hypothesized relationships between the variables we would use the following 
approach for adjusting for important covariates when examining the association between race, sex and HF 
incidence (and post-HF survival): 
 Three models would be constructed, with white women as the referent category: model 1 would 
include indicator variables for white men, black women and black men and age (restricted cubic splines 
with 4 knots); model 2 would be additionally adjusted for body mass index (restricted cubic splines with 4 
knots), and history of diabetes, hypertension, high cholesterol, MI/CABG or stroke (all yes/no); model 3 
would be additionally adjusted for the following covariates: household income (<$15000, $15000-$24999 
& ≥$25000); education (< high school, high school/vocational training/junior college, college degree or 
higher), smoking status (4 categories: never/former/current <19.5 pack-years/current ≥ 19.5 pack-years), 
alcohol intake (linear), total physical activity in MET-hours (linear & quadratic terms), marital status 
(married/living as married with partner, separated/divorced, widowed, single/never married) and 
enrollment source (community health centers vs general population). The knots for the splines would be 
equally spaced based on Harrell’s recommended percentile distribution.  
 3.8.3.3 Covariates for the association between neighborhood deprivation and HF incidence  
 Based on the conceptual model in figure 2 we would use the following approach for adjusting for 
important covariates when examining the association neighborhood deprivation index and HF incidence  
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 Four models would be constructed, model 1 would include deprivation index (1df), age (restricted 
cubic splines with 4 knots) race and sex and interaction terms between deprivation index and race and 
sex. Model 2 would be additionally adjusted for household income (<$15000, $15000-$24999 & 
≥$25000); education (< high school, high school/vocational training/junior college, college degree or 
higher). Model 3 would be additionally adjusted for body mass index (restricted cubic splines with 4 
knots), smoking status (4 categories: never/former/current <19.5 pack-years/current ≥ 19.5 pack-years), 
alcohol intake (linear), total physical activity in MET-hours (linear & quadratic terms) and history of 
diabetes, hypertension, high cholesterol, MI/CABG or stroke (all yes/no).  
 3.8.3.4 Covariates for the association between weight-height index and heart failure 
incidence (and post-HF survival) 
 Based on the DAG in figure 1 we would use the following approach for adjusting for important 
covariates when examining the association weight-height index and HF incidence/post-HF survival.  
 Three models would be constructed; model 1 would include weight-index (restricted cubic splines 
with 5 knots), age (restricted cubic splines with 4 knots), race and sex. Model 2 would be additionally 
adjusted for household income (<$15000, $15000-$24999 & ≥$25000); education (< high school, high 
school/vocational training/junior college, college degree or higher), smoking (4 categories: 
never/former/current <19.5 pack-years/current ≥ 19.5 pack-years) and alcohol intake (linear) and total 
physical activity in MET-hours (linear & quadratic terms). Model 3 would include model 2 variables + 
history of diabetes, hypertension, high cholesterol, MI/CABG or stroke (all yes/no); in order to 
investigate the effect of mediators. Interaction terms to test for additivity of effects by race and sex would 
be included. 
 3.8.3.5. Rationale for the number of degrees of freedom spent on certain covariates 
Annual household Income 
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 Over 68.6% of study participants in this SCCS sub-cohort (n= 27,078) have annual household 
income <$15,000, 17.8% have income between $15,000-24,999, 12.1% have income ≥ $25,000 and 1.5% 
have missing income data. Thus, using more than 3 categories for income, may raise statistical concerns 
related to sparse cells and model instability in the multivariable models. Income would therefore be 
modelled using 3 categories <$15,000, $15,000-$24,999 and ≥$25,000. However, we acknowledge that 
there may be some residual confounding and potential bias in our effect estimates. 
Level of Education 
 Education would be modelled using 3 categories defined as: < High school, High 
school/Vocational training/Junior college and College degree or higher. For this variable as well, we are 
making decisions based on a trade-off between spending degrees of freedom to adequately control for 
confounding and avoiding sparse cells for the higher educational levels. These categorization of the 
income and education variables would be used for all multivariable models in aims 1 to 4 
 Alternatively, we could choose our categories based on the functional form of the variable that 
best suits the “dose-response” relationship (using all 7 categories) with outcome (HF). The latter approach 
has obvious shortcomings related to decreased precision and data sparseness as earlier mentioned. 
Cigarette Smoking 
 In light of the fact that a) we’re principally interested in the smoking variable as a confounder 
rather than as a main predictor and b) the literature suggests that the effect of smoking on the occurrence 
of coronary heart disease (CHD) is much more preponderant than the progression towards HF (and hence 
it could be considered a “weak” confounder of the obesity-HF link), we would consider approaches which 
spend the least degrees of freedom in our multivariable models.  
 In all models, smoking would be modelled using 4 categories – never/former/current <19.5 pack-
years/current ≥ 19.5 pack-years; 19.5 the median pack-years among current smokers. 
Alternatively, we could consider the following approaches: 
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a) 3 categories for smoking status: never, former and current. 
b) Using these 3 categories and further splitting both former and current categories at specific cut-
points (e.g. the median) of pack-years (and the number of cigarettes smoked per day).  
c) A more parsimonious approach with 2 categories (never vs ever) + 1 continuous variable for 
cigarette-years (or pack years) [133]. By using this approach, the effect of pack-years would be 
estimated by comparing only subjects who had the same value for smoking status, that is, only 
smokers. In addition, one would center pack-years by subtracting the mean pack-years value 
from the original value for all smokers, while keeping 0 for never smokers. Such a linear 
transformation of pack-years does not change its estimated effect, but it allows the effect of ever 
smoking to compare average smokers with never smokers, since both groups are assigned a 
value of 0 for centered cigarette-years [133]. Without this transformation of cigarette-years, the 
estimated hazard ratio for ever smoking would be more difficult to interpret, as it would compare 
never smokers and hypothetical smokers with 0 cigarette years. Thus, the model using both 
variables provides interpretable estimates of both the qualitative effect of smoking status and the 
quantitative effects of smoking exposure.  
Sensitivity analyses would be performed to observe any changes in parameter estimates with varying 
functional forms of the smoking variable. 
 For all other covariates, in the final models, the degrees of freedom to be spent on each variable 
would be modified depending on the predictive “promise” of each variable based on the Spearman rank 
correlations (equivalent to the Kruskall Wallis test for categorical variables) between each covariate and 
the outcome without performing any hypothesis tests. 
3.8.4 Substantive analyses for Aim 1 
 To investigate differences in a) the incidence of HF and b) post-HF survival between groups 
defined by race and sex; more specifically: white women, black women, white men and black men. 
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 To investigate the incidence of HF, duration of follow-up would be computed from date of entry 
into the SCCS until the date of the first diagnosis of HF, date of death, or December 31, 2010, whichever 
occurred first. Incidence rates (IR) of heart failure were calculated for white women, black women, white 
men and black men by dividing the number of HF cases by person-time of follow-up, and the rates are 
presented per 1,000 person-years. The 95% confidence intervals (CI) would be calculated using the 
quadratic approximation to the Poisson log likelihood for the log-rate parameter [134]. To account for age 
differences between the demographic categories, age-standardized rates would be computed using the age 
distribution of the SCCS participants.  
 Multivariable Cox models would be utilized to test whether differences in crude IRs between 
categories defined by race and sex persisted after adjustment for baseline covariates. Three models would 
be constructed, with white women as the referent category: model 1 would include indicator variables for 
white men, black women and black men and age (restricted cubic splines with 4 knots). The covariates for 
models 2 and 3 and the cumulative number degrees of freedom spent for each model are tabulated below: 
 Covariates Functional form Degrees of 
freedom 
Model 1 Race and Sex 4 categories - white women (ref), white 
men, black women & black men. 
3 
 Age Restricted cubic splines (nk = 4) 3 
Model 2 Model 1 variables   
 BMI Restricted cubic splines (nk = 4) 3 
 History of diabetes, 
hypertension, high cholesterol, 
MI/CABG, stroke 
 
All (yes/no) 
5 
Model 3 Model 2 variables   
 Income (<$15000, $15000-24999 & ≥$25000) 2 
 Education < HS, HS/vocational training/junior 
college, college degree or higher) 
2 
 Smoking Status never/former/current <19.5 pack-
years/current ≥ 19.5 pack-years 
3 
 Alcohol intake Linear  1 
 Physical activity in met-hrs Linear + quadratic 2 
Total   24 
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The knots for the splines would be equally spaced based on Harrell’s recommended percentile distribution 
[127].  
 For analyses of post-HF survival among those with a diagnosis of incident HF (n = 4341), follow-
up time would be defined as time from HF diagnosis to death or December 31st 2010 whichever occurred 
first. When date of death is coincident with date of HF diagnosis, follow-up time was set to 0.5 days. We 
computed cumulative mortality for both HF cases and non-cases using contingency tables. Kaplan-Meier 
survival curves would be plotted by race and sex. Cox models would be used to investigate differences in 
cumulative hazard for death (all-cause mortality) using white women as the referent group. Model 1 
would comprise indicator variables for white men, black women and black men and age (restricted cubic 
splines with 4 knots). Variables included in models 2 and 3 would be the same as described previously. P-
values for race-by-sex interaction would be computed in models for HF incidence and post-HF survival. 
3.8.5. Substantive analyses for Aim 2 
 To investigate whether neighborhood characteristics (defined by a composite deprivation index) 
predict the risk of a) incident heart failure b) post-HF survival in SCCS beyond individual-level 
socioeconomic status (defined by household income and highest level of education attained).  
 In our data, individuals (level-1 units) are nested within census tracts (level-2 units) and the social 
and economic characteristics of the latter were used to assess neighborhood deprivation. Several options 
are available for modelling this data; each having important trade-offs.  
 3.8.5.1 Multilevel Modelling (MLM) 
   3.8.5.1.1 Multilevel Cox proportional hazards model 
 Given the nested structure of the data, a multilevel Cox proportional hazards model [135] could 
be considered appropriate to model the association between deprivation index measured at the census 
track level and log hazard of incident HF.  
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 Using MLM, we will test for the effects of neighborhood deprivation index (the level-2 predictor) 
on the risk of incident HF after adjustment for individual-level factors (level-1 predictors) including 
household income (and education) and demographics (age, gender and race). 
 The reduced-form of the multi-level model is as follows [135, 136]: 
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 Where hij(t) represents the hazard function, γ00(t) represents the intercept, and h0(t) represents the 
baseline hazard function whose distribution is unspecified. Time t is defined as the number of days from 
the participant’s entry into the study to the first diagnosis of incident heart failure. Wkj represents the 
neighborhood variable, level-2 predictor (deprivation index), and Xij represents the set of individual-level 
variables, level-1 predictors (age, gender, race, income and education). U0j represents the intercept 
random effect, and Rij represents the individual residual. The subscript j represents our level-2 units – the 
census tracts and the subscript i represents individuals. 
 The intra-class correlation coefficient would be computed (using the latent variable approach) and 
used to estimate the proportion of variance explained by differences at the census-tract level. This 
approach uses the closed form solution of the ICC in the multi-level logistic model to make an 
approximate estimation of the ICC in the multi-level Cox Proportional hazards model.  
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, where 00 = group-level variance [137].  
 Neighborhood deprivation index would be modeled as a continuous variable with 1df to preserve 
parsimony. In separate unadjusted multi-level models, we would also use restricted cubic splines (with 4 
knots) and quartiles to explore the functional form of the association between deprivation index and 
incident heart failure. 
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 In the minimally adjusted models we will estimate the age-, race- and sex-adjusted hazard ratios 
between neighborhood deprivation and incident heart failure. We would also investigate cross-level 
interactions between deprivation index and race and sex. Individual-level socioeconomic characteristics 
(income and education) will then be added.  
 All multilevel analyses will be performed using Multilevel modeling for Windows (MLwiN) 
version 1.10.0007, using the macro for the survival models [138, 139]. The first-order marginal quasi-
likelihood (MQL) estimation procedure would be used to obtain preliminary estimates then a predictive 
quasi-likelihood approach (PQL) (combined with a second-order Taylor expansion series) would be 
utilized to obtain more accurate estimates [136]. Effect estimates would be presented as hazard ratios with 
95% confidence intervals. 
 3.8.5.1.2 Other MLM Approaches 
 We would consider alternative approaches to fit the baseline hazard and examine differences in 
the estimates of our coefficients based on certain distributional assumptions.  
 First, we will consider fitting a multilevel Poisson regression model that assumes a piece-wise 
constant function for the distribution for the baseline hazard using STATA (version 13, Stata Corp, 
College Station, Texas, USA) .  
 Second, we would consider the “stgenreg” package by Crowther et al to build a multilevel 
exponential proportional hazards model [140]. For both models we would estimate the hazard ratios for 
deprivation index adjusting for individual level factors.  
 The advantage of the Poisson and parametric models is that they are more parsimonious, we 
obtain smooth hazard functions that can be estimated at any point and if our distributional assumptions 
are correct we may obtain more accurate parameter estimates. In recent years the incidence rate of heart 
failure in the US has been relatively constant with improved survival being the major driver of the 
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increased prevalence; so an exponential distribution (which assumes constant hazard throughout the study 
period) for the baseline hazard may not be  inappropriate.  
 3.8.5.1.3 Pitfalls of the MLM Approaches 
 While MLM approaches could be an acceptable fit given the hierarchical structure of our data, 
there are some limitations to their use in light of certain peculiarities of our data.  
 First, based on our preliminary analyses, there are 4666 census tracts in the data with the number 
of persons per census track varying between 1 and 21+. Ergo, there are many census tracks or level-2 
units with singleton data points and worse some with zero cases of HF. This may lead to a few problems 
including: 
a) In non-linear models, simulations done using multi-level logistic models have suggested that in 
cases of unbalanced data with a very small group size (⩽2), the group level variance components 
are over estimated by over 30%, with an upwards bias that is most accentuated when dealing 
with unbalanced data [141]. 
b) In addition, the fixed effect coefficients are biased up by as much as 16% [141]. 
c) There may be some issues related to stability of parameter estimates and convergence of the 
models especially in the light of singleton data points with zero cases in some census tracts.  
 In addition, based on the evidence from previous studies investigating the contribution of 
neighborhood effects on other HF and CVD outcomes [137], we do not anticipate a high ICC (> 0.5), 
hence having some very small clusters is not the ideal scenario for considering multi-level modeling. 
 MLM would be considered as 1 of the options for sensitivity analyses as this would allow an 
assessment of the robustness of our findings while using an approach with larger variances and more 
random components.  
 We will consider other modelling options that take into account the correlation of the data of the 
individuals nested within census tracks. However, we would still utilize MLM to compute the ICC as it is 
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provides information – the proportion of the variance that is explained by differences across 
neighborhoods – not captured by other methods.  
 3.8.5.2 Cox Proportional hazards model adjusting for Non-Independence using Huber-
White sandwich Estimators. 
 Given the non-independence of the data points within each census track, and the limitations of a 
multilevel modelling approach in this setting, our primary statistical analysis approach for aim 2 will be a 
Cox proportional hazards model that takes into account non-independence using the Huber-White cluster 
Sandwich estimator of variance, Hc  [127] whose general formula for linear and nonlinear models is given 
below:  
 
 Where I is the information criteria i.e. the second derivative of the log likelihood, log L [127]: 
 
and U is the score statistic i.e. the first derivative of log L [127] 
 
Log L is computed under the null hypothesis, Ho: equal sample proportions, P1 (s1/n1) = P2 (s2/n2) = P as: 
 
 In the specific case of the Cox Model, the cluster sandwich estimator, Hc uses special score 
residuals for U (the score vector) given there are no per-observation score contributions [127, 142]. 
 We would fit the following models successively: 
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 Covariates Functional form Degrees of freedom 
Model 1 Deprivation index Restricted cubic splines (nk = 4) 3 
Age Restricted cubic splines (nk = 4) 3 
Race and sex Race (whites vs blacks); Sex  2 
Model 2 Model 1 variables   
Income (<$15000, $15000-24999 & ≥$25000)  2 
Education < HS, HS/vocational training/junior 
college, college degree or higher) 
2 
Model 3 Model 2 variables   
 Smoking Status never/former/current <19.5 pack-
years/current ≥ 19.5 pack-years 
3 
 Alcohol intake Linear  1 
 BMI Restricted cubic splines (nk = 4) 3 
 History of diabetes, 
hypertension, high 
cholesterol, 
MI/CABG, stroke 
 
All yes/no 
 
5 
 Physical activity in 
met-hrs 
Linear + quadratic 2 
Total   26 
 
 We would equally present the ICC (computed using the latent variable approach) as it is provides 
information about the proportion of the variance that is explained by differences across neighborhoods 
which has a greater public health relevance. Hazard ratios for 1 interquartile range increase in deprivation 
index would equally be presented as these have an intuitive interpretation: i.e. the hazard of the event 
occurring for a typical person in the middle of the upper half of the distribution to the hazard of the event 
for a typical person in the middle of the lower half of the distribution. 
3.8.6 Substantive analyses for Aim 3 
 For aim 3, we would first derive the appropriate weight-height index (W/Hn) for the current 
cohort based on the coefficient of the log weight and log height variables in a bivariate Cox model for the 
log hazard of HF.  
 Hypothetically, by regressing a dependent variable, y on the natural logarithm of (W/Hn) i.e. 
log𝑒 𝑊 𝐻
𝑛⁄   we get the following (natural logs are implied throughout so the e is dropped): 
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𝑦 = 𝑐 + log 𝑊 𝐻𝑛⁄ , assuming a slope of 1. 
𝑦 = 𝑐 + log 𝑊 + log 𝐻−𝑛  
𝑦 = 𝑐 + log 𝑊 − nlog 𝐻  
 So the absolute value of the ratio of the coefficients of log W and log H is n. 
 In the case specific case of the Cox Model for the log hazard of HF (with no intercept), when log 
hazard of HF is regressed on log W and log H we get 
𝑦 =  𝛼1 log 𝑊 + 𝛼2 log 𝐻  
Where y = log hazard (HF), 𝛼2 is negative if y and W/H
n are positively correlated and vice versa. 
And n would be given by |𝛼2 𝛼1⁄ | 
 Second, in separate Cox models, we would regress the restricted cubic splines of the natural log 
of the data-derived weight-height index and that of BMI on the log hazard of HF. Then, model fit 
statistics (LR chi square, χ² and AIC) would be used to compare the performance of the data-derived 
weight-index versus that of BMI in relation to a model utilizing restricted cubic splines of log weight and 
log height.  
 Third, we would run models with log BMI and log height to see if log height is still significant in 
a model containing BMI. We would also compare the effect size for a 1 interquartile range increase in 
BMI and the computed W/Hn index. 
 Fourth, we would use multivariable Cox models which take into account nonlinearity and non-
additivity to model a flexible dose-response association between the better performing weight-height 
index (W/Hn) (modelled using restricted cubic splines with 5 evenly spaced knots) and HF risk adjusting 
for relevant covariates in a sequential fashion as shown in the table below:   
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 Covariates Functional form Degrees of 
freedom 
Model 1 Weight-height index Restricted cubic splines (nk = 5) 4 
Age Restricted cubic splines (nk = 4) 3 
Race and sex Race (whites vs blacks); Sex 
(women vs Women) 
2 
 W/Hn×race terms  Linear + non-linear interaction 
terms. 
4 
Model 2 Model 1 variables   
Income (<$15000, $15000-24999 & 
≥$25000)  
2 
Education < HS, HS/vocational training/junior 
college, college degree or higher) 
2 
 Smoking Status never/former/current <19.5 pack-
years/current ≥ 19.5 pack-years 
3 
 Alcohol intake Linear  1 
 Physical activity in MET-hrs Linear + quadratic 2 
Model 3 Model 3 variables   
 History of diabetes, 
hypertension, high cholesterol, 
MI/CABG, stroke 
 
All yes/no 
 
5 
Total   28 
  
 Interactions between W/Hn and race as well as sex would be tested. Fourth, we would repeat the 
multivariable models for the relationship between waist circumference and HF. We would present plots of 
predicted probabilities (or HRs) of incident heart failure versus weight-height index stratified by race 
and/or sex. These analyses would be repeated using waist circumference. 
 For the analyses for WC, we have data for 3304 participants and there are 251 cases observed 
among these participants. Using the rule of thumb of 10-15 cases per df (or parameter to be estimated) 
that leaves us with 17-25 degrees of freedom allowed in our model. We would reduce the df spent on 
some less important covariates (based on prior literature). Below is the proposed df to be spent in the 
multivariable cox model for WC. Formal power calculations for WC are presented in section 4.9. 
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 Covariates Functional form Degrees of freedom 
Model 1 WC Restricted cubic splines (nk = 4) 3 
Age Restricted cubic splines (nk = 4) 3 
Race and sex Race (whites vs blacks); Sex  2 
Model 2 Model 1 variables   
Income (<$15000, ≥$15000)  1 
Education < HS, HS/vocational training/junior 
college, college degree or higher) 
2 
 Smoking Status Never, former and current  2 
 Alcohol intake Linear  1 
 Physical activity in MET-hrs Linear + quadratic 2 
Model 4 Model 3 variables   
 History of diabetes, 
hypertension, high 
cholesterol, MI/CABG, 
stroke 
 
All yes/no 
 
5 
Total   21 
 
 For the association between (W/Hn) and post-HF survival we would perform similar analyses as 
we did for the association with HF risk. Hazard ratios for 1 interquartile range increase in W/Hn, WC and 
BMI would equally be presented as these have an intuitive interpretation: i.e. the hazard of the event 
occurring for a typical person in the middle of the upper half of the distribution to the hazard of the event 
for a typical person in the middle of the lower half of the distribution. 
 For all our models we would verify the PHM assumption by utilizing Schoenfeld residuals from 
the Cox Models and log (-log) plots. Martingale residuals and dfbetas would be used to investigate the 
functional form of predictor variables and influential observations respectively. 
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3.9 Power Calculations 
 Based on our preliminary findings, the number of incident HF cases (identified in Medicare 
between March, 2002 and September, 2010) among SCCS participants in our sub cohort (N= 27078) are 
801, 511, 1940 and 1089 among white women (n =5252), white men (n=3202), black women (n=11688) 
and black men (n = 6936) respectively making a total of 4341 incident HF cases.       
3.9.1 Aim 1 
 We plan to investigate survival and mortality risk among SCCS participants diagnosed with 
incident HF by race and sex. There are close to 952 deaths amongst the 4341 incident HF cases.  
  3.9.1.1 Aim 1a 
 Using white women as the referent group, we can compute the power to investigate differences in 
log hazard for HF for white men, black men and black women at an alpha of 0.05 as follows: 
a. White women vs White men 
 Cumulative Incidence of CHF among whites = 0.155. Proportion of women among whites = 0.62. 
With P1 = 0.62, SD (P1) = √0.62*0.38 = 0.49. With number of events = 1312 and assuming an R-square 
of 0.20 for the correlation (to get conservative estimates of power; given that pseudo r-square from 
logistic regression was 0.10) with candidate covariates we get 97% power to detect a HR of 1.3 
 Power Events HR SD Alpha* R2 
0.77 1312 1.2 0.49 0.05 0.20 
0.97 1312 1.3 0.49 0.05 0.20 
0.99 1312 1.4 0.49 0.05 0.20 
0.99 1312 1.5 0.49 0.05 0.20 
0.99 1312 1.6 0.49 0.05 0.20 
0.999 1312 1.7 0.49 0.05 0.20 
0.999 1312 1.8 0.49 0.05 0.20 
0.999 1312 1.9 0.49 0.05 0.20 
0.999 1312 2.0 0.49 0.05 0.20 
 
b. White women vs Black men 
 Cumulative Incidence of CHF among these 2 groups = 0.155. Proportion of women = 0.43. With 
P1 = 0.43, SD (P1) = √0.43*0.57 = 0.495. With number of events = 1890 and assuming an R-square of 0.2 
for the correlation with candidate covariates we get 94% power to detect a HR of 1.2 
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 Power Events HR SD Alpha* R2 
0.94 1890 1.2 0.495 0.05 0.20 
0.99 1890 1.3 0.495 0.05 0.20 
0.99 1890 1.4 0.495 0.05 0.20 
0.999 1890 1.5 0.495 0.05 0.20 
0.999 1890 1.6 0.495 0.05 0.20 
0.99 1890 1.7 0.495 0.05 0.20 
0.999 1890 1.8 0.495 0.05 0.20 
0.999 1890 1.9 0.495 0.05 0.20 
0.999 1890 2.0 0.495 0.05 0.20 
 
 
c. White women vs. Black women 
 
Cumulative Incidence of CHF among these 2 groups = 0.162. Proportion of white women = 0.31. With P1 
= 0.31, SD (P1) = √0.31*0.69 = 0.46. With number of events = 2741 and assuming an R-square of 0.2 for 
the correlation with candidate covariates we get 94% power to detect a HR of 1.2 
 Power Events HR SD Alpha* R2 
0.98 2741 1.2 0.495 0.05 0.20 
0.99 2741 1.3 0.495 0.05 0.20 
0.999 2741 1.4 0.495 0.05 0.20 
0.999 2741 1.5 0.495 0.05 0.20 
0.999 2741 1.6 0.495 0.05 0.20 
0.999 2741 1.7 0.495 0.05 0.20 
0.999 2741 1.8 0.495 0.05 0.20 
0.999 2741 1.9 0.495 0.05 0.20 
0.999 2741 2.0 0.495 0.05 0.20 
 
 
 3.9.1.2 Aim 1b 
 Again, with white women as the referent group, we would compute the power to investigate 
differences in log hazard for all-cause mortality among HF cases for white men, black men and black 
women at an alpha of 0.05 as follows: 
a. White women vs White men, with HF 
 Cumulative Incidence of death among white HF cases = 0.226. Proportion of women among 
white cases = 0.61. With P1 = 0.61, SD (P1) = √0.61*0.39 = 0.49. With number of deaths = 296 and 
assuming an R-square of 0.10 for the correlation with candidate covariates we get 90% power to detect a 
HR of 1.5 
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 Power Events HR SD Alpha* R2 
0.31 296 1.2 0.49 0.05 0.10 
0.55 296 1.3 0.49 0.05 0.10 
0.78 296 1.4 0.49 0.05 0.10 
0.90 296 1.5 0.49 0.05 0.10 
0.96 296 1.6 0.49 0.05 0.10 
0.99 296 1.7 0.49 0.05 0.10 
0.997 296 1.8 0.49 0.05 0.10 
0.999 296 1.9 0.49 0.05 0.10 
0.999 296 2.0 0.49 0.05 0.10 
 
b. White women vs Black men, with HF 
 Cumulative mortality among these 2 groups = 0.242. Proportion of women = 0.42. With P1 = 
0.42, SD (P1) = √0.42*0.58 = 0.49. With number of events = 457 and assuming an R-square of 0.1 for the 
correlation with candidate covariates we get 94% power to detect a HR of 1.2 
 Power Events HR SD Alpha* R2 
0.45 457 1.2 0.493 0.05 0.10 
0.75 457 1.3 0.493 0.05 0.10 
0.92 457 1.4 0.493 0.05 0.10 
0.98 457 1.5 0.493 0.05 0.10 
0.997 457 1.6 0.493 0.05 0.10 
0.99 457 1.7 0.493 0.05 0.10 
0.999 457 1.8 0.493 0.05 0.10 
0.999 457 1.9 0.493 0.05 0.10 
0.999 457 2.0 0.493 0.05 0.10 
 
 
c. White women vs. Black women, with HF 
 
Cumulative Incidence of death among these 2 groups = 0.178. Proportion of white women = 0.29. With 
P1 = 029, SD (P1) = √0.29*0.71 = 0.45. With number of events = 487 and assuming an R-square of 0.1 for 
the correlation with candidate covariates we get 89% power to detect a HR of 1.4 
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 Power Events HR SD Alpha* R2 
0.40 487 1.2 0.45 0.05 0.10 
0.70 487 1.3 0.45 0.05 0.10 
0.89 487 1.4 0.45 0.05 0.10 
0.97 487 1.5 0.45 0.05 0.10 
0.993 487 1.6 0.45 0.05 0.10 
0.999 487 1.7 0.45 0.05 0.10 
0.999 487 1.8 0.45 0.05 0.10 
0.999 487 1.9 0.45 0.05 0.10 
0.999 487 2.0 0.45 0.05 0.10 
3.9.2 Aim2 
 3.9.2.1 Power for main analyses 
 a) Association between deprivation index and HF risk 
 We would be investigating the association between deprivation index and the log hazard of HF. 
neighborhood deprivation index data was available for 26818 persons and 4300 cases were observed 
among these participants; hence the probability of an event, Pr (E) = 0.1603. We obtained the r-squared 
for the association between deprivation index and all the other covariates using a multiple linear 
regression model; R2 = 0.2307. We then computed the power to detect a range of hazard ratios for a 1 
standard deviation increase in deprivation index for alpha = 0.05 and got over 99% power to detect a HR 
of 1.1. These estimates may be inflated considering our data are clustered in census tracks and our SEs are 
larger than would be otherwise. 
Power E HR SD Alpha* Pr(E) R2 
0.999 4300 1.1 1 0.05 0.1603 0.2307 
0.999 4300 1.2 1 0.05 0.1603 0.2307 
0.999 4300 1.3 1 0.05 0.1603 0.2307 
0.999 4300 1.4 1 0.05 0.1603 0.2307 
0.999 4300 1.5 1 0.05 0.1603 0.2307 
0.999 4300 1.6 1 0.05 0.1603 0.2307 
0.999 4300 1.7 1 0.05 0.1603 0.2307 
0.999 4300 1.8 1 0.05 0.1603 0.2307 
0.999 4300 1.9 1 0.05 0.1603 0.2307 
0.999 4300 2 1 0.05 0.1603 0.2307 
 
 b) Association between deprivation index and post-HF all-cause mortality 
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 We would also be investigating the association between deprivation index and the log hazard of 
all-cause mortality among HF cases. Neighborhood deprivation index data is available for 4300 cases and 
940 deaths were observed among these participants; hence the probability of death, Pr (E) = 0.2186. We 
obtained the r-squared for the association between deprivation index and all the other covariates using a 
multiple linear regression model; R2 = 0.2179. We then computed the power to detect a range of hazard 
ratios for a 1 standard deviation increase in deprivation index for alpha = 0.05 and got over 99% power to 
detect a HR of 1.1. In truth, our power estimates would be a little more modest given we have clustered 
data and our SEs are larger than would be otherwise. 
Power E HR SD Alpha* Pr(E) R2 
0.999 940 1.1 1 0.05 0.2186 0.2179 
0.999 940 1.2 1 0.05 0.2186 0.2179 
0.999 940 1.3 1 0.05 0.2186 0.2179 
0.999 940 1.4 1 0.05 0.2186 0.2179 
0.999 940 1.5 1 0.05 0.2186 0.2179 
0.999 940 1.6 1 0.05 0.2186 0.2179 
0.999 940 1.7 1 0.05 0.2186 0.2179 
0.999 940 1.8 1 0.05 0.2186 0.2179 
0.999 940 1.9 1 0.05 0.2186 0.2179 
0.999 940 2 1 0.05 0.2186 0.2179 
 
 3.9.2.2 Power for multilevel modelling 
The power for the multi-level analysis was estimated using simulations in MLPowSim. Based on our 
preliminary analyses we have over 4666 census tracts covered by the 27,078 participants included in our 
ancillary study. So we estimated that that we have on average 6 persons per census track. For our 
calculations we used a range of 5-7 persons per census track and 4000-4250 census track in order to be 
conservative in our power estimates. We used a Poisson distribution for the baseline hazard, standard 
normal distribution for the deprivation index (mean =0, variance =1) and a beta coefficient of 0.1 per unit 
change in deprivation index with an intercept of 0.1. We performed 50 simulations at alpha = 0.05 
specifying a penalized quasi-likelihood (PQL) approach for estimating our regression coefficients and we 
got over 99% power for all scenarios.  
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# of Census 
tracts 
n per 
census tract 
Power for 
Intercept 
Power for 
Slope 
4000 5 0.99 0.99 
4000 7 0.99 0.99 
4050 5 0.99 0.99 
4050 7 0.99 0.99 
4100 5 0.99 0.99 
4100 7 0.99 0.99 
4150 5 0.99 0.99 
4150 7 0.99 0.99 
4200 5 0.99 0.99 
4200 7 0.99 0.99 
4250 5 0.99 0.99 
4250 7 0.99 0.99 
 
 
3.9.3 Aim3 
 3.9.3.1 BMI (or W/Hn) and HF Incidence 
 For this aim, we’re investigating the association between BMI (or W/Hn) and the log hazard of 
HF. Weight and height data was available for 26713 persons and 4268 cases were observed among these 
participants; hence the probability of an event, Pr (E) = 0.1598. We obtained the r-squared for the 
association between BMI and all the other covariates using a multiple linear regression model; R2 = 
0.2088. We then computed the power to detect a range of hazard ratios for a 1 standard deviation increase 
in BMI for alpha = 0.05 and got over 99% power to detect a HR of 1.1. 
Power E HR SD Alpha* Pr(E) R2 
0.999 4268 1.1 1 0.05 0.1598 0.2088 
0.999 4268 1.2 1 0.05 0.1598 0.2088 
0.999 4268 1.3 1 0.05 0.1598 0.2088 
0.999 4268 1.4 1 0.05 0.1598 0.2088 
0.999 4268 1.5 1 0.05 0.1598 0.2088 
0.999 4268 1.6 1 0.05 0.1598 0.2088 
0.999 4268 1.7 1 0.05 0.1598 0.2088 
0.999 4268 1.8 1 0.05 0.1598 0.2088 
0.999 4268 1.9 1 0.05 0.1598 0.2088 
0.999 4268 2 1 0.05 0.1598 0.2088 
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 3.9.3.2 Waist circumference and HF Incidence 
 Waist circumference data was available for 3395 persons and 251 cases were observed by the end 
of follow-up; hence the probability of an event, Pr (E) = 0.0739. We obtained the r-squared for the 
association between WC and all the other covariates using a multiple linear regression model; R2 = 
0.1253. We then computed the power to detect a range of hazard ratios for a 1 standard deviation increase 
in WC given E = 251, N= 3395 and alpha = 0.05 and got at least 97% power to detect a HR of 1.3.  
Power E HR SD Alpha* Pr(E) R2 
0.29 251 1.1 1 0.05 0.0739 0.1253 
0.77 251 1.2 1 0.05 0.0739 0.1253 
0.97 251 1.3 1 0.05 0.0739 0.1253 
0.99 251 1.4 1 0.05 0.0739 0.1253 
0.99 251 1.5 1 0.05 0.0739 0.1253 
1 251 1.6 1 0.05 0.0739 0.1253 
1 251 1.7 1 0.05 0.0739 0.1253 
1 251 1.8 1 0.05 0.0739 0.1253 
1 251 1.9 1 0.05 0.0739 0.1253 
1 251 2 1 0.05 0.0739 0.1253 
  
 3.9.3.3 BMI (or W/Hn) and post-HF survival 
 Weight and height data was available for 4268 HF cases and 934 deaths were recorded among 
these participants; hence the probability of death, Pr (E) = 0.2188. We obtained the r-squared for the 
association between BMI and all the other covariates using a multiple linear regression model; R2 = 
0.2085. We then computed the power to detect a range of hazard ratios for a 1 standard deviation increase 
in BMI for alpha = 0.05 and got over 99% power to detect a HR of 1.2.  
Power E HR SD Alpha* Pr(E) R2 
0.736 934 1.1 1 0.05 0.2188 0.2085 
0.999 934 1.2 1 0.05 0.2188 0.2085 
0.999 934 1.3 1 0.05 0.2188 0.2085 
0.999 934 1.4 1 0.05 0.2188 0.2085 
0.999 934 1.5 1 0.05 0.2188 0.2085 
0.999 934 1.6 1 0.05 0.2188 0.2085 
0.999 934 1.7 1 0.05 0.2188 0.2085 
0.999 934 1.8 1 0.05 0.2188 0.2085 
0.999 934 1.9 1 0.05 0.2188 0.2085 
0.999 934 2 1 0.05 0.2188 0.2085 
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Abstract 
Background  
There is a paucity of data regarding HF incidence among low-income and minority populations. Our 
objective was to investigate HF incidence and post-HF survival by race and sex among low-income adults 
in the southeastern US. 
Methods  
Participants were 27,078 white and black men and women enrolled during 2002-2009 in the Southern 
Community Cohort Study (SCCS) who had no history of HF and were receiving Centers for Medicare or 
Medicaid services (CMS).  Incident HF diagnoses through December 31, 2010 were ascertained using 
ICD-9 codes 428.x via linkage with CMS research files.  
Results 
Most participants were black (68.8%), women (62.6%) and earned < $15,000/year (69.7%); mean age 
was 55.5 (10.4) years. Risk factors for HF were common: hypertension (62.5%), diabetes (26.5%), 
myocardial infarction (8.6%) and obesity (44.8%).  Over a median follow-up of 5.2 years, 4,341 
participants were diagnosed with HF.  The age-standardized incidence rates were 34.8, 37.3, 34.9 and 
35.6 PY/1000 in white women, white men, black men and black women, respectively, remarkably higher 
than previously reported. Among HF cases, 952 deaths occurred over a median follow-up 2.3 years. Men 
had lower survival; hazard ratios and 95% confidence intervals were 1.63 (1.27-2.08), 1.38 (1.11-1.72) 
and 0.90 (0.73-1.12) for white men, black men and black women compared with white women.  
Conclusions 
In this low-income population, HF incidence was higher for all race-sex groups than previously reported 
in other cohorts. The SCCS is a unique resource to investigate determinants of HF risk in a segment of the 
population underrepresented in other existing cohorts.  
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Introduction 
 There are over 26 million persons living with heart failure (HF) worldwide [1].  In the US, over 
5.7 million adults (≈ 2.5% of the US adult population) are estimated to have HF [2].  About half of 
persons diagnosed with HF die within 5 years and the estimated total costs of HF in the US exceeded $30 
billion in 2012 [3, 4].  Several established cardiovascular disease (CVD) cohorts have investigated HF 
incidence and mortality, including the Framingham Heart Study (FHS), Cardiovascular Health Study 
(CHS), Multi-ethnic Study of Atherosclerosis (MESA) and Atherosclerosis Risk in Communities (ARIC) 
[5-8]. The FHS included predominantly white individuals.  Other cohorts, including CHS, MESA, and 
ARIC, enrolled multi-ethnic middle-class populations from select communities and their relatively small 
sample sizes limited assessment of differential risk patterns between demographic groups defined by both 
race and sex.  
 While data from these previous cohorts suggest differences in HF incidence rates and post-HF 
survival between population subgroups, knowledge gaps persist regarding the magnitude and direction of 
these differences, particularly in multi-ethnic low income populations with high burden of CVD risk 
factors.  The prospective Southern Community Cohort Study (SCCS) provided a valuable opportunity to 
investigate differences in the incidence of HF as well as in post-HF survival between groups defined by 
race and sex: white women, black women, white men and black men [18].  
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Methods 
Study sample 
 The SCCS is a prospective cohort study designed to investigate the incidence of cancer and other 
chronic diseases, including differential patterns by race and sex, in a low-income under-insured 
population underrepresented in previous studies.  Between 2002 and 2009, the SCCS enrolled 
approximately 86,000 adults (≈ two-thirds black) aged 40-79 living in 12 southeastern states to 
investigate various chronic disease outcomes [18].  Approximately 86% of participants were recruited at 
community health centers (CHC), which provide primary health and preventive care services for low-
income populations so that the cohort is made up of a segment of society (minority, poor, rural) seldom 
included in sizeable numbers in previous cohort studies; particularly those investigating CVD [18, 20].  
The remaining 14% were recruited via mail-based general population sampling.  Data on socioeconomic, 
demographic (including self-reported race), lifestyle, and anthropometric characteristics, as well as 
personal medical history, were ascertained at cohort enrollment via standardized computer-assisted 
personal interviews for CHC participants, and via self-administered mailed questionnaire for general 
population participants. Detailed description of SCCS methods has been previously published [18, 20]. 
SCCS participants (n = 27,078) included in the current analyses were individuals aged ≥ 65 years 
(n = 7001) at cohort enrollment, or persons < 65 years (n = 20,077) at enrollment who: a) reported being 
covered by Medicaid (which provides medical benefits to low-income adults and uninsured persons) on 
the baseline questionnaire; or b) reported being covered by Medicare (the primary health insurance 
program for persons aged ≥ 65) on the baseline questionnaire; or c) did not report Medicare or Medicaid 
on the baseline questionnaire but had a Centers for Medicare and Medicaid Services (CMS) claim within 
90 days of being enrolled in SCCS.  The restriction to these groups ensures that participants would likely 
have continuous coverage in Medicare and/or Medicaid from the time of SCCS enrollment to the end of 
the follow-up period (December 31st, 2010), for the ascertainment of incident HF events.  Analyses were 
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restricted to self-reported African American or black and non-Hispanic white SCCS participants, since 
too few persons in other racial groups were available for stable statistical analysis. 
Outcome ascertainment 
 Heart failure events were ascertained via linkage of the SCCS cohort with CMS Research 
Identifiable Files (which include Medicare institutional and non-institutional files, and the Medicaid 
Analytic Extract files).  Incident HF was defined as the first occurrence of a medical claim with an 
International Classification of Diseases, 9th revision, discharge code of 428.x (428.0 to 428.9) within the 
Medicare institutional (Medicare Provider Analysis and Review, MEDPAR, which includes inpatient, 
outpatient and skilled nursing facility base files), Part B carrier (includes non-institutional physician 
services and durable medical equipment), or outpatient-based claims files or the Medicaid Analytic 
Extract (MAX) Inpatient and Other Services claims files, from the date of SCCS enrollment through 
December 31st, 2010. Detailed description of the CMS research files are published elsewhere [143].   
 Deaths, including dates and causes of death, were ascertained via linkage of the SCCS cohort 
with both the Social Security Administration (SSA) vital status service for epidemiologic researchers and 
the National Death Index (NDI) through December 31st, 2010. Both NDI and SSA are well-established 
and reliable means of identifying deaths in the US, and are expected to capture nearly all deaths [51, 122, 
123]. 
Statistical Analysis 
 Descriptive statistics (means and standard deviations for continuous variables and counts and 
percentages for categorical variables) were computed for all study participants by race and sex.  
 To investigate the incidence of HF, duration of follow-up was computed from date of entry into 
the SCCS until the date of the first diagnosis of HF, date of death, or December 31st, 2010, whichever 
occurred first.  Incidence rates (IR) of heart failure were calculated for white women, black women, white 
men and black men by dividing the number of HF cases by person-time of follow-up, presented per 1,000 
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person-years. The 95% confidence intervals (CI) were calculated using the quadratic approximation to the 
Poisson log likelihood for the log-rate parameter [134].  To account for age differences between the 
demographic categories, age-standardized rates were computed using the overall age distribution of the 
SCCS participants.  
 Multivariable Cox models were utilized to test whether differences in crude IRs between 
categories defined by race and sex persisted after adjustment for baseline covariates.  Three models were 
constructed, with white women as the referent category: model 1 included indicator variables for white 
men, black women and black men and age (restricted cubic splines with 4 knots); model 2 additionally 
adjusted for body mass index (restricted cubic splines with 4 knots), and history of diabetes, hypertension, 
high cholesterol, MI/CABG or stroke (all yes/no); model 3 additionally adjusted for the following 
covariates: annual household income (<$15,000; $15,000-$24,999; ≥$25,000); education (< high school, 
high school/vocational training/junior college, college degree or higher), smoking (never, former, current 
<19.5 pack-years, current ≥ 19.5 pack-years, 19.5 being the median pack-years among current smokers), 
alcohol intake (linear and quadratic term), marital status (married/living as married with partner, 
separated/divorced, widowed, single/never married) and enrollment source (community health centers vs 
general population). Knots were placed at quantiles of covariate distributions, equally spaced in sample 
size [144].  
 For analyses of post-HF survival among those with a diagnosis of incident HF, follow-up time 
was defined as time from HF diagnosis to death or December 31st 2010 whichever occurred first.  When 
date of death was coincident with date of HF diagnosis, follow-up time was set to 0.5 days.  We 
computed cumulative mortality for both HF cases and non-cases using contingency tables. Age-adjusted 
estimates of the survivor functions (adjusted to the mean age of SCCS participants diagnosed with HF) 
were obtained from a stratified Cox model fit and plotted for all race-sex groups.  Cox models were used 
to investigate differences in cumulative hazard for death (all-cause mortality) using white women as the 
referent group.  Model 1 comprised indicator variables for white men, black women and black men and 
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age (restricted cubic splines with 4 knots).  Variables included in models 2 and 3 are the same as 
described previously.  P-values for race-by-sex interaction were computed in models for HF incidence 
and post-HF survival; and a p-value < 0.05 was considered statistically significant.  Model assumptions 
were verified using Schoenfeld residuals and log (-log) plots. 
 All analyses were performed using STATA (version 12.1, Stata Corp, College Station, Texas, 
USA) and the ‘rms’ package for R version 3.1.1 (R Core Team 2014) [144, 145]. 
Ethics statement 
 SCCS participants provided written informed consent, and protocols were approved by the 
Institutional Review Boards of Vanderbilt University Medical Center and Meharry Medical College. 
 
Results 
 Among the 27,078 SCCS participants included in this study, 68.8% were black, 62.6% were 
women, 69.7% had annual household income < $15,000 and 38.4% had less than a high school education.  
The mean (SD) age at enrollment was 55.5 (10.4) years. At baseline, risk factors for HF were common: 
hypertension (62.5%); diabetes (26.5%); myocardial infarction (8.6%); and obesity, BMI ≥ 30 kg/m2 
(44.8%) (Table 1).  
 Overall, white men were older and had the highest prevalence of MI and stroke at baseline (Table 
1).  In contrast, black women were more likely to be obese at baseline and report a history of diabetes and 
hypertension.   
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Table 1. Comparison* of baseline characteristics of 27, 078 SCCS participants who were receiving 
Medicare or Medicaid during follow-up between 2002 and 2010, according to race and sex  
 Overall  
N = 27,078 
White Women 
n = 5,252 
White Men  
n = 3,202 
Black Women  
n = 11,688 
Black Men  
n = 6,936 
Age (SD), years 55.5 (10.4) 57.7 (10.6)  58.7 (10.5) 54.4 (10.4) 54.3 (9.5)  
Age Categories %      
  40-54 51.2 41.9 38.0 56.1 56.1 
  55-64 22.9 23.6 22.7 21.5 24.9 
  ≥ 65 25.9 34.5 39.3 22.4 18.9 
BMI (kg/m2) (SD) 30.4 (7.8) 30.7 (8.2) 28.7 (6.4) 32.4 (8.2) 27.7 (6.1) 
BMI Categories %       
   < 18.5 1.7 2.2 1.1 1.4 2.0 
   18.5 - < 25.0 24.0 23.6 28.2 16.5 35.0 
   25 - < 30.0 29.5 28.0 36.4 25.4 34.3 
   ≥ 30.0 44.8 46.2 34.3 56.7 28.8 
History of MI % 8.6 8.6 17.7 6.1 8.6 
History of Stroke % 9.6 10.0 10.8 9.1 9.4 
Diabetes % 26.5 24.3 23.8 29.8 23.8 
Hypertension % 62.5 57.0 56.7 67.6 60.5 
High Cholesterol % 39.5 49.5 47.1 38.0 31.0 
Education %      
 < High school (HS) 38.4 32.0 29.0 40.4 44.2 
   HS/Junior college/VT  53.1 58.7 53.1 52.1 49.0 
   ≥ College degree  8.5 9.4 17.9 6.5 6.8 
Annual Income < $15,000, % 69.7 65.9 53.4 74.5 71.8 
Smoking %      
   Never 34.7 37.0 21.7 45.1 21.3 
   Former 25.3 26.8 40.4 20.5 25.3 
   Current  40.1 36.2 37.9 34.5 53.4 
Alcohol Intake %      
  0 drink per day 54.9 66.8 48.8 61.0 38.5 
>0-2 drinks per day 33.2 29.7 35.6 31.4 37.6 
>2 drinks per day 11.9 3.5 15.6 7.5 23.9 
* All comparisons between demographic groups were significant (p=0.02 for stroke; p<0.0001 for all other baseline 
variables).  
VT: Vocational Training; MI: Myocardial Infarction; SD: Standard Deviation 
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HF incidence 
 Over a median (25th, 75th percentile) follow-up time of 5.2 (3.1, 6.7) years, 4,341 participants 
(16%) developed incident HF (IR: 32.8/1000 person-years; 95% CI: 31.8-33.8).  White men had the 
highest age-standardized IR, 37.3/1000 PY, compared with 34.8, 34.9 and 35.6 in white women, black 
men and black women, respectively (Table 2). 
 In models adjusted for age and other risk factors for HF, black women had a significantly lower 
risk of HF when compared with white women [HR=0.89; 95% CI: 0.82-0.98].  The risk of HF was similar 
among white men (HR=1.09; 95% CI: 0.97-1.23) and black men (HR=1.04; 95% CI: 0.94-1.15) 
compared with white women (Table 2).  There was no evidence of race-by-sex interaction [p = 0.22]. 
Table 2. Risk of incident heart failure among participants in the Southern Community Cohort Study, 
overall and stratified by race and sex 
 
Model 1: Includes age (restricted cubic splines with 4 knots), race and sex. Model 2: Model 1 + BMI (restricted 
cubic splines with 4 knots), history of diabetes, hypertension, high cholesterol, MI and stroke (all yes/no). Model 3: 
Model 2 + annual household income (<$15000, $15000-$24999 & ≥$25000), education (< high school, high 
school/vocational training/junior college, college degree or higher), smoking (never, former, current < 19.5 pack-
years, current ≥ 19.5 pack-years) and alcohol intake (linear and quadratic term), marital status (married/living as 
married with partner, separated/divorced, widowed, single/never married) and enrollment source (community health 
centers vs general population). P-value for race×sex interaction = 0.22. CI: Confidence Interval 
 Overall 
N = 27,078 
White Women  
n = 5,252 
White Men 
n = 3,202  
Black Women 
n = 11,688 
Black Men 
n = 6,936 
Incident HF cases (n) 4,341 801 511 1,940 1,089 
Person-Years (PY) 132,500 23,339 13,934 60,639 34,589 
Cumulative  
Incidence (%) 
16.0 15.3 16.0 16.6 15.7 
Incidence Rate/1000PY (95% CI)  
Crude 32.8 (31.8, 33.8) 34.3 (32.0, 36.8) 36.7 (33.6, 40.0) 32.0 (30.6, 33.4) 31.5 (29.7, 33.4) 
Age-adjusted 35.1 (34.1, 36.2) 34.8 (32.4, 37.2) 37.3 (34.0, 40.6) 35.6 (33.9, 37.2) 34.9 (32.7, 37.1) 
Hazard Ratio (95% CI) 
Model 1  1.00 1.04 (0.93, 1.16) 1.02 (0.94, 1.11) 0.99 (0.91, 1.09) 
Model 2  1.00 1.02 (0.91, 1.14) 0.91 (0.83, 0.99) 1.06 (0.97, 1.17) 
Model 3  1.00 1.09 (0.97, 1.23) 0.89 (0.82, 0.98) 1.04 (0.94, 1.15) 
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Post-HF survival 
 Among the 4,341 individuals who developed incident HF, 952 died (cumulative mortality = 
21.9%) over a median (25th, 75th percentile) post-HF follow-up time of 2.3 (0.9, 4.2) years (Table 3).  
Men had higher percent mortality than women (29% vs. 18%), with little difference by race.  In persons 
without HF (n= 22,737), there were 1,929 deaths, corresponding to a percent mortality of 8.5%.  
 Figure 1 shows age-adjusted survival curves for persons diagnosed with HF stratified by race and 
sex.  The 5-year post-HF survival probability was significantly lower among white men (0.55; 95% CI: 
0.49-0.61) and black men (0.64; 95% CI: 0.60-0.67) compared with white women (0.73; 95% CI: 0.69-
0.78) and black women (0.77; 95% CI: 0.74-0.79), respectively [p < 0.0001].  Racial differences within 
sex groups were not statistically significant. Similar patterns were observed for 1-year and 3-year survival 
probabilities.  
 Compared with white women, the risk of death was 60% (95% CI: 27%-202%) higher in white 
men and 35% (95%CI: 9%-65%) higher in black men in analyses adjusted for age, BMI, hypertension, 
diabetes, high cholesterol, past history of MI/CABG and stroke (Table 3).  These findings were robust to 
further adjustment for lifestyle factors and enrollment source.  In contrast, comparisons between black 
women and white women suggested minimal non-significant relative differences in risk by race in all 
models. The race-sex interaction term was not statistically significant [p = 0.92]. 
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Table 3. Percent mortality of SCCS participants according to heart failure status, overall and stratified by 
race and sex 
 
Model 1: Includes age (restricted cubic splines with 4 knots); race and sex. Model 2: Model 1 + BMI (restricted 
cubic splines with 4 knots), history of diabetes, hypertension, high cholesterol, MI and stroke (all yes/no). Model 3: 
Model 2 + annual household income (<$15000, $15000-$24999 & ≥$25000); education (< high school, high 
school/vocational training/junior college, college degree or higher), smoking (never, former, current < 19.5 pack-
years, current ≥ 19.5 pack-years) and alcohol intake (linear and quadratic term), marital status (married/living as 
married with partner, separated/divorced, widowed, single/never married) and enrollment source (community health 
centers vs general population). P-value for race×sex interaction = 0.92. CI: Confidence Interval 
 
 
 
 
 
 
 
 
 
 
 Overall 
N = 4,341 
White Women 
n = 801 
White Men 
n = 511 
Black  Women 
n = 1,940 
Black  Men 
n = 1,089 
Deaths (n) 952 144 152 343 313 
Percent Mortality 
(%) 
21.9 18.0 29.7 17.7 28.7 
Risk of death: Hazard ratio (95% CI) 
Model 1  1.00 (ref) 1.73 (1.37, 2.17) 0.91 (0.75, 1.10) 1.61 (1.32, 1.96) 
Model 2  1.00 (ref) 1.60 (1.27, 2.02) 0.89  (0.73, 1.09) 1.35 (1.09, 1.65) 
Model 3  1.00 (ref) 1.63 (1.27, 2.08) 0.90 (0.73, 1.12) 1.38 (1.11, 1.72) 
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Figure 1:  Age-adjusted Survival curves for SCCS participants diagnosed with HF stratified by race and 
sex 
 
The adjusted survival estimates were computed at the mean age (58 years) of all participants with HF (n = 
4341).  Compared with white women and black women, white men and black men had significantly lower 
survival (p<0.0001).  The 1-year, 3-year and 5-year age-adjusted survival estimates were (0.91, 0.83, 
0.77); (0.90, 0.82, 0.74); (0.84, 0.71, 0.64) and (0.85, 0.73, 0.58) for black women, white women, black 
men and white men respectively. 
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Discussion 
 We investigated heart failure incidence and post-HF mortality in a large multi-ethnic low-income 
sample from the southeastern United States.  Our principal findings are: 1) the incidence rate for HF was 
remarkably high across all race and sex groups in the SCCS, 2) there was no significant difference in age-
adjusted incidence rates across groups defined by race and sex but after full adjustment for socioeconomic 
status and traditional cardiovascular risk factors black women had the lowest risk of HF, and 3) higher 
post-HF mortality among men with no significant racial differences. 
 The incidence rates for heart failure in the SCCS exceeded those previously reported from 
established CVD cohorts (Table 4).  In CHS (n = 5,888; age range: ≥ 65 years) for example, the age-
standardized HF incidence rates after 10 years of follow-up among white men, black men, white women 
and black women were 30.2, 19.2, 27.5 and 22.6 per 1000 PY respectively [5].  In ARIC (n = 14,933; age 
range: 45-64), Loehr et al found IRs of 6.0, 9.1, 3.4 and 3.8 per 1000 PY, respectively, in these race-sex 
groups [8].  The FHS and MESA reported even lower IRs (7.2 and 4.2 per 1000 PY in men and women in 
FHS and 3.1 per 1000 PY overall in MESA) [6, 7].  The higher SCCS HF incidence could be explained in 
part by notably higher prevalence of CVD risk factors (in particular hypertension, diabetes, obesity, prior 
history of MI) in the SCCS study sample at baseline compared with ARIC, CHS, FHS and MESA (Table 
5).  In addition, SCCS participants were largely of low socioeconomic status, with over two-thirds having 
annual household income <$15,000.  Prior evidence suggests a strong independent association between 
socioeconomic status and HF risk; [9, 10, 105, 146] thus participants in SCCS may be at higher risk of 
unfavorable societal stressors and an elevated risk of adverse cardiovascular outcomes including HF.  
 White men had the highest crude incidence rate of HF in the SCCS, consistent with findings from 
the CHS.  However, minimal differences in age-adjusted incidence rates and HF risk between groups after 
adjustment for CVD risk factors (except for black women who had significantly lower risk) suggest 
homogeneity of HF risk profile. Similarly, in ARIC, crude racial and sex differences in incidence density 
were attenuated by adjustment for CVD risk factors [8].  
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Table 4: Comparison of heart failure incidence between SCCS, ARIC, MESA and CHS cohorts 
 HF Incidence Rates (IR) per 1000 PY 
  SCCS* 
45-64 yrs 
ARIC[8] 
45-64 yrs  
SCCS* 
65-79 yrs 
CHS[5] ** 
≥ 65 yrs  
 
SCCS* 
40-79 yrs 
MESA[6] 
45-84 yrs 
 n = 15,321 n = 14,933 n = 7,001 
 
n = 5,888 
5-yr                 10-yr 
 n = 27,078 n = 6,814 
Overall 35.8 5.7 39.5 19.3 24.0 Overall 33.7 3.4 
White Women 38.3 3.4 34.6 14.5 19.2    
White Men 39.7 6.0 38.3 24.9 30.2 Whites 34.3 2.4 
Black Women 35.1 8.1 42.4 19.6 22.6    
Black Men 34.0 9.1 41.9 23.5 27.5 Blacks 33.4 4.6 
 
*Incidence rates computed for SCCS participants aged 45-64, 65-79 and 40-79 for comparability with the ARIC, 
CHS and MESA cohorts respectively. In addition, the rates are standardized to the age distribution of the SCCS 
study participants within these age ranges. 
**The tabulated values are computed from values presented in Arnold et al and standardized to the age distribution 
of CHS participants. 
ARIC: Atherosclerosis Risk in Communities; CHS: Cardiovascular Health Study; MESA: Multi-ethnic Study of 
Atherosclerosis; SCCS: Southern Community Cohort Study. 
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Table 5: Comparison of baseline characteristics of SCCS, MESA, ARIC and CHS participants 
 
SCCS   
(n= 27,078) 
ARIC[8]  
(n= 14,993) 
CHS[5]  
(n= 5,888) 
MESA[6]  
(n = 5,923)† 
FHS[7]  
(n=9,405)‡ 
Age (years)* 55.5 (10.4) 54 (6) 72.8 (5.6) 61.8 (10.3) 41 (10) 
Women (%) 62.6 54 57.6 53 53 
Blacks (%) 68.8 27 15.7 26.1 ≈ 0 
Education (<high school) (%) 38.4 24 29.5 16 56§ 
BMI (kg/m2)* 30.4 (7.8) 27.3 (5.1) 26.7 (4.7) 28.0 (5.4) 24.9 (3.8)|| 
Obese (BMI > 30) % 44.8 26 19 32 10.8|| 
Diabetes (%) 26.5 11 16.4 11.6 4.1 
Hypertension (%) 62.5 33 57.7 42 7 
Myocardial infarction (%) 8.6 4 9.6 n/a 1.6# 
Stroke (%) 9.6 1.4 4.2 n/a 0.5** 
Ever smoked cigarettes (%) 65.3 58.2 53.5 49 57.3§ 
 
*Tabulated values are mean (SD). n/a = not applicable.  
†
By design, participants enrolled in MESA were free of CVD at baseline so the prevalence of MI and stroke at baseline in this 
cohort may be best described as not applicable.  
‡
The baseline data for the FHS pertains whenever available to both the original cohort and the offspring cohort given this larger 
sample was utilized to compute HF incidence rates referenced in the manuscript. In the absence of such data, we have presented 
data from the original cohort (or subsamples thereof) as a proxy and indicated so in each case. 
§
Obtained from a subsample of the parental FHS cohort data (n=1037, 45-62yrs and CHD-free at baseline). 
||
Obtained from a subsample of the parental FHS cohort data (n=2922, 30-62yrs and CHD-free at baseline). 
#
Obtained from the parental FHS cohort data (n=5209) and pertains to the composite of MI, CHD-related sudden death and 
angina pectoris. 
**Obtained from the parental FHS cohort data (n=5209). 
ARIC: Atherosclerosis Risk in Communities; CHS: Cardiovascular Health Study; SCCS: Southern Community 
Cohort Study; MESA: Multi-ethnic Study of Atherosclerosis; FHS: Framingham Heart Study.  
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 Overall, the 5-year post-HF survival in SCCS was higher than the 52% previously reported (data 
from the Olmsted county study) [3].  This may be due in part to the fact that SCCS participants had 
shorter post-HF follow-up time, were younger at baseline (55.5 vs 74 years) and temporal trends 
suggesting improved post-HF survival [3] related to recent improvements in therapeutic options.  In 
addition, participants in the Olmsted county study were mostly non-Hispanic Whites who may be at 
higher risk of HF with reduced ejection fraction (HFrEF), which has a less favorable prognosis compared 
with heart failure with preserved ejection fraction (HFpEF) [22, 23]. 
 The relative patterns of post-HF survival for the four demographic subgroups in SCCS were 
substantially different from those seen in ARIC and CHS.  In ARIC, compared with white men and 
women, black men and women had the lowest survival probability following admission for HF.  The 5-
year case fatality for white women, white men, black women and black men were 35.8%, 41.2%, 46.1% 
and 51.8%, respectively.  The racial differences were significant, with black men having the highest all-
cause mortality following admission, but the differences by sex were non-significant.  In CHS, the 
mortality rate in white women, white men, black women and black men were 35.5, 40.5, 33.6 and 44.4 
per 100 PY respectively.  After full adjustment for covariates there were no significant racial differences, 
but women had a 15% lower risk of all-cause mortality [HR: 0.85; 95% CI: 0.73, 0.99] [51].  In SCCS, 
white men had the lowest 5-year survival post-HF diagnosis; but after full adjustment, there were mainly 
sex-differences in post-HF mortality with higher risk of death among men and no significant racial 
differences. This could be explained in part by the higher prevalence of MI among men.  MI is associated 
with greater risk for the development of HFrEF which is known to have a worse prognosis compared with 
HFpEF [22, 23].  However, MI does not fully account for the higher risk of post HF mortality among 
men, as this risk persisted even after full adjustment for relevant baseline covariates (including history of 
MI).  
 Limitations of our study should be noted.  Our study sample may not be representative of the 
background population of the Southeastern states as the recruitment and sampling scheme utilized by the 
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SCCS was tailored towards low-income, rural and under-insured populations not often included in 
sizeable numbers in other cohorts investigating chronic disease outcomes. Also, HF was ascertained via 
linkage with CMS Research Identifiable Files using ICD-9 codes 428.x, rather than independent 
physician adjudication.  However, the diagnosis codes (ICD-9 428.x) algorithm for identification of HF 
used in this study has been previously validated and utilized in other cohorts [119-121].  A review of the 
detection of HF in administrative claims data that included eight studies conducted among Medicare 
beneficiaries reported positive predictive values (PPVs) between 76% and 99%, with the majority of the 
studies reporting PPVs over 90% [119].  These codes have also been used with high specificity in a 
number of studies [120, 121]  even though no independent validation was conducted by the SCCS 
investigators.  An over-representation of groups with elevated HF risk (persons > 65 and persons < 65 
receiving Medicare) in our SCCS sub-cohort compared with the SCCS base population, may have 
contributed to higher HF incidence rates than would be expected for the total SCCS cohort. However with 
the mean age of the total cohort being ≈ 52.6 years [107] versus 55.5 years for our sub-cohort, the small 
age difference between both populations may have had less than dramatic effects on the HF incidence. In 
addition, with studies suggesting that the sensitivity of ICD-9 code 428.x for HF ascertainment varies 
between 62.8 and 89% [119, 124], it is plausible that we may have underestimated the incidence rate of 
HF in our sub-cohort.  Also, when contrasting the incidence rates between our study and previous CVD 
cohorts (like ARIC and CHS) we used data for comparable age groups between studies (Table 4).  
However, the fact that HF represents a myriad of clinical conditions, the lack of universality in the 
definition of HF and the heterogeneity in the methods for HF ascertainment between studies makes head-
to-head comparisons between studies difficult.  Our analyses required assumptions regarding the 
continuous coverage in CMS of persons less than 65 years, raising the possibility of incomplete capturing 
of HF events in this age stratum of the SCCS cohort.  However, we found that over 81.9% of persons 
aged < 65 who reported CMS coverage at baseline had a claim for any condition within 90 days of being 
enrolled in SCCS.  This suggests that an even greater proportion of participants included in this study 
filed at least one claim at some point during follow-up from 2002 to 2010 and thus any HF event would 
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likely have been captured if it occurred.  Data on baseline covariates (including anthropometric and 
cardiovascular risk factors) were based on self-report of a physician diagnosis and use of medications 
(diabetes and hypertension).  While self-report may be susceptible to recall and misclassification bias, 
these methods have been successfully used and validated in large epidemiologic cohorts, including the 
SCCS. Many of the questions on the SCCS questionnaire were adapted from questionnaires used and 
validated in other settings; and a series of independent validation studies using biomarkers, repeat 
interviews or medical records have demonstrated the reliability of the questionnaire within the SCCS 
population for variables such as smoking status, self-reported diseases including diabetes, height and 
weight [18]. 
 The SCCS cohort is comprised of a substantial number of individuals from minority and low-
income populations who are traditionally under-represented in most studies investigating CVD and heart 
failure in particular.  The incidence rates for HF in the SCCS exceeded that of most existing 
cardiovascular cohorts.  Therefore, the SCCS provides an unparalleled opportunity to investigate patterns 
in HF incidence and mortality among the highest risk individuals.  In addition, both black and white 
participants included in this cohort had minor differences in income and education levels thereby 
curtailing confounding by socioeconomic differences.  The availability of a large sample of participants 
and HF cases provided the opportunity to adequately explore differential patterns across sex and racial 
categories.  Also, linkage with the NDI and SSA allowed for robust ascertainment of all-cause mortality.  
In conclusion, in this low-income multiethnic population, we found higher incidence rates for HF in all 
race-sex groups than previously reported in other CVD cohorts which was paralleled by high prevalence 
of CVD risk factors at baseline. This suggests that SCCS can be a unique resource to investigate 
determinants of HF risk in a segment of the population underrepresented in other existing cohorts. 
 
 
 
116 
 
 Neighborhood deprivation predicts heart failure risk in a low-income population of blacks 
and whites in the southeastern United States 
Elvis A. Akwo, MD, MS1,5; Edmond K. Kabagambe, DVM, PhD1, 5; Frank E. Harrell, PhD2, 5; William J. 
Blot, PhD1, 3; Justin M. Bachmann, MD, MPH4,5; Thomas J. Wang, MD4,5; Deepak K. Gupta, MD* 4, 5, 
Loren Lipworth, ScD* 1, 5 
1 Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, 
Nashville, Tennessee, 37203. 
2 Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, 37203.  
3 International Epidemiology Institute, Rockville, Maryland, 20850.  
4 Division of Cardiovascular Medicine, Vanderbilt Heart & Vascular Institute, Department of Medicine, 
Vanderbilt University School of Medicine, Nashville, Tennessee, 37203. 
5Vanderbilt Center for Translational and Clinical Cardiovascular Research (V-TRACC), Vanderbilt 
University School of Medicine, Nashville, Tennessee, 37203. 
Address correspondence to: 
Dr. Loren Lipworth 
Division of Epidemiology 
Department of Medicine 
Vanderbilt University School of Medicine 
2525 West End Avenue, Suite 600 
Nashville, TN 37203 
Phone : 615-343-0639 
Fax : 615-343-5938 
loren.lipworth@vanderbilt.edu 
Word Count: Manuscript (4966), abstract (346). 
Running Title: Neighborhood deprivation and heart failure. 
AHA Journal Subject Terms: [Epidemiology] [Heart failure] 
 
 
117 
 
Abstract 
Background  
Recent data suggest that neighborhood socioeconomic environment predicts heart failure (HF) hospital 
readmissions, yet evidence for the association with HF incidence and post-HF mortality is scant. We 
sought to investigate whether neighborhood deprivation predicts the risk of incident HF and post-HF 
survival beyond individual socioeconomic status (SES) in a low-income population. 
Methods  
Participants included in this study were 27,078 white and black men and women recruited during 2002-
2009 in the Southern Community Cohort Study (SCCS), who had no history of HF and were receiving 
Centers for Medicare or Medicaid services (CMS).  Incident HF diagnoses through December 31, 2010 
were ascertained using ICD-9 codes 428.x via linkage with CMS research files. Participant residential 
information was geocoded and the census tract was determined by a spatial join to the US Census 
Bureau’s TIGER/Line Shapefiles using geographic information systems technology. The neighborhood 
deprivation index was constructed using principal components analysis based on census tract-level 
socioeconomic variables. Cox models with Huber-White cluster sandwich estimator of variance were 
utilized to investigate the association between deprivation index and both HF risk and post-HF mortality. 
Results 
The study sample was predominantly middle-age (mean 55.5 years), black (69%), female (63%), and of 
low income (70% earned < $15,000/year).  Over half of the participants lived in the most deprived 
neighborhoods. Over a median follow-up of 5.2 years, 4,300 participants were diagnosed with HF. After 
adjustment for demographic, lifestyle and clinical factors, a 1 interquartile (IQR) increase in deprivation 
index was associated with a 12% increase in the risk of HF [HR= 1.12; 95% CI: 1.07-1.18] and 4.7% of 
the variance in HF risk [ICC = 4.8; 95% CI: 3.6-6.4] was explained by neighborhood deprivation. Among 
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HF cases, 940 deaths occurred over a median follow-up 2.3 years. In multivariable-adjusted models 
deprivation index was not associated with the risk of post-HF mortality [HR= 1.05; 95% CI: 0.95-1.17].  
Conclusions 
In this low-income population, scant neighborhood resources compound the risk of HF above and beyond 
individual socioeconomic status and traditional cardiovascular risk factors. Improvements in community 
resources may be a significant axis for curbing the burden of HF. 
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Introduction 
 Heart failure (HF) is a major public health problem, particularly in the southeastern United States 
(US) which has been described as the “heart failure belt” [147].  This region of the US has the highest 
high prevalence of established HF risk factors (including coronary heart disease, high blood pressure, 
diabetes and obesity) which themselves may be associated with socioeconomic characteristics that 
influence health outcomes. While evidence from middle-class persons suggests that individual 
socioeconomic status (SES) contributes to HF risk,[9, 10, 105, 146] recent data support that neighborhood 
factors may also predict HF readmissions independent of individual-level SES [11].  However, it is not 
known whether such neighborhood factors are independent predictors of other HF outcomes such as HF 
incidence and post-HF mortality among persons with already low individual SES.   
The Southern Community Cohort Study is a prospective cohort study that recruited persons of 
low individual SES from 12 states in the southeastern United States.  Within this cohort, we tested the 
hypothesis that neighborhood characteristics (defined by a composite deprivation index) predict the risk 
of incident HF and post-HF survival beyond individual-level socioeconomic status (defined by annual 
household income and highest level of education attained). 
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Methods 
Design and study population 
 The SCCS is a prospective cohort study designed to investigate the incidence of cancer and other 
chronic diseases, including differential patterns by race and sex, in a resource-limited under-insured 
population underrepresented in previous studies [18].  A total of 84,797 participants aged 40-79 were 
enrolled into the SCCS between March 2002 and September 2009 [148].  Approximately 86% of 
participants were recruited at community health centers (CHC), which provide primary health and 
preventive care services for resource-limited populations such that the cohort is made up of a segment of 
society seldom included in substantial numbers in previous cohort studies; particularly those investigating 
cardiovascular disease (CVD) [18, 20].  The remaining 14% were recruited via mail-based sampling of 
the general population.  Demographic, socioeconomic, lifestyle, and anthropometric data, as well as 
personal medical history, were ascertained at cohort enrollment via standardized computer-assisted 
personal interviews for CHC participants, and via self-administered mailed questionnaire for persons 
recruited from the general population. Detailed description of SCCS methods has been previously 
published [18, 20, 107]. 
 For the current analyses, we included 27,078 participants who were either ≥ 65 years old at cohort 
enrollment (n = 7,001), or < 65 years at enrollment (n = 20,077) and: a) reported being covered by 
Medicaid (which provides medical benefits to low-income adults and uninsured persons) on the baseline 
questionnaire; or b) reported being covered by Medicare (the primary health insurance program for 
persons aged ≥ 65) on the baseline questionnaire; or c) did not report Medicare or Medicaid on the 
baseline questionnaire but had a Centers for Medicare and Medicaid Services (CMS) claim within 90 
days of being enrolled in SCCS.  The restriction to these groups increases the likelihood of participants 
having continuous coverage in Medicare and/or Medicaid from the time of SCCS enrollment to the end of 
the follow-up period (December 31st, 2010), for the ascertainment of incident HF events.  Analyses were 
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restricted to self-reported African American or black and non-Hispanic white SCCS participants, since 
too few persons in other racial groups were available for stable statistical analyses. 
Census tracts  
 Census tracts were used as proxies for neighborhoods in this study.  Census tracts are small, 
relatively permanent statistical subdivisions of a county or equivalent entity that are updated by local 
participants prior to each decennial census as part of the US Census Bureau's Participant Statistical Areas 
Program [126].  Census tract boundaries are delineated with the intention of being maintained over a long 
time period so that statistical comparisons can be made from census to census. Across the US, census 
tracts usually cover a contiguous area and generally have a population size between 1200-8000 persons, 
with an optimum size of 4000.  The 27,078 SCCS participants included in the current analyses resided in 
4,666 census tracts.    
 At the time of the SCCS baseline interview, study participants provided information on their 
residential address which was then geocoded by a multi-stage process incorporating both batch and 
interactive processes [149].  The census tract for the geocoded address was then determined by a spatial 
join to the US Census Bureau’s Topologically Integrated Geographic Encoding and Referencing 
(TIGER/Line®) Shapefiles [150] using ESRI ArcMap 10.0 software (ESRI, Redlands, CA) that utilizes 
GIS (geographic information systems) technology. Geocoding of SCCS participants’ addresses and 
linkage to geographic information datasets such as census tract data allowed development of residence-
specific metrics including the SCCS-derived deprivation index.   
Neighborhood deprivation Index  
 The SCCS-derived deprivation index is a clustering of social and economic indicators which 
reflect neighborhood deprivation and have been linked to adverse health outcomes.  It was constructed 
using principal components analysis based on 11 census tract-level variables representing 4 main 
dimensions [128, 151]: 1) Social indicators: percentage of housing units with ≥1 occupant per room, 
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percentage of occupied housing units with renter/owner costs >50% of income and percent female-headed  
households with dependent children;  2) Wealth and income: percentage of households with income 
<$30,000 per year, percentage of persons with income below the 1999 poverty status, percentage of 
households with public assistance income, percentage of households with no car and median value of 
owner-occupied housing units;  3) Education: percentage of persons aged ≥25 that did not graduate high 
school; and  4) Occupation: percentage of males and females who are unemployed and percentage males 
in professional occupations.  
 In the original description of the neighborhood deprivation index by Messer et al using data from 
across 8 study areas, the first principal component was retained, as it explained over 67% of the variance 
(while the second principal component explained less than 10% of the variance) with component loadings 
ranging between 0.2-0.4, suggesting similar contribution of each of the component variables to the first 
principal component [128]  Signorello et al found that in the SCCS, the first principal component 
explained most of the variability (over 60%) in the component measures as well, as such it was retained 
for the construction of the deprivation index in the SCCS [151].  
Individual socioeconomic variables and other covariates  
 SCCS participants reported their highest level of education attained, in 8 categories ranging from 
less than high school to graduate-level degrees. Participants also reported the range of their total 
household income for the year prior to enrollment, in 5 categories ranging from less than $15,000 to over 
$100,000 or more. History of tobacco smoking was self-reported as never, former and current and also in 
terms of number of cigarettes per day and alcohol use in number of drinks per day. The presence of 
traditional cardiovascular risk factors at baseline was based on a self-reported history of physician-
diagnosed hypertension, diabetes mellitus, high cholesterol, as well as self-reported use of medications for 
hypertension, diabetes mellitus, or high cholesterol.  History of myocardial infarction and stroke was 
based on self-report and confirmed via medical records for a small random sample of SCCS participants. 
While self-report of baseline covariates may be susceptible to recall bias, these methods have been 
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successfully used and validated in large epidemiologic cohorts, including the SCCS.[18] Many of the 
questions on the SCCS questionnaire were adapted from questionnaires used and validated in other 
settings; and a series of independent validation studies using biomarkers, repeat interviews or medical 
records have demonstrated the reliability of the questionnaire within the SCCS population for variables 
such as smoking status, self-reported diseases including diabetes, height and weight [18]  Total amount of 
moderate and vigorous exercise was measured in metabolic equivalent-hours per day. 
Outcome ascertainment 
 Heart failure events were ascertained via linkage of the SCCS cohort with CMS Research 
Identifiable Files (which include Medicare institutional and non-institutional files, and the Medicaid 
Analytic Extract files).  Incident HF was defined as the first occurrence of a medical claim with an 
International Classification of Diseases, 9th revision, discharge code of 428.x within the Medicare 
institutional (Medicare Provider Analysis and Review, MEDPAR, which includes inpatient, outpatient 
and skilled nursing facility base files), Part B carrier (includes non-institutional physician services and 
durable medical equipment), or outpatient-based claims files or the Medicaid Analytic Extract (MAX) 
Inpatient and Other Services claims files, from the date of SCCS enrollment through December 31st, 
2010. Detailed description of the CMS research files are published elsewhere [143].   
 Deaths, including dates and causes of death, were ascertained via linkage of the SCCS cohort 
with both the Social Security Administration (SSA) vital status service for epidemiologic researchers and 
the National Death Index (NDI) through December 31st, 2010. Both NDI and SSA are well-established 
and reliable means of identifying deaths in the US, and are expected to capture nearly all deaths [51, 122, 
123].  When date of death was coincident with date of HF diagnosis, follow-up time was set to 0.5 days.  
Statistical Analysis 
 Descriptive statistics (means and standard deviations for continuous variables and counts and 
percentages for categorical variables) were computed for all study participants overall and by tertiles of 
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deprivation index.  Tertile cut-points were based on the distribution of the values of deprivation index for 
census tracts (n = 4666) covered by the population included in the current analyses. 
Covariate selection and spending degrees of freedom  
 The selection of variables to be included in the multivariable models was based on the 
hypothesized relationships between the baseline covariates in question, deprivation index and the 
outcomes of interest (HF incidence and post-HF death).  The functional form of the covariates (i.e. 
degrees of freedom spent) and deprivation index was based on a priori knowledge and the rank 
correlations between the covariate and the outcomes. 
Modelling hierarchical data 
 For the current analyses, the data were organized in a hierarchical fashion comprising 2 levels 
with individual participants (level-1units) nested within census tracts (level-2 units).  Given the nested 
structure of the data, the non-independence of the data points within each census track and the limitations 
of a multilevel modelling approach in this setting (unbalanced data with many small clusters), we utilized 
a Cox proportional hazards model that accounts for non-independence using the Huber-White cluster 
sandwich estimator of variance, Hc [127] whose general formula for linear and nonlinear models is given 
below: 
 
where I is the information matrix (the second derivative of the log likelihood, log L) [127] and U is the 
score statistic –  the first derivative of log L. In the specific case of the Cox model, the cluster sandwich 
estimator, Hc uses special score residuals for U (the score vector) given there are no per-observation score 
contributions [127, 142]. 
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 The proportion of variance explained by differences at the census-tract level was estimated from 
the intra-class correlation coefficient (ICC), which was computed based on the latent variable approach.  
This approach uses the closed-form solution of the ICC in the multi-level logistic model to make an 
approximate estimation of the ICC in the multi-level Cox proportional hazards model.  
00
2
00 3
ICC

 


, where 00 = group-level variance [137].  
Deprivation Index and Heart Failure Incidence  
 Multivariable-adjusted Cox analyses were used to model a flexible association between 
deprivation index (modelled using restricted cubic splines with 4 knots) and HF accounting for 
nonlinearity and non-additivity of effects by race.  The fully adjusted model was then used to dynamically 
create plots of log relative hazard of incident HF versus deprivation index by race.  The covariates 
included in the full model were: age at enrollment (restricted cubic splines with 4 knots), race 
(white/black), deprivation index×race interaction terms (linear and nonlinear), sex (men/women), 
cigarette smoking (never, former, current <19.5 pack-years, current ≥ 19.5 pack-years, 19.5 being the 
median pack-years among current smokers), alcohol intake (linear), total MET-hours of moderate or 
greater exercise (linear and quadratic term), body mass index (BMI, restricted cubic splines with 4 knots), 
history of diabetes, hypertension, high cholesterol, MI/CABG or stroke (all yes/no), annual household 
income (<$15,000; $15,000-$24,999; ≥$25,000) and education (< high school, high school/vocational 
training/junior college, college degree or higher). 
 In further analyses, multivariable Cox models assuming linearity of effects (with deprivation 
index modelled as a rescaled continuous variable using the interquartile range, IQR) were used to estimate 
the effect of a 1 IQR increase in deprivation index on HF incidence while adjusting for relevant covariates 
in a sequential fashion.  Hazard ratios (HR) for a 1 interquartile range increase in deprivation index (as a 
continuous measure) compare the hazard of the event occurring for a typical person in the middle of the 
upper half (the 75th percentile) of the distribution of deprivation index to the hazard of the event for a 
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typical person in the middle of the lower half (25th percentile) of the distribution.  Model 1 included 
deprivation index (as a linear IQR-rescaled predictor), age at enrollment (restricted cubic splines with 4 
knots), race (white/black), sex (men/women) and the deprivation index×race interaction term.  Model 2 
additionally adjusted for lifestyle and clinical covariates including: cigarette smoking (never, former, 
current <19.5 pack-years, current ≥ 19.5 pack-years, 19.5 being the median pack-years among current 
smokers), alcohol intake (linear), total MET-hours of moderate or greater exercise (linear and quadratic 
term), body mass index (restricted cubic splines with 4 knots), history of diabetes, hypertension, high 
cholesterol, MI/CABG or stroke (all yes/no).  In model 3, annual household income (<$15,000; $15,000-
$24,999; ≥$25,000) and education (< high school, high school/vocational training/junior college, college 
degree or higher) were added to investigate the potential mediating effects of individual-level SES.  Knots 
were placed at quantiles of covariate distributions, equally spaced in sample size [127].   
 We conducted a sensitivity analysis (using similar multivariable models) excluding HF cases 
diagnosed within 2 years of follow-up.  The exclusion of incident HF within the first 2 years of follow up 
limits the possibility that HF cases occurring soon after enrollment in the SCCS may not have been 
influenced by baseline values of neighborhood deprivation.  
Deprivation Index and Post-HF Survival 
 Multivariable-adjusted Cox analyses as described previously for HF incidence were utilized to 
model the relationship between deprivation index and post-HF survival. Model assumptions were verified 
using Schoenfeld residuals and log (-log) plots. 
 All analyses were performed using STATA (version 12.1, Stata Corp, College Station, Texas, 
USA) and the ‘rms’ package for R version 3.1.1 (R Core Team 2014) [144, 145]. 
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Ethical approval 
 Participants enrolled in SCCS provided written informed consent, and protocols were approved 
by the Institutional Review Boards of Vanderbilt University Medical Center and Meharry Medical 
College. 
Results 
Characteristics of the study population 
 Among the 27,078 SCCS participants with CMS data, 260 (0.96%) had missing values for 
deprivation index and were therefore excluded from these analyses.  Baseline characteristics of the 26,818 
included participants are shown in Table 1, overall and by tertiles of deprivation index.  Tertile cut-points 
were based on the distribution of deprivation index at the census tract-level (not individuals).  Tertile 1 
represents the least deprived census tracts (i.e. the neighborhoods with the most community resources), 
while tertile 3 represents the most deprived.  The inequality in the number of individuals per tertile of 
deprivation index is explained in part by the wide variation in the number of persons per census tract 
(mean = 6; range: 1-243) and that census tracts with higher deprivation tended to have more individuals 
per census tract, i.e. more persons lived in the most disadvantaged neighborhoods. 
 The mean (SD) age of the study participants at cohort enrollment was 55.5 (10.4) years, 62.7% 
were women, 69.0% were black, 69.9% had annual household income < $15,000, 38.6% had less than a 
high school education and 44.8% were obese (BMI ≥ 30 kg/m2).  There was a modest negative correlation 
between neighborhood deprivation and annual household income (Spearman’s rank correlation 
coefficient, ρ = - 0.23) as well as education (ρ = - 0.17).  Compared with persons living in the least 
deprived neighborhoods (tertile 1), participants living in the most deprived neighborhoods (tertile 3) were 
more likely to be younger, black, and obese, have less than a high school education, earn less than 
$15,000 a year, and be current smokers.  They were also more likely to report a history of diabetes and 
hypertension at baseline, but they were less likely to report a history of MI or high cholesterol.  
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Table 1. Baseline characteristics of SCCS participants receiving Medicare or Medicaid during follow-up 
between 2002 and 2010, overall and by tertileǂ of deprivation index 
  
 Deprivation Index 
 Overall  Tertile 1 Tertile 2 Tertile 3  
 0.85 (1.21) -0.76 (0.34) 0.03 (0.21) 1.61 (0.93) 
Census tracts, n 4,666 1, 556 1, 555 1, 555 
Participants, n N = 26, 818 n = 4, 256 n = 6, 478 n = 16, 084 
Age, years (SD) 55.5 (10.4)  58.1 (10.7) 56.8 (10.4) 54.2 (10.1) 
Age quartiles, %     
          40-46 24.8 19.0 20.3 28.1 
          47-53 26.6 22.0 24.7 28.6 
          54-64 22.9 21.0 24.8 22.6 
          ≥ 65 25.7 38.0 30.2 20.7 
Women, % 62.7 60.0 64.6 62.6 
Blacks, % 69.0 37.3 49.8 85.2 
Education %     
          < High school  38.6 25.5 36.4 42.9 
         HS/Junior college/VT§ 53.1 57.0 55.0 51.3 
         ≥ College degree  8.3 17.5 8.6 5.8 
Annual Income, %     
         < $15,000 69.9 53.3 65.0 76.2 
         $15, 000-24, 999 17.9 18.2 20.6 16.8 
         ≥$25, 000 12.2 28.5 14.4 7.0 
Smoking, %     
        Never 34.6 34.6 36.6 33.9 
        Former 25.2 32.7 28.4 22.0 
        Current  19.7 32.7 35.0 44.2 
Alcohol Intake, %     
        0 drink per day 55.0 53.6 62.1 52.5 
        >0-2 drinks per day 33.1 36.8 29.8 33.5 
        >2 drinks per day 11.9 9.6 8.1 14.0 
Physical exerciseϙ, met-hrs/day, (SD) 0.87 (2.3) 1.12 (2.6) 0.77 (2.1) 0.85 (2.3) 
BMI, kg/m2 (SD) 30.4 (7.8) 29.9 (7.4) 30.7 (7.6) 30.4 (7.9) 
BMI Categories, %      
        Underweight, BMI < 18.5 1.7 1.4 1.6 1.7 
        Lean, BMI 18.5 - < 25.0 24.0 24.6 21.3 24.9 
        Overweight, BMI 25 - < 30.0 29.5 32.5 30.4 28.4 
        Obese, BMI ≥ 30.0 44.8 41.5 46.7 45.0 
Diabetes, % 26.5 24.5 28.1 26.4 
Hypertension, % 62.5 58.4 63.4 63.3 
High Cholesterol, % 39.5 45.4 44.3 35.9 
History of MI, % 8.6 10.0 10.1 7.6 
History of Stroke, % 9.6 9.4 9.9 9.5 
* Other than for physical activity (p = 0.66), all comparisons between tertiles of deprivation index were significant (p < 0.0001 
for all comparisons). ϙPhysical Exercise = Total moderate and vigorous exercise in MET-hours.  
ǂ Tertile cut-points were based on the distribution of deprivation index at the census tract-level (not individuals). The 3rd tertile 
(with higher mean deprivation index) is the most deprived i.e. represents census tracts with the least community resources while 
tertile 1 is the most affluent. The inequality in the number of individuals per tertile of deprivation index is explained in part by the 
significant variation in the number of persons per census tract and the fact that census tracts with the higher deprivation had more 
individuals per census tract i.e. there were more persons living in the most disadvantaged neighborhoods. 
§VT: Vocational training. 
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Deprivation Index and HF incidence 
 Over a median (25th, 75th percentile) follow-up time of 5.2 (3.2, 6.8) years, 4,300 participants 
(16%) developed incident HF.  SCCS participants in the 3rd tertile of deprivation index had the highest 
cumulative incidence of HF, 17%, compared with 13% and 15.7% for persons in tertiles 1 and 2, 
respectively. 
 Figure 1 shows a graph of the log relative hazard (Xβ) of HF plotted against deprivation index.  
Among whites, the log relative hazard of HF rises sharply with increasing deprivation index then levels-
off after a deprivation index of approximately 0.5.  Among blacks on the other hand, the curve has a more 
gradual slope and it plateaus at higher values of deprivation index (approximately 2.0).  
 Table 2 shows the risk of incident HF associated with neighborhood deprivation index adjusted 
for relevant covariates in a sequential fashion (models 1 to 3).  Overall, after adjustment for age, sex and 
race, a 1 IQR increase in deprivation index was associated with a 14% increase in the risk of HF [HR= 
1.14; 95% CI: 1.09 to 1.19].  Subsequent adjustment for lifestyle and clinical factors was associated with 
a minimal change in the point estimate [HR= 1.15; 95% CI: 1.05 to 1.21].  In the full model, further 
adjustment for the individual level SES factors of income and education (in addition to demographics, 
lifestyle and clinical factors) showed only a modest attenuation of the strength of the association; namely, 
a 1 IQR increase in deprivation index was associated with a 12% increase in the risk of HF [HR= 1.12; 
95% CI: 1.07 -1.18].  The ICC was 4.8% [95% CI: 3.6-6.4], suggesting that 4.% of the variance in HF 
risk was explained by neighborhood deprivation. 
 The race stratified analyses showed similar patterns of increased risk of HF per 1 IQR increase in 
deprivation index.  In the full models, there was a 20% increase in the risk [HR= 1.20; 95% CI: 1.07 -
1.34] of HF per 1 IQR increase in deprivation index among whites and an 11% increase among blacks 
[HR= 1.11; 95% CI: 1.05 -1.17], p for interaction = 0.0005.   
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 In sensitivity analyses excluding HF cases diagnosed within 2 years of follow-up, the effect 
estimates were similar, with a HR of 1.13 [95% CI: 1.06 -1.20] for the overall cohort in fully adjusted 
models. 
 Fig 1. Plot of Log Relative Hazard (Xβ) for incident heart failure versus deprivation index among black 
and white individuals in the Southern Community Cohort Study. 
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 Table 2: Hazard ratios for incident heart failure per 1 interquartile range increase in deprivation index, 
overall and by race 
 Overall 
N = 26, 818 
Whites 
n = 8, 303 
Blacks 
n = 18, 515 
Model 1 1.14 (1.09, 1.19) 1.34 (1.21, 1.47) 1.09 (1.04, 1.15) 
Model 2 1.15 (1.05, 1.21) 1.27 (1.14, 1.41) 1.12 (1.06, 1.18) 
Model 3 1.12 (1.07, 1.18) 1.20 (1.07, 1.34) 1.11 (1.05, 1.17) 
 
Data presented as hazard ratio (95% confidence interval).  Model 1: Includes deprivation index, age (restricted cubic 
splines with 4 knots), race and sex.  Model 2: Model 1 + smoking (never, former, current < 19.5 pack-years, current 
≥ 19.5 pack-years), alcohol intake (linear) and Total moderate and vigorous sports in MET-hours (linear + 
quadratic) + BMI (restricted cubic splines with 4 knots), diabetes (yes/no), hypertension (yes/no), high cholesterol 
(yes/no), history of MI (yes/no) and history of stroke (yes/no).  Model 3: Model 2 + annual household income 
(<$15000, $15000-$24999 & ≥$25000) and education (< high school, high school/vocational training/junior college, 
college degree or higher.  P-value for deprivation index×race interaction = 0.0005. 
Intra-class correlation coefficient = 4.8% (95% CI: 3.6, 6.4) 
CI: Confidence interval; HR: Hazard ratio; HF: Heart failure; BMI: Body mass index 
 
 
Deprivation Index and Post-HF Survival 
 Among the 4,300 SCCS participants who developed incident HF, 940 died (cumulative mortality 
= 21.9%) over a post-HF median (25th, 75th percentile) follow-up time of 2.3 (0.9, 4.2) years.   
Participants in the 3rd tertile of deprivation index had the highest cumulative mortality, 22.9% compared 
with 21.2% and 19.6 for persons in tertiles 1 and 2, respectively.  
 Figure 2 shows a graph of the log relative hazard (Xβ) of post-HF mortality plotted against 
deprivation index.  While the initial portions of the plots of log relative hazard of post-HF mortality 
against deprivation index in blacks and whites were suggestive of a gradual slope, they were mostly flat 
for the range of observed values of deprivation index. 
 Overall, in the full model adjusted for demographics, individual SES, lifestyle and clinical factors 
at baseline, a 1 IQR increase in deprivation index was associated with a nonsignificant 5% increase in the 
risk of all-cause mortality post-HF [HR= 1.05; 95% CI: 0.95 -1.17] (Table 3).  A similar finding was 
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observed among blacks [HR= 1.07; 95% CI: 0.94 -1.21] while the hazard ratio was close to unity among 
whites [HR= 1.00; 95% CI: 0.79 -1.25].   
Fig 2. Plot of Log Relative Hazard (Xβ) of post-heart failure death versus deprivation index among black 
and white individuals in the Southern Community Cohort Study. 
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Table 3: Hazard ratios for post-heart failure death per 1 interquartile range increase in deprivation index, 
overall and by race 
 Overall 
N = 4, 300 
Whites 
n = 1, 290 
Blacks 
n = 3, 010 
Model 1 1.11 (1.00, 1.23) 1.11 (0.90, 1.38) 1.10 (0.98, 1.24) 
Model 2 1.07 (0.97, 1.19) 1.05 (0.84, 1.31) 1.08 (0.96, 1.22) 
Model 3 1.05 (0.95, 1.17) 1.00 (0.79, 1.25) 1.07 (0.94, 1.21) 
 
Data presented as hazard ratio (95% confidence interval).  Model 1: Includes deprivation index, age (restricted cubic 
splines with 4 knots), race and sex.  Model 2: Model 1 + smoking (never, former, current < 19.5 pack-years, current 
≥ 19.5 pack-years), alcohol intake (linear) and Total moderate and vigorous sports in MET-hours (linear + 
quadratic) + BMI (restricted cubic splines with 4 knots), diabetes (yes/no), hypertension (yes/no), high cholesterol 
(yes/no), history of MI (yes/no) and history of stroke (yes/no).  Model 3: Model 2 + annual household income 
(<$15000, $15000-$24999 & ≥$25000) and education (< high school, high school/vocational training/junior college, 
college degree or higher. P-value for deprivation index×race interaction = 0.96. 
Intra-class correlation coefficient = 5.7% (95% CI: 2.6, 12.1) 
CI: Confidence interval; HR: Hazard ratio; HF: Heart failure; BMI: Body mass index 
 
 
Discussion 
 We investigated the association between neighborhood deprivation index and HF incidence as 
well as post-HF mortality in a large population of low-income blacks and whites from the southeastern 
United States.  Our main findings were: 1) persons living in the most deprived neighborhoods appear to 
have a greater burden of CVD risk factors, 2) higher levels of neighborhood deprivation are significantly 
associated with an increase in HF risk independent of individual SES and traditional CVD risk factors, 
and 3) there is no strong evidence of an association between neighborhood deprivation and post-HF 
mortality. 
 The existing literature provides evidence of a strong independent association between individual 
socioeconomic characteristics, such as income, education and occupation, and HF risk [9, 10, 105, 146].  
In addition, recent data suggests that neighborhood SES also plays a significant role in predicting HF 
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outcomes including HF admissions and readmissions, [11, 152] but evidence for the association with HF 
incidence has been scant.  The current investigation demonstrates an independent association between 
increasing neighborhood deprivation and increased risk of HF with a non-negligible proportion of the 
variance (~ 5%) of HF incidence in this population explained by neighborhood socioeconomic factors.  
Furthermore, the dose-response curve indicates increasing HF risk with increasing levels of neighborhood 
deprivation in both blacks and whites before the curve plateaus.  Neighborhood factors have been shown 
to predict the incidence of coronary heart disease (CHD) [136, 137, 153] and we now extend this to heart 
failure.  Further, given that our study was conducted within a population with relatively low individual 
SES, under-represented in previous studies, it is particularly noteworthy to find that a dearth of 
community-level resources further compounds the risk of HF in this population.  
 The neighborhood deprivation index utilized for this study was a composite obtained from 11 
components using principal component analysis.  Thus, it remains uncertain what specific neighborhood 
characteristics are responsible for our findings, but several hypotheses may explain the impact of scant 
community resources on health outcomes.  The availability of exercise facilities, healthy food outlets, 
institutional resources (including healthcare facilities), and tobacco advertising vary considerably across 
neighborhoods [154-156].  If food deserts are more preponderant in the most deprived neighborhoods, 
that could reduce access to healthier food choices and potentially increase the consumption of high-
calorie foods and foods with high sodium content.  Also, the combination of fewer physical activity 
resources, unaffordable gym memberships, and higher crime rate may predispose persons living in these 
communities to reduced physical activity and sedentariness.  The combined influence of poor nutritional 
habits and physical inactivity could explain the higher rates of obesity that have been observed in poverty-
dense counties in the US [12, 157].  The high rates of obesity are paralleled by high prevalence of 
obesity-related comorbid conditions including diabetes and high blood pressure (possibly abetted in part 
by the consumption of foods with high salt content) which further compound the risk of HF in these 
communities.  
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 In the current cohort, compared with the neighborhoods with the most resources, the more 
deprived neighborhoods each had higher prevalence of obesity, hypertension and diabetes at baseline and 
this may have contributed to the observed trend of increasing HF risk with worsening deprivation.  But 
the similar prevalence of these risk factors across the two upper tertiles of neighborhood deprivation may 
explain in part the plateau observed in the dose-response curve for HF incidence after an initial increase.  
However, we did observe higher proportions of persons with previous history of MI in the neighborhoods 
with the most resources which may have been due in part to an overrepresentation of older persons and 
whites (who have a higher risk of MI) in these areas.  Nevertheless, after adjustment for all these factors, 
a strong independent association between neighborhood deprivation and HF risk persisted, which could 
not be explained by mediation via CVD risk factors or individual SES.  This suggests that some of the 
correlates of neighborhood deprivation may be less tangible and harder to measure.  Some authors have 
hypothesized that persons living in deprived neighborhoods may be at higher risk of unfavorable societal 
stressors like noise, air pollution and violence which may culminate in chronic psychological stress and 
predispose individuals to adverse health outcomes including HF [153, 158].  Marked institutional 
deficiencies in resource-limited settings are usually mirrored by reduced access to quality education, 
occupational opportunities and health facilities.  These could expose individuals in these communities to 
reduced scholarship, income and logistics and hence curtail individual ability to seek preventative care, 
self-management and adherence to recommended treatment guidelines (evidence-based lifestyle strategies 
and multifactorial medical management approaches) for conditions such as diabetes and hypertension – 
predisposing them to elevated risk of HF.  Finally, reduced social ties and community perceptions about 
health in low SES communities could mitigate health-seeking behaviors including early screening for 
diabetes and hypertension, adherence to therapy and holistic management of these chronic conditions 
which is pivotal to improve outcomes.  
 While previous data found an association between neighborhood factors and mortality in the 
general population, [159] among persons with HF, we found no evidence of an association with all-cause 
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mortality.  Meanwhile, significant associations have been observed between neighborhood characteristics 
and lower adherence to therapy, worse quality of care, and worse outcomes (including rehospitalizations) 
among patients with HF [160-167].  As these intermediate outcomes may be correlated with death among 
persons with HF, we may have expected to find a significant association between neighborhood SES and 
post-HF mortality.  However we had a relatively limited post-HF follow-up time (~2.3 years) and it is 
plausible that a longer time is required to notice the impact of socioeconomic environment on long-term 
outcomes such as death.  In future studies, it may be relevant to re-visit the association with all-cause 
mortality and investigate the association with cardiovascular death after a more significant post-HF 
follow-up time. 
 The current study has a few noteworthy limitations.  Some authors consider a ‘neighborhood’ to 
be a spatially defined collection of people, infrastructures, and institutions influenced by common 
environmental, sociocultural, and economic forces [168].  The extent to which a census tract is a rational 
proxy for ‘neighborhood’ remains uncertain. However, as a relatively permanent statistical subdivision of 
a county or equivalent entity, census tracts cover a contiguous area with long term boundaries, and harbor 
an optimum population close to 4000 persons on average.  Thus, using them as proxies for neighborhoods 
appears reasonable for the purpose of investigating the health outcomes of a population with shared 
socioeconomic environment.  Most of our covariate data (past history of MI, stroke, hypertension, 
diabetes and high cholesterol) were based on self-report of a physician diagnosis and use of medications.   
While self-report could be susceptible to recall and misclassification bias, these methods have been 
validated in the SCCS as well as other epidemiologic studies [18].  Several of the questions on the SCCS 
questionnaire were adapted from questionnaires that were validated in other settings; and a series of 
independent validation studies using biomarkers, repeat interviews or medical records have demonstrated 
the reliability of the questionnaire within the SCCS population for variables such as smoking status and 
self-reported diseases including diabetes [18].  HF was ascertained by linking our baseline SCCS data 
with CMS Research Identifiable Files using ICD-9 codes 428.x, rather than independent physician 
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adjudication.  Nonetheless, the diagnosis codes algorithm for identification of HF used in this study has 
been previously validated and utilized in other cohorts [119-121].  A review of the detection of HF in 
administrative claims data that included studies conducted among Medicare beneficiaries reported 
positive predictive values (PPVs) mostly over 90% [119].    
 Our study leverages data from a large biracial cohort with a sizable number of low-income 
participants living in resource-limited settings and who are traditionally under-represented in previous 
cohorts investigating HF outcomes.  Thus, it provided the unique opportunity to investigate the role of 
neighborhood factors on HF risk and post-HF survival in a sample of people already having scant 
individual resources.  The ability to perform geocoding of participant residential information and linkage 
to geographic information datasets such as census tract data allowed development of residence-specific 
metrics including the SCCS-derived deprivation index which we were able to utilize as a proxy for 
neighborhood SES.  The large number of level-2 units (census tracts) covered by the study participants 
allowed for stable statistical analyses and provided some credence to the representativeness of the whole 
SCCS cohort by the sub-sample utilized for the current analysis.  
 In conclusion, we found that neighborhood socioeconomic factors significantly predict HF 
incidence independent of individual income and education level and traditional CVD risk factors, but 
longer follow-up may be needed to examine the association with post-HF survival.  The American Heart 
Association and other cardiovascular societies recognize that improvements in cardiovascular health 
requires strategies that target the entire spectrum of the healthcare system including public policy, 
prevention, acute care, chronic care and rehabilitation.  However, the more “upstream measures” which 
focus on public policy and prevention may have the greatest potential to mitigate the burden of CVD and 
improve human health.  Areas with the most acute socioeconomic deprivation are most likely at the 
highest risk for CVD (including HF) and CVD mortality and hence may benefit most from such 
improvements in public health policies including, but not limited to, improvements in community-level 
resources. 
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Abstract 
Background  
Previous studies have used body mass index (BMI) as the default weight-height index for the prediction 
of heart failure (HF) risk and mortality and have assumed linearity of effects or utilized BMI categories.  
We sought to propose an empirically-derived weight-height index (W/Hn) and investigate the dose-
response relationship between weight-height indices (as proxies for total adiposity) and HF risk as well 
post-HF mortality. 
Methods  
Study participants were black and white enrollees (n = 27,078) of the Southern Community Cohort Study 
with no history of HF at baseline and who were receiving Centers for Medicare and Medicaid Services 
(CMS).  Incident HF diagnoses through December 31, 2010 were ascertained using ICD-9 codes 428.x 
via linkage with CMS research files.  For W/Hn, n was defined as the ratio of the coefficients of the log 
height and log weight parameters from a Cox model for the log relative hazard of HF and post-HF 
mortality.  Cox models were used to investigate the dose-response relationship between surrogate 
measures of adiposity – W/Hn, BMI and waist circumference (WC) – and both HF risk and post-HF 
mortality. 
Results 
For incident HF, n was found to be 1.81 among whites and 1.21 among blacks while for post-HF 
mortality, the corresponding values were 4.02 and 2.68 respectively.  In models for predicting HF risk or 
post-HF mortality, log W/Hn yielded better model fit (smaller AIC) compared to log BMI especially 
among blacks. After full adjustment for baseline covariates, a 1 interquartile range (IQR) increase in 
W/Hn remained associated with a significant 31% increase in the risk of incident HF [HR = 1.31; 95% CI: 
1.22-1.39] among whites and a 33% increase in risk [HR= 1.33; 95% CI: 1.27-1.39] among blacks. 
Similar findings were observed for BMI. For WC, the HR was 1.66 [95% CI: 1.29 -2.14] among whites 
and 1.46 [95% CI: 1.20 -1.77] among blacks. The plot of log relative hazard of HF vs. BMI was J-shaped; 
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the nadir for the curve for blacks occurred at a higher BMI (30 versus 25kg/m2). There was an inverse 
nonlinear dose-response trend between post-HF mortality risk and BMI which mostly plateaus beyond a 
BMI ≈ 30kg/m2. 
Conclusions 
Empirically-derived weight-height indices offered a better model fit for the prediction of incident HF and 
post-HF mortality compared to BMI. There were unique nonlinear dose-response patterns observed 
between BMI and both HF risk and post-HF mortality that could potentially inform current clinical 
guidelines or recommendations regarding risk stratification. 
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Introduction 
 Data from a variety of communities across the US suggest that poverty-dense counties have high 
levels of obesity which are paralleled by high prevalence of cardio-metabolic conditions including 
cardiovascular disease (CVD) and heart failure (HF) [12].  Thus, it is important to critically examine the 
link between obesity and HF particularly among populations with scant resources.  
 Prior epidemiologic evidence is suggestive of an association between excess body weight and 
increased risk of HF [13-15] as well as a contrasting decrease in the risk of post-HF mortality – a 
phenomenon coined as the obesity paradox [109, 111, 112, 114, 117]  However, most studies 
investigating these relationships utilized categories of body mass index (BMI) or assumed linearity of 
effects thereby limiting the elucidation of the natural dose-response relationship between measures of 
obesity and HF risk as well as post-HF survival.  
 More importantly, less thought has been given to the suitability of BMI – weight (W)/height (H)2 
– in investigating the link between obesity and both HF risk and post-HF survival despite differences in 
the performance of various weight-height indices across population groups defined by race and sex [16, 
17].  Additionally, predictors with “pleiotropic” effects usually have differential functional relationships 
with varying outcomes suggesting the need to use the data to empirically derive an appropriate weight-
height index for each outcome. Such approaches may be utilized to adequately model the intricacies in 
these data and reveal novel insights that may improve our understanding of anthropometry and general 
obesity in relation to HF risk and post-HF survival.    
 The Southern Community Cohort Study (SCCS) [18] provided the opportunity to investigate: a) 
the appropriate functional form of a data-derived weight-height index (W/Hn) for the association with 
incident HF and post-HF survival, and b) the dose-response relationships between W/Hn (as a surrogate 
measure of general obesity) and waist circumference (WC, a surrogate for visceral fat), with incident HF 
and post-HF survival in a large sample of blacks and whites drawn from resource-limited settings.  
142 
 
Methods 
Design and Study Population 
 The SCCS is a unique ongoing prospective investigation tracking a population of 84,797 adults, 
two-thirds black, aged 40-79, recruited in 12 southeastern states between 2002 and 2009 to investigate the 
incidence of cancer and other chronic diseases [18, 148]  Over 86% of the participants in the SCCS were 
identified from community health centers (CHC), institutions providing primary health and preventative 
services mainly to low-income populations [18, 20], so that the cohort is made up of a segment of society 
(minority, poor, rural) seldom included in sizeable numbers in previous cohort studies; particularly those 
investigating CVD.  The remaining 14% were recruited via mail-based sampling of the general 
population.  Data on demographic, socioeconomic, lifestyle, and anthropometric characteristics, as well as 
personal medical history, were obtained at cohort enrollment using standardized computer-assisted 
personal interviews for CHC participants, and via self-administered mailed questionnaire for persons 
recruited from the general population.  Detailed description of SCCS methods has been previously 
published [18, 20, 107].  
 Participants (n = 27,078) included in the current analyses were SCCS enrollees aged ≥ 65 (n = 
7001) at cohort enrollment, or persons < 65 years (n = 20,077) at enrollment who: a) reported being 
covered by Medicaid (which provides medical benefits to low-income adults and uninsured persons) on 
the baseline questionnaire; or b) reported being covered by Medicare (the primary health insurance 
program for persons aged ≥ 65) on the baseline questionnaire; or c) did not report Medicare or Medicaid 
on the baseline questionnaire but had a Centers for Medicare and Medicaid Services (CMS) claim within 
90 days of being enrolled in SCCS. The restriction to these groups maximizes the likelihood that 
participants would have continuous coverage in Medicare and/or Medicaid from the time of SCCS 
enrollment to the end of the follow-up period (December 31st, 2010), for the ascertainment of incident HF 
events. Analyses were restricted to self-reported African American or black and non-Hispanic white 
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SCCS participants, since too few persons in other racial groups were available for stable statistical 
analysis. 
Assessment of anthropometric data  
 SCCS participants reported their height and weight at baseline.  These were validated using data 
from a random sample (n ≈ 14,000) of SCCS participants for whom measured weight and height were 
either a) abstracted from contemporaneous CHC medical records or b) obtained via measurements 
performed by trained interviewers using a SECA 703 digital scale and a stadiometer on the day of the 
interview [107]  There was a very high correlation (r > 0.95) between measured and self-reported weight 
and height [18].  The latter were used to compute W/Hn and BMI – weight (kg)/height (m)2 – the main 
predictors for the current analyses. 
 Waist and hip circumferences were measured for a subset of the cohort using a standardized 
protocol with a tape measure over a single layer of clothing [107]  Of the 27,078 SCCS participants in the 
current study, 3304 had WC data. 
Outcome ascertainment 
 Ascertainment of HF events was performed via linkage of the SCCS cohort with CMS Research 
Identifiable Files (which include Medicare institutional and non-institutional files, and the Medicaid 
Analytic Extract files).  Incident HF was defined as the first occurrence of a medical claim with an 
International Classification of Diseases, 9th revision, discharge code of 428.x (428.0 to 428.9) within the 
Medicare institutional (Medicare Provider Analysis and Review, MEDPAR, which includes inpatient, 
outpatient and skilled nursing facility base files), Part B carrier (includes non-institutional physician 
services and durable medical equipment), or outpatient-based claims files or the Medicaid Analytic 
Extract (MAX) Inpatient and Other Services claims files, from the date of SCCS enrollment through 
December 31st, 2010.  Detailed description of the CMS research files are published elsewhere.[143]   
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 Deaths, including dates and causes of death, were ascertained via linkage of the SCCS cohort 
with both the Social Security Administration (SSA) vital status service for epidemiologic researchers and 
the National Death Index (NDI) through December 31st, 2010. Both NDI and SSA are well-established 
and reliable means of identifying deaths in the US, and are expected to capture nearly all deaths [51, 122, 
123]. 
Statistical Analysis 
 Descriptive statistics (means and standard deviations for continuous variables and counts and 
percentages for categorical variables) were computed for all study participants, overall and by race.  
 For all participants included in the current study, duration of follow-up for incident HF was 
computed from date of enrollment into the SCCS until the date of the first diagnosis of HF, date of death, 
or December 31, 2010, whichever occurred first.  For HF cases, post-HF follow-up time was defined as 
time from HF diagnosis to death or December 31st 2010 whichever occurred first.  When date of death 
was coincident with date of HF diagnosis, follow-up time was set to 0.5 days. 
 To investigate the association between W/Hn and incident HF, the following analyses were 
performed in a step-wise fashion. 
a. Deriving the value of n and computing W/Hn.   
 The log relative hazard of incident HF, Y, regressed on the logarithm of a generic weight-height 
index (W/Hn) in a Cox model (with no intercept) could be expressed as follows: 
𝑌 = log 𝑊 𝐻𝑛⁄ , assuming a slope of 1. 
𝑌 = log 𝑊 + log 𝐻−𝑛  
𝑌 = log 𝑊 − nlog 𝐻  
So the absolute value of the ratio of the coefficients of log H and log W is n. 
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 Thus, if a bivariate Cox model for the log relative hazard of incident HF, with the latter regressed 
on log W and log H yields α1 and α2 as their regression coefficients: 
𝑌 =  𝛼1 log 𝑊 + 𝛼2 log 𝐻 , 
where Y = log relative hazard (incident HF), then n is given by the absolute value of the ratio of the 
coefficients:  
n = |𝛼2 𝛼1⁄ | 
 This approach was used to obtain the value of n and compute W/Hn for all participants included 
in the current analyses.  
b. Comparing the performance of W/Hn and BMI in HF risk prediction 
 First, we constructed a bivariate Cox model for the log relative hazard of HF comprising the 
natural log of BMI and log height, both modelled as restricted cubic splines with 5 knots.  A Chunk test 
was performed for the linear and nonlinear terms of log height at alpha of 0.05 to test if the height 
variable contributes significant additional information to the single-predictor model containing BMI.   
 Second, in separate Cox models, we regressed the restricted cubic splines of the natural log of 
W/Hn and that of BMI on the log relative hazard of HF.  Then, model fit statistics (LR chi square, χ² and 
AIC) were computed and used to compare the performance of W/Hn versus that of BMI vis-à-vis a model 
utilizing restricted cubic splines of both log weight and log height as the latter was expected to preserve 
the most information.  
c. Investigating the association between W/Hn and HF risk  
 Multivariable Cox models accounting for nonlinearity and non-additivity were utilized to model a 
flexible dose-response association between W/Hn (modelled using restricted cubic splines with 5 evenly 
spaced knots) and HF risk adjusting for relevant covariates.  Model 1 included W/Hn, age at enrollment 
(restricted cubic splines with 4 knots), race (white/black), sex (men/women) and W/Hn×race interaction 
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terms.  Model 2 additionally adjusted for annual household income (<$15,000; $15,000-$24,999; 
≥$25,000); education (< high school, high school/vocational training/junior college, college degree or 
higher), smoking (never, former, current <19.5 pack-years, current ≥ 19.5 pack-years, 19.5 being the 
median pack-years among current smokers), alcohol intake (linear) and total physical activity in met-
hours (linear + quadratic term).  Model 3 additionally adjusted for the following covariates: history of 
diabetes, hypertension, high cholesterol, MI/CABG or stroke (all yes/no). Knots were placed at quantiles 
of covariate distributions, equally spaced in sample size.[127]  Plots of log relative hazard of incident HF 
versus W/Hn stratified by race were constructed based on data from the variable-rich model.  
 Similar multivariable Cox models (models 1 through 3) were used to estimate the effect of an 
interquartile range (IQR) increase in W/Hn (modelled as a linear IQR-rescaled predictor) on incident HF.  
The hazard ratio (HR) and 95% confidence interval (CI) for a 1 interquartile range increase in W/Hn (as a 
continuous measure) compares the hazard of the event occurring for a typical person in the middle of the 
upper half (the 75th percentile) of the distribution of W/Hn to the hazard of the event for a typical person 
in the middle of the lower half of the distribution.  P-values for the interactions between weight-height 
indices and race were computed. 
 Steps a through c were repeated for the association between W/Hn and post-HF mortality. 
d. Investigating the association between WC and HF risk  
 Similar analyses (models, effect estimation and plots) were performed for the association between 
WC and HF risk.  However, given the reduced amount of data available for the analyses involving WC, 
models 1 through 3 were simplified to reduce the degrees of freedom spent and preserve power.   
 Model 1 included WC (restricted cubic splines with 4 knots), age (restricted cubic splines with 4 
knots), race (white/black), sex (men/women) and WC×race interaction terms.  Model 2 additionally 
adjusted for annual household income (<$15,000/≥$15,000); education (< high school, high 
school/vocational training/junior college, college degree or higher), smoking (never, former, current), 
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alcohol intake (linear) and total physical activity in met-hours (linear).  Model 3 additionally adjusted for 
the following covariates: history of diabetes, hypertension, high cholesterol, MI/CABG or stroke (all 
yes/no).  
 All analyses were performed using STATA (version 12.1, Stata Corp, College Station, Texas, 
USA) and the ‘rms’ package for R version 3.1.1 (R Core Team 2014) [144, 145]. 
Ethics statement 
 Participants enrolled in SCCS provided written informed consent, and protocols were approved 
by the Institutional Review Boards of Vanderbilt University Medical Center and Meharry Medical 
College. 
 
Results 
Characteristics of the Study Population 
 Table 1 shows the distribution of baseline characteristics of the 27, 078 participants included in 
the current study, overall and by race.  The mean (SD) age of the study participants at cohort enrollment 
was 55.5 (10.4) years; 68.8 % were black, 62.6% were women, 69.7% had annual household income < 
$15,000, 38.4% had less than a high school education and 44.8% were obese (BMI ≥ 30Kg/m2).  Overall, 
black SCCS participants were younger, more likely to be obese and to have less than a high school 
education, less than $15,000 annual income, a past history of high blood pressure and diabetes at baseline.  
White SCCS participants on the other hand were more likely to be heavy smokers and report a past 
history of high cholesterol, myocardial infarction and stroke at baseline. 
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Table 1. Comparison* of baseline characteristics of 27, 078 SCCS participants who were receiving 
Medicare or Medicaid during follow-up between 2002 and 2010, by race  
 Overall Whites Blacks 
 n = 27,078 n = 8,454 n = 18,624 
Age (SD), years 55.5 (10.4)  58.0 (10.6) 54.3 (10.1) 
Age quartiles %    
  40-46 24.6 18.2 27.5 
  47-53 23.7 19.9 25.4 
  54-64 25.9 25.6 26.0 
  ≥ 65 25.8 36.3 21.1 
Women % 62.6 62.1 62.8 
Education %    
 < High school (HS) 38.4 30.9 41.8 
   HS/Junior college/VT**  53.1 56.5 51.6 
   ≥ College degree  8.5 12.6 6.6 
Annual Income < $15,000, % 69.7 61.1 73.5 
Smoking %    
   Never 34.7 31.3 36.2 
   Former 25.3 31.9 22.3 
   Current & pack-years < 19.5 19.6 9.3 24.3 
   Current & pack-years ≥ 19.5 20.4 27.6 17.2 
Alcohol Intake %    
    0 drink per day 54.9 60.0 52.7 
    >0-2 drinks per day 33.2 31.9 33.7 
    >2 drinks per day 11.9 8.1 13.6 
Total Physical Activity (SD), met-hrs  17.2 (15.6) 16.6 (14.9) 17.4 (15.9) 
BMI (kg/m2) (SD) 30.4 (7.8) 30.0 (7.6) 30.6 (7.8) 
BMI Categories %     
        Underweight, BMI < 18.5 1.7 1.8 1.6 
        Lean, BMI 18.5 - < 25.0 24.0 25.3 23.4 
        Overweight, BMI 25 - < 30.0 29.5 31.2 28.7 
        Obese, BMI ≥ 30.0 44.8 41.7 46.3 
History of MI % 8.6 12.1 7.0 
History of Stroke % 9.6 10.3 9.2 
Diabetes % 26.5 24.1 27.6 
Hypertension % 62.5 56.9 65.0 
High Cholesterol % 39.5 48.6 35.4 
 
* Other than for sex (p = 0.32), all comparisons between racial groups were statistically significant (p = 0.004 for 
stroke, p = 0.0001 for total physical activity and p<0.0001 for all other baseline variables).  
**VT: Vocational training.
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Empiric weight-height indices used to investigate HF risk and Post-HF mortality 
 For incident HF, the calculated exponent of height, n, in the empiric weight-height index (W/Hn) 
was found to be 1.81 among whites and 1.21 among blacks while for post-HF mortality, the 
corresponding values were 4.02 and 2.68 respectively (Table 2).  Table 2 shows the distribution of the 
empiric weight-height indices and their correlations with BMI and WC.  The W/Hn index for the 
association with HF risk was strongly correlated with WC (and BMI) in both whites and blacks while 
BMI appeared weakly correlated with WC among blacks.  Similar patterns (correlations with BMI) were 
observed for empiric weight-height indices used to investigate post-HF mortality but there were limited 
data to compute reliable correlation coefficients with WC.  
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Table 2: Empiric weight-height indices derived for both Incident HF and post-HF mortality in SCCS 
 
Incident HF Post-HF mortality 
 Whites 
n* = 8,454 
 
 
 
Blacks 
n* = 18,624 
 
 
Whites 
nϙ = 1,312 
 
 
 
Blacks 
nϙ = 3,029 
 
 
 BMI W/H1.81 BMI W/H1.21 BMI W/H4.07 BMI W/H2.68 
Range 13.2 – 78.3 14.5 – 86.8 11.4 – 80.7 15.3 – 121.5 14.0 – 78.3 4.4 – 29.0 14.5 – 80.7 9.9 – 56.7 
Mean (SD) 30.0 (7.6) 33.1 (8.4) 30.6 (7.8) 46.3 (11.4) 32.1 (8.5) 11.4 (3.6) 32.6 (8.8) 22.9 (6.4) 
Median (IQR) 28.5 (9.1) 31.6 (9.9) 29.3 (10.0) 44.5 (14.5) 30.6 (10.8) 10.6 (4.5) 31.2 (11.6) 22.0 (8.6) 
Pearson’s correlations (ρ)     
W/Hn § 0.99 1.00 0.98 1.00 0.91 1.00 0.99 1.00 
WCǂ 0.85 0.85 0.78 0.80     
 
* Out of the 27, 078 whites and blacks included in these analyses, 365 (1.35%) had missing weight and/or height data at baseline.  
ϙ Out of the 4,341 persons who were diagnosed with HF on follow-up, 73 (1.7%) had missing weight and/or height data.  
ǂ WC: waist circumference; data were available for 1406 White and 1962 Black participants. There were insufficient WC data among HF cases to compute 
correlations with empiric weight-height indices derived for the association with post-HF mortality. 
§ For Incident HF, the exponent of height in W/Hn = 1.81 among whites and 1.21 among blacks. For post-HF mortality, the exponent of height in W/Hn = 4.02 
among whites and 2.68 among blacks. 
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Model fit for models utilizing W/Hn to investigate HF risk and post-HF mortality 
 Model fit statistics for separate Cox models utilizing log weight + log height, log W/Hn or log 
BMI to predict HF risk and post-HF mortality are presented in Table 3.  For predicting HF risk, using log 
W/Hn yielded better model fit statistics (smaller AIC and higher LR χ²) compared to using log BMI 
especially among blacks. A similar pattern was observed for models predicting post-HF mortality in 
blacks and whites.  
Table 3: Model fit statistics for models utilizing weight-height indices for predicting HF risk and post-HF 
mortality 
Incident HF Post-HF Mortality 
Whites Whites 
Model* LR χ² AIC LR χ² AIC 
Log W + Log 
H 
141.08 22274.60 57.55 3839.73 
Log W/Hn 125.29 22282.40 45.51 3843.77 
Log BMI 125.12  22282.56  38.91  3850.37  
Blacks Blacks 
Model* LR χ² AIC LR χ² AIC 
Log W + Log 
H 
224.46 55959.06 121.46 9488.58 
Log W/Hn 218.01 55957.51 110.63 9491.42 
Log BMI 207.75  55967.77  108.94  9493.11  
 
*All variables were modelled using restricted cubic splines with 5 knots. 
§ For Incident HF, the exponent of height in W/Hn = 1.81 among whites and 1.21 among blacks. For post-HF 
mortality, the exponent of height in W/Hn = 4.02 among whites and 2.68 among blacks. 
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Association between surrogate measures of total and visceral adiposity with HF risk  
 Over a median follow-up time of 5.2 (range: 0.1 – 8.9) years, 4,341 incident cases of HF were 
ascertained corresponding to a cumulative incidence of 16%.  Table 4 shows the HR (and 95% CI) for 
incident HF per 1 IQR increase in W/Hn and BMI adjusted for demographic, lifestyle and clinical factors 
in a sequential fashion (models 1 to 3).  After adjustment for age and sex, a 1 IQR increase in W/Hn was 
associated with a 49% increase in the risk of HF [HR= 1.49; 95% CI: 1.41-1.58] among whites and a 43% 
increase [HR= 1.43; 95% CI: 1.37-1.49] in risk among blacks. For BMI, similar effect estimates were 
observed with HRs of 1.51 [95% CI: 1.42 -1.60] and 1.44 [95% CI: 1.38-1.51] among whites and blacks 
respectively.  After full adjustment for relevant covariates, a 1 IQR increase in W/Hn remained associated 
with a significant 31% increase in the risk of incident HF [HR = 1.31; 95% CI: 1.22-1.39] among whites 
and a 33% increase in risk [HR= 1.33; 95% CI: 1.27-1.39] among blacks. Similar findings were observed 
for BMI. 
 For WC, the association with incident HF appeared stronger with HRs of 1.74 [95% CI: 1.38 -
2.18] among whites and 1.60 [95% CI: 1.36 -1.89] among blacks in the minimally-adjusted model and 
HRs of 1.66 [95% CI: 1.29 -2.14] among whites and 1.46 [95% CI: 1.20 -1.77] among blacks in the fully 
adjusted model (Table 5). 
 The plot of log hazard of HF versus W/Hn (on a standardized scale) appears to have a J-shape 
with lower values associated with increased risk of HF in both blacks and whites then both curves rise 
sharply after a nadir – which occurs earlier in the curve for whites compared to that of blacks (Figure 1a).  
The plot for BMI is almost identical to the former with the troughs found at ≈ 25Kg/m2 among whites and 
≈ 30 Kg/m2 among blacks (Figure 1b). Figure 1c shows the plot for WC.  Among blacks, the plot is 
suggestive of an ostensibly linear increase in log hazard of HF with increasing WC.  Among whites, 
whilst the curve appears nonlinear with a trough at ≈ 90cm, in the region where we have the most data 
(and tighter confidence bands), the risk of HF increases in a seemingly linear fashion.   
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Fig 1a. The log relative hazard of HF plotted against a 
standardized weight-height index among Blacks and 
Whites in SCCS.  
Fig 1b. The log relative hazard of HF plotted against BMI 
among Blacks and Whites in SCCS.  
                                                                                                      
 
Fig 1c. The log relative hazard of HF plotted 
against waist circumference among Blacks and 
Whites in SCCS. 
Fig 1. The log relative hazard of HF plotted against 3 
surrogate measures of obesity among Blacks and Whites 
in SCCS. 
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Association between surrogate measures of total adiposity and post-HF mortality  
 Among the 4,341 SCCS participants who developed incident HF, 952 died (a cumulative 
mortality of 21.9%) over a median follow-up time of 2.3 (range: 0 – 8.8) years.  The HR (and 95% CI) for 
post-HF mortality per 1 IQR increase in W/Hn and BMI are shown in Table 4. After adjustment for age 
and sex, a 1 IQR increase in W/Hn was associated with a 27% decrease in the risk of all-cause mortality 
after a HF diagnosis [HR= 0.73; 95% CI: 0.61 – 0.87] among whites and a 37% decrease [HR= 0.63; 95% 
CI: 0.55 – 0.71] in risk among blacks.  Similar effect estimates were observed for BMI with HRs of 0.73 
[95% CI: 0.62 – 0.87] and 0.63 [95% CI: 0.56 – 0.72] among whites and blacks respectively.  After full 
adjustment for relevant covariates, a 1 IQR increase in W/Hn remained associated with a significant 30% 
decrease in the risk of post-HF mortality [HR = 0.70; 95% CI: 0.58 – 0.85] among whites and a 33% 
decrease in risk [HR= 0.67; 95% CI: 0.58 – 0.77] among blacks.  Comparable estimates were obtained for 
BMI. 
 The plot of log relative hazard of post-HF mortality versus W/Hn (on a standardized scale) was 
suggestive of a negative nonlinear relationship between W/Hn and the risk of all-cause mortality 
following a HF diagnosis (Figure 2a).  Among whites the risk decreased sharply with increasing values 
of W/Hn then plateaued, whereas among blacks, the initial sharp decrease was followed by a more gentle 
decrease throughout the range of values of W/Hn.  An identical pattern was observed for the plot of BMI 
with the plateau observed among whites occurring at a BMI ≈ 30 Kg/m2 (Figure 2b).  
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Table 4: Hazard ratios for incident HF and post-HF mortality per 1 IQR increase in weight-height indices 
Incident HF 
 Whites Blacks 
 BMI W/Hn BMI W/Hn 
Model 1 1.51 (1.42, 1.60) 1.49 (1.41, 1.58) 1.44 (1.38, 1.51) 1.43 (1.37, 1.49) 
Model 2 1.49 91.40, 1.58) 1.48 (1.39, 1.57) 1.46 (1.39, 1.53) 1.45 (1.39, 1.52) 
Model 3 1.32 (1.23, 1.40) 1.31 (1.22, 1.39) 1.33 (1.27, 1.40) 1.33 (1.27, 1.39) 
Post-HF Mortality 
 Whites Blacks 
 BMI W/Hn BMI W/Hn 
Model 1 0.73 (0.62, 0.87) 0.73 (0.61, 0.87) 0.63 (0.56, 0.72) 0.63 (0.55, 0.71) 
Model 2 0.76 (0.64, 0.91) 0.75 (0.62, 0.90) 0.71 (0.62, 0.81) 0.70 (0.61, 0.80) 
Model 3 0.70 (0.58, 0.84) 0.70 (0.58, 0.85) 0.68 (0.59, 0.78) 0.67 (0.58, 0.77) 
 
Model 1: Includes age (restricted cubic splines with 4 knots), race and sex. Model 2: Model 1 + annual household 
income (<$15000, $15000-$24999 & ≥$25000) and education (< high school, high school/vocational training/junior 
college, college degree or higher, smoking (never, former, current < 19.5 pack-years, current ≥ 19.5 pack-years), 
alcohol intake (linear) and total physical activity in MET-hours (linear + quadratic). Model 3: Model 2 + diabetes 
(yes/no), hypertension (yes/no), high cholesterol (yes/no), history of MI (yes/no) and history of stroke (yes/no). P-
value for BMI×race interaction = 0.24. P-value for W/Hn ×race interaction = 0.24. CI: Confidence Interval 
 
Table 5: Hazard ratios for incident HF per 1 IQR increase in WC, overall and by race 
 
Overall Whites Blacks 
Model 1 1.65 (1.45, 1.89) 1.74 (1.38, 2.18) 1.60 (1.36, 1.89) 
Model 2 1.64 (1.43, 1.88) 1.80 (1.42, 2.28) 1.58 (1.33, 1.88) 
Model 3 1.53 (1.32, 1.78) 1.66 (1.29, 2.14) 1.46 (1.20, 1.77) 
 
Model 1: Includes age (restricted cubic splines with 4 knots), race and sex. Model 2: Model 1 + annual household 
income (<$15000, $15000-$24999 & ≥$25000) and education (< high school, high school/vocational training/junior 
college, college degree or higher, smoking (never, former, current < 19.5 pack-years, current ≥ 19.5 pack-years), 
alcohol intake (linear) and total physical activity in MET-hours (linear + quadratic). Model 3: Model 2 + diabetes 
(yes/no), hypertension (yes/no), high cholesterol (yes/no), history of MI (yes/no) and history of stroke (yes/no). 
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Fig 2a. The log relative hazard of post-HF mortality plotted 
against a standardized weight-height index among Blacks 
and Whites in SCCS.  
Fig 2b. The log relative hazard of post-HF mortality 
plotted against BMI among Blacks and Whites in SCCS.  
  
 
Fig 2. The log relative hazard of post-HF mortality plotted against weight-height indices among Blacks and Whites in 
SCCS. 
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Discussion 
 In this large sample of low-income blacks and whites from the southeastern US, we investigated 
the association between surrogate measures of obesity and incident HF as well as post-HF mortality.  Our 
principal findings were: 1) Compared to BMI, empirically-derived weight-height indices offer a better 
model fit when investigating the association with incident HF and post-HF mortality; 2)  There exists an 
independent positive nonlinear association between surrogate measures of general (weight-height indices) 
as well as visceral obesity (waist circumference) and incident HF; and 3)  There is an independent 
negative nonlinear dose-response relationship between surrogate measures of general obesity (weight-
height indices) and post-HF mortality. 
 Most previous studies investigating the association between obesity and both HF risk and post-
HF survival have utilized BMI (W/H2) as a surrogate measure of total adiposity [105, 169]  Meanwhile, 
some investigators have suggested that other weight-height indices including the ponderal index, W/H 
and W/H3 could be equally appropriate depending on the demographic characteristics of the study 
population [16, 17, 82].  In the current study we propose a novel empirically-derived weight-height index 
(W/Hn) that utilizes information from the outcome measure to inform its functional form.  We obtained 
better model fit statistics using the empiric index in models used to predict both HF risk and post-HF 
survival.  This suggests that for the purpose of predicting HF outcomes it may be more apropos to use 
empirical indices rather than BMI which has been the default proxy for total adiposity utilized in 
prediction models including the HF risk calculator (C index = 0.741) developed by the Meta-Analysis 
Global Group in Chronic Heart Failure (MAGGIC) [169].  More so, in multivariable logit models for 
post-HF mortality in SCCS we obtained slightly higher C-statistics utilizing W/Hn compared to BMI (data 
not shown). 
 However, when investigating dose-response patterns and computing summary effect estimates for 
the obesity-HF association, we did observe similar patterns for either index – BMI or W/Hn.  Overall, 
there was a significant independent association of comparable magnitude between both indices and HF 
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risk (with no evidence of heterogeneity of effects by race) which is corroborated by findings from 
previous studies.  For example, using data from the Framingham Heart Study, Kenchaiah et al found HRs 
(95%CI) of 1.05 (1.02-1.09) and 1.07 (1.04-1.10) per kg/m2 among men and women respectively after 
full adjustment for demographic variables, traditional cardiovascular (CV) risk factors (including 
smoking, diabetes, hypertension, past history of MI, total cholesterol) and left ventricular (LV) 
hypertrophy [13].  Using data from the Atherosclerosis Risk in Communities study, Ndumele et al found 
a HR of 1.32 per 5kg/m2 after adjusting for traditional CV risk factors, N-terminal pro b-type natriuretic 
peptide (NT-BNP) and estimated glomerular filtration rate (eGFR) [15].  Ndumele et al also found a 
strong independent association between BMI and cardiac troponin T, a biomarker of subclinical 
myocardial injury which has been linked with incident HF [15].  This could explain in part the 
independent association between BMI and HF after adjusting for causal intermediaries like diabetes and 
hypertension.  
 In addition to that, obesity has been shown to be independently associated with impaired 
myocardial contractile function and relaxation as well as structural myocardial abnormalities [170, 171].  
The most common structural changes observed include concentric remodeling, LV hypertrophy (which 
includes concurrent cardiac myocyte hypertrophy, fibrosis and apoptosis at the cellular level), dilated 
cardiomyopathy and increased right ventricular (RV) wall thickness which occur in varying degrees 
depending on obesity class and the presence or absence of hypertension [90, 92-99].  The presence of LV 
hypertrophy predisposes obese persons to abnormalities in diastolic function including increased LV end-
diastolic pressure [90, 92] and abnormal load-dependent myocardial strain [103].  Data from animal 
models suggest that the structural and functional changes seen in obese individuals are related to 
metabolic derangements including decreased insulin sensitivity, decreased serum adiponectin levels, 
increased sympathetic tone, activation of the Renin Angiotensin Aldosterone System (RAAS) and low-
grade systemic inflammation (increased C - reactive protein and Tumor Necrosis Factor, TNF) [14].   
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 Still, in contrast to previous investigations on the obesity-HF association, which have either 
assumed a linear dose-response or reported effect estimates based on pre-specified categories (including 
those defined by the World Health Organization, WHO), we found a nonlinear J-shaped dose-response 
curve between BMI and HF risk. This J-shape pattern (suggestive of higher HF risk at very low or high 
values of BMI or W/Hn) mirrors patterns observed for the association between BMI and other outcomes 
including end-stage renal disease and all-cause mortality [172-174].  Elevated HF risk with increasing 
BMI maybe explained by abnormalities associated with increasing levels of adiposity including chronic 
myocardial injury and myocardial dysfunction [14].  This hypothesis is bolstered by the quasi-linear dose-
response curve (in the BMI range where we have the most data) observed for the association between WC 
(a proxy for visceral adiposity) and HF risk.  On the other hand, the underlying reasons behind higher risk 
at very low BMI remain uncertain and could be related to frailty and reduced lean mass.  Importantly, 
while the nadir for the dose-response curve for blacks occurred at a BMI ≈ 30kg/m2, that for whites 
occurred at a lower BMI, ≈ 25kg/m2.  If we utilized the WHO BMI categories as a referent framework, 
this would imply that among whites, the risk of HF rises with increasing BMI close to the cut-point for 
persons considered ‘overweight’; meanwhile, among blacks, HF risk surges closer to the threshold for the 
‘obese’ category.  This would be consistent with previous data suggesting differential body composition 
by race whereby on average, whites have higher visceral fat and percent body fat (as well as higher risk of 
adverse outcomes including ESRD [175], atrial fibrillation [108] and cardiovascular mortality [107]) than 
blacks at similar BMI [176, 177] – another argument against the ubiquitous utilization of pre-specified 
BMI categories for risk stratification.  
 While the epidemiologic data linking obesity to increased HF risk and the biologic evidence for 
the nefarious effects of excess body weight on the myocardium appear to be compelling, several studies 
have suggested that overweight and obese persons with HF have a demonstrably higher survival 
compared to leaner subjects – a phenomenon coined as the obesity paradox [109, 111, 112, 114, 117].  
For example, in a meta-analysis of 9 observational studies, Oreopoulos et al found a 33% lower risk [HR 
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= 0.67; 95% CI: 0.62 - 0.73] of all-cause mortality among obese persons with HF compared to persons 
with ‘normal’ weight [112].   Overall, our findings appear to corroborate this paradox for either index 
(BMI and W/Hn). Several hypotheses have been suggested to explain this phenomenon. Obese persons 
appear to have a higher metabolic reserve while leaner patients with HF may have a higher likelihood of 
being cachectic and thus could be at a higher risk of death [113].  Also, compared to persons with 
‘normal’ weight, overweight and obese persons were found to have lower atrial natriuretic peptide levels 
which was correlated with having higher muscle mass and muscle strength [116].  The latter have been 
associated with improved survival in other patient populations and this may be analogous to patients with 
congestive HF as well [117].  Finally, certain underlying biological characteristics of obese persons with 
HF may play a role including the secretion of soluble TNF-α receptors which have beneficial neutralizing 
effects and elevated blood pressure which raises the tolerance of obese individuals to higher doses of 
cardio-protective agents including beta blockers, aldosterone antagonists and RAAS inhibitors [114, 115]. 
 In light of existing data suggesting that in persons with HF, intentional weight loss mitigates 
some of the concurrent hemodynamic abnormalities and reduces left ventricular (LV) mass [90, 92, 93, 
100, 114, 118], some cardiovascular societies recommend intentional weight reduction, albeit at higher 
cut-points for BMI [114].  The American Heart Association, the Heart Failure Society and the European 
Society of Cardiology recommend intentional weight loss in persons with HF at BMI cut-points of 40, 35 
and 30 kg/m2, respectively [114].  Importantly, one of the unique aspects of the nonlinear dose-response 
relationship observed between BMI at cohort entry and post-HF mortality in the current investigation of 
the SCCS data was that the initial inverse trend mostly plateaus beyond a BMI ≈ 30kg/m2.  While this is 
not clinical trial data, this observation appears to lend some credence to the above recommendations. 
Nevertheless, the ubiquitous utilization of BMI cut-points to guide patient care remains somewhat 
contentious as it seemingly assumes discontinuities in risk.  An alternative decision-making paradigm 
may be to develop a highly discriminant prediction model for HF-related outcomes (including post-HF 
mortality and hospitalizations) using the relevant anthropometric, lifestyle, clinical and demographic 
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factors and using the estimates of predicted risk for individuals and cost-effectiveness ratios of efficacious 
interventions to make decisions in clinical or public heath settings.  In addition, for any such models 
including the HF risk calculator developed by the MAGGIC (C index = 0.741), it would be interesting to 
explore differences in model fit (as well as discriminant and calibration properties) when utilizing BMI 
versus empiric weight-height indices derived for specific race-sex groups or more robust measures of 
adiposity whenever available. 
 Limitations of the study include the utilization of self-reported height and weight for calculation 
of weight-height indices but a prior SCCS validation study showed very high correlation (r > 0.95) 
between self-reported and measured weight and height [18].  Data from the National Health and Nutrition 
Examination Survey (NHANES) also suggest that BMI based on self-report has good concordance with 
BMI from measured values.[178]  Data on baseline covariates (including CVD risk factors) were based 
on self-report of a physician diagnosis and use of medications.  While self-report could be susceptible to 
recall and misclassification bias, these methods have been successfully utilized and validated in large 
epidemiologic cohorts, including the SCCS.  Several of the questions on the SCCS questionnaire were 
adapted from questionnaires that were validated in other settings; and a series of independent validation 
studies using biomarkers, repeat interviews or medical records have demonstrated the reliability of the 
questionnaire within the SCCS population for variables such as smoking status and self-reported diseases 
including diabetes [18].  Another potential drawback is that for the analyses of weight-height indices in 
relation to post-HF mortality, we relied exclusively on the anthropometric and covariate data at cohort 
entry and we lacked these data at the time of HF diagnosis and these may have changed over time.  Also, 
HF was ascertained via linkage with CMS Research Identifiable Files using ICD-9 codes 428.x (428.0 – 
428.9), rather than independent physician adjudication.  Nonetheless, the diagnosis codes algorithm for 
identification of HF used in this study has been previously validated and utilized in other cohorts [119-
121].  A review of the detection of HF in administrative claims data that included studies conducted 
among Medicare beneficiaries reported positive predictive values (PPVs) mostly over 90% [119].  These 
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codes have also been used with high specificity in a number of studies [120, 121] even though no 
independent validation was conducted by the SCCS investigators.   Data on the utilization of medication 
(ACE Inhibitors, beta blockers, statins etc), devices, investigations and procedures would have been 
useful in informing the analyses and these were unavailable from the linkages performed with the 
administrative claims data. In addition information on important predictors like LV ejection fraction 
(LVEF), NT proBNP, eGFR, or New York Heart Association class may have influenced the observed 
dose-response curves and summary effect estimates for post-HF mortality.  Similarly additional clinic 
data on blood pressure values, HbA1c and serum lipid levels may have informed the analyses for the 
association with HF risk but we did adjust for past history of diabetes and hypertension and high 
cholesterol at baseline.   
 The current investigation leverages data from a large multiethnic cohort with a sizable number of 
participants from minority and low-income populations who are traditionally under-represented in 
previous cohorts investigating CVD and HF in particular.  With a large burden of CVD risk factors at 
baseline including obesity, this cohort provides a unique opportunity to investigate dose-response 
between surrogate measures of obesity and HF-related outcomes in a population that is at a particularly 
high risk of adverse CVD outcomes.  The availability of a large sample of participants and HF cases 
afforded the opportunity to adequately explore flexible dose-response patterns across racial categories. 
 In this low-income biracial cohort, empirically-derived weight-height indices (utilized as a 
surrogate of general obesity) offered a better model fit when investigating the association with incident 
HF and post-HF mortality compared to the default index – BMI.  However, weight appears to be the more 
predominant component of the composite weight-height index (W/Hn) hence small changes in n – the 
exponent of the height variable – based on information provided by the outcome data may have modest 
effects on model fit statistics and predictions but do not change summary effect estimates and dose-
response curves.  More importantly, there were unique nonlinear dose-response patterns observed 
between BMI and both HF risk and post-HF mortality that could potentially inform current clinical 
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guidelines or add to the knowledge base required to improve the existing recommendations regarding risk 
stratification and the holistic management of the nutritional status and energy balance of persons with HF.  
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Appendix  
Appendix 1 shows a DAG for the association between weight-height index (as a surrogate for total body 
fat) and HF risk  
Appendix 2 – 5: Causal diagrams showing the hypothesized association between clusters of variables 
representing anthropometric, socioeconomic, neighborhood, lifestyle & cardio-metabolic factors, CVD 
and incident HF (and post-HF survival).
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Appendix 1: Directed acyclic graph showing the hypothesized relationships between anthropometric, socioeconomic, lifestyle, 
cardiometabolic factors and Incident HF. 
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Appendix 2: Causal Diagram showing a summarized version of the hypothesized association between clusters of anthropometric, 
socioeconomic, lifestyle & cardiometabolic factors, CVD and Incident HF 
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Appendix 3: Causal Diagram showing a summarized version of the hypothesized association between clusters of anthropometric, 
socioeconomic, lifestyle & cardiometabolic factors, CVD and Post-HF Survival 
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Appendix 4: Causal Diagram showing a summarized version of the hypothesized association between clusters of anthropometric, 
socioeconomic, lifestyle & cardiometabolic factors, CVD and Incident HF (or post-HF survival) 
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Appendix 5: Causal Diagram showing a summarized version of the hypothesized association between clusters of neighborhood, 
socioeconomic, lifestyle & cardiometabolic factors, CVD and Incident HF (or post-HF survival). 
 
